
<html lang="en"     class="pb-page"  data-request-id="3a85cf9b-ec9a-492b-9855-2bb52f589257"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2012.55.issue-22;wgroup:string:ACHS website Group;website:website:acspubs;article:article:10.1021/jm3005306;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Orally Active Metabotropic Glutamate Subtype 2 Receptor Positive Allosteric Modulators: Structure–Activity Relationships and Assessment in a Rat Model of Nicotine Dependence" /></meta><meta name="dc.Creator" content="Shyama  Sidique" /></meta><meta name="dc.Creator" content="Raveendra-Panickar  Dhanya" /></meta><meta name="dc.Creator" content="Douglas J.  Sheffler" /></meta><meta name="dc.Creator" content="Hilary Highfield  Nickols" /></meta><meta name="dc.Creator" content="Li  Yang" /></meta><meta name="dc.Creator" content="Russell  Dahl" /></meta><meta name="dc.Creator" content="Arianna  Mangravita-Novo" /></meta><meta name="dc.Creator" content="Layton H.  Smith" /></meta><meta name="dc.Creator" content="Manoranjan S.  D’Souza" /></meta><meta name="dc.Creator" content="Svetlana  Semenova" /></meta><meta name="dc.Creator" content="P. Jeffrey  Conn" /></meta><meta name="dc.Creator" content="Athina  Markou" /></meta><meta name="dc.Creator" content="Nicholas D. P.  Cosford" /></meta><meta name="dc.Description" content="Compounds that modulate metabotropic glutamate subtype 2 (mGlu2) receptors have the potential to treat several disorders of the central nervous system (CNS) including drug dependence. Herein we des..." /></meta><meta name="Description" content="Compounds that modulate metabotropic glutamate subtype 2 (mGlu2) receptors have the potential to treat several disorders of the central nervous system (CNS) including drug dependence. Herein we des..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="October 23, 2012" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm3005306" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2012 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm3005306" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm3005306" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm3005306" /></link>
        
    
    

<title>Orally Active Metabotropic Glutamate Subtype 2 Receptor Positive Allosteric Modulators: Structure–Activity Relationships and Assessment in a Rat Model of Nicotine Dependence | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm3005306" /></meta><meta property="og:title" content="Orally Active Metabotropic Glutamate Subtype 2 Receptor Positive Allosteric Modulators: Structure–Activity Relationships and Assessment in a Rat Model of Nicotine Dependence" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3005306/production/images/large/jm-2012-005306_0015.jpeg" /></meta><meta property="og:description" content="Compounds that modulate metabotropic glutamate subtype 2 (mGlu2) receptors have the potential to treat several disorders of the central nervous system (CNS) including drug dependence. Herein we describe the synthesis and structure–activity relationship (SAR) studies around a series of mGlu2 receptor positive allosteric modulators (PAMs). The effects of N-substitution (R1) and substitutions on the aryl ring (R2) were identified as key areas for SAR exploration (Figure 3). Investigation of the effects of varying substituents in both the isoindolinone (2) and benzisothiazolone (3) series led to compounds with improved in vitro potency and/or efficacy. In addition, several analogues exhibited promising pharmacokinetic (PK) properties. Furthermore, compound 2 was shown to dose-dependently decrease nicotine self-administration in rats following oral administration. Our data, showing for the first time efficacy of an mGlu2 receptor PAM in this in vivo model, suggest potential utility for the treatment of nicotine dependence in humans." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm3005306"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm3005306">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm3005306&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm3005306&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm3005306&amp;href=/doi/10.1021/jm3005306" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2012</span><span class="cit-fg-volume">, 55</span><span class="cit-fg-issue">, 22</span><span class="cit-fg-pageRange">, 9434-9445</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/55/22" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm301020q" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm300573d" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Orally Active Metabotropic Glutamate Subtype 2 Receptor Positive Allosteric Modulators: Structure–Activity Relationships and Assessment in a Rat Model of Nicotine Dependence</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Shyama++Sidique">Shyama Sidique</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Raveendra-Panickar++Dhanya">Raveendra-Panickar Dhanya</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Douglas+J.++Sheffler">Douglas J. Sheffler</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hilary+Highfield++Nickols">Hilary Highfield Nickols</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Li++Yang">Li Yang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Russell++Dahl">Russell Dahl</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Arianna++Mangravita-Novo">Arianna Mangravita-Novo</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Layton+H.++Smith">Layton H. Smith</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Manoranjan+S.++D%E2%80%99Souza">Manoranjan S. D’Souza</a></span><span class="author-xref-symbol author-aff-symbol"><sup>□</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Svetlana++Semenova">Svetlana Semenova</a></span><span class="author-xref-symbol author-aff-symbol"><sup>□</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=P.+Jeffrey++Conn">P. Jeffrey Conn</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Athina++Markou">Athina Markou</a></span><span class="author-xref-symbol author-aff-symbol"><sup>□</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nicholas+D.+P.++Cosford">Nicholas D. P. Cosford</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text"><sup>‡</sup>Apoptosis and Cell Death Research Program and <sup>§</sup>Conrad Prebys Center for Chemical Genomics, Sanford-Burnham Medical Research Institute, 10901 N. Torrey Pines Road, La Jolla, California 92037, United States, Departments of <sup>∥</sup>Pharmacology, <sup>⊥</sup>Pathology, Microbiology and Immunology, and <sup>#</sup>Vanderbilt Center for Neuroscience Drug Discovery, Vanderbilt University Medical Center, Nashville, Tennessee 37232, United States, and <sup>□</sup>Department of Psychiatry, School of Medicine, University of California San Diego, La Jolla, California 92093, United States</span></div><div class="corresp-info"><strong>*</strong>Tel: 858-646-3100. Fax: 858-795-5225. E-mail: <a href="/cdn-cgi/l/email-protection#3d535e524e5b524f597d4e5c535b524f595f484f53555c5013524f5a"><span class="__cf_email__" data-cfemail="432d202c30252c31270330222d252c31272136312d2b222e6d2c3124">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm3005306&amp;href=/doi/10.1021%2Fjm3005306" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2012</span></span><span class="cit-volume">, 55</span><span class="cit-issue">, 22</span><span class="cit-pageRange">, 9434–9445</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">September 25, 2012</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>14 April 2012</li><li><span class="item_label"><b>Published</b> online</span>23 October 2012</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 26 November 2012</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm3005306" title="DOI URL">https://doi.org/10.1021/jm3005306</a></div><div class="article_header-article-copyright"><strong>Copyright © 2012 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D9434%26pageCount%3D12%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DShyama%2BSidique%252C%2BRaveendra-Panickar%2BDhanya%252C%2BDouglas%2BJ.%2BSheffler%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D55%26issueNum%3D22%26contentID%3Djm3005306%26title%3DOrally%2BActive%2BMetabotropic%2BGlutamate%2BSubtype%2B2%2BReceptor%2BPositive%2BAllosteric%2BModulators%253A%2BStructure%25E2%2580%2593Activity%2BRelationships%2Band%2BAssessment%2Bin%2Ba%2BRat%2BModel%2Bof%2BNicotine%2BDependence%26numPages%3D12%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D9445%26publicationDate%3DNovember%2B2012">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm3005306"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1593</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">21</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm3005306" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Orally Active Metabotropic Glutamate Subtype 2 Receptor Positive Allosteric Modulators: Structure–Activity Relationships and Assessment in a Rat Model of Nicotine Dependence&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Shyama&quot;,&quot;last_name&quot;:&quot;Sidique&quot;},{&quot;first_name&quot;:&quot;Raveendra-Panickar&quot;,&quot;last_name&quot;:&quot;Dhanya&quot;},{&quot;first_name&quot;:&quot;Douglas&quot;,&quot;last_name&quot;:&quot;J. Sheffler&quot;},{&quot;first_name&quot;:&quot;Hilary&quot;,&quot;last_name&quot;:&quot;Highfield Nickols&quot;},{&quot;first_name&quot;:&quot;Li&quot;,&quot;last_name&quot;:&quot;Yang&quot;},{&quot;first_name&quot;:&quot;Russell&quot;,&quot;last_name&quot;:&quot;Dahl&quot;},{&quot;first_name&quot;:&quot;Arianna&quot;,&quot;last_name&quot;:&quot;Mangravita-Novo&quot;},{&quot;first_name&quot;:&quot;Layton&quot;,&quot;last_name&quot;:&quot;H. Smith&quot;},{&quot;first_name&quot;:&quot;Manoranjan&quot;,&quot;last_name&quot;:&quot;S. D’Souza&quot;},{&quot;first_name&quot;:&quot;Svetlana&quot;,&quot;last_name&quot;:&quot;Semenova&quot;},{&quot;first_name&quot;:&quot;P.&quot;,&quot;last_name&quot;:&quot;Jeffrey Conn&quot;},{&quot;first_name&quot;:&quot;Athina&quot;,&quot;last_name&quot;:&quot;Markou&quot;},{&quot;first_name&quot;:&quot;Nicholas&quot;,&quot;last_name&quot;:&quot;D. P. Cosford&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2012&quot;,&quot;month&quot;:&quot;10&quot;,&quot;day&quot;:&quot;23&quot;,&quot;issue&quot;:&quot;22&quot;,&quot;volume&quot;:&quot;55&quot;,&quot;pages&quot;:&quot;9434-9445&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm3005306&quot;},&quot;abstract&quot;:&quot;Compounds that modulate metabotropic glutamate subtype 2 (mGlu2) receptors have the potential to treat several disorders of the central nervous system (CNS) including drug dependence. Herein we describe the synthesis and structure–activity relationship (SAR) studies around a series of mGlu2 receptor positive allosteric modulators (PAMs). The effects of N-substitution (R1) and substitutions on the aryl ring (R2) were identified as key areas for SAR exploration (Figure 3). Investigation of the effects of varying substituents in both the isoindolinone (2) and benzisothiazolone (3) series led to compounds with improved in vitro potency and/or efficacy. In addition, several analogues exhibited promising pharmacokinetic (PK) properties. Furthermore, compound 2 was shown to dose-dependently decrease nicotine self-administration in rats following oral administration. Our data, showing for the first time efficacy of an mGlu2 receptor PAM in this in vivo model, suggest potential utility for the treatment of nicotine de&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm3005306&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm3005306" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm3005306&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm3005306" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm3005306&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm3005306" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm3005306&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm3005306&amp;href=/doi/10.1021/jm3005306" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm3005306" /></input><a href="/doi/pdf/10.1021/jm3005306" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (788 KB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm3005306&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm3005306%26sid%3Dliteratum%253Aachs%26pmid%3D23009245%26genre%3Darticle%26aulast%3DSidique%26date%3D2012%26atitle%3DOrally%2BActive%2BMetabotropic%2BGlutamate%2BSubtype%2B2%2BReceptor%2BPositive%2BAllosteric%2BModulators%253A%2BStructure%25E2%2580%2593Activity%2BRelationships%2Band%2BAssessment%2Bin%2Ba%2BRat%2BModel%2Bof%2BNicotine%2BDependence%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D55%26issue%3D22%26spage%3D9434%26epage%3D9445%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291713" title="Polyacrylamide">Polyacrylamide</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=291184" title="Nicotine">Nicotine</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/55/22" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jmcmar.2012.55.issue-22/production/jmcmar.2012.55.issue-22.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3005306/production/images/medium/jm-2012-005306_0015.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3005306/production/images/large/jm-2012-005306_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3005306&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Compounds that modulate metabotropic glutamate subtype 2 (mGlu<sub>2</sub>) receptors have the potential to treat several disorders of the central nervous system (CNS) including drug dependence. Herein we describe the synthesis and structure–activity relationship (SAR) studies around a series of mGlu<sub>2</sub> receptor positive allosteric modulators (PAMs). The effects of N-substitution (R<sup>1</sup>) and substitutions on the aryl ring (R<sup>2</sup>) were identified as key areas for SAR exploration (Figure 3). Investigation of the effects of varying substituents in both the isoindolinone (<b>2</b>) and benzisothiazolone (<b>3</b>) series led to compounds with improved in vitro potency and/or efficacy. In addition, several analogues exhibited promising pharmacokinetic (PK) properties. Furthermore, compound <b>2</b> was shown to dose-dependently decrease nicotine self-administration in rats following oral administration. Our data, showing for the first time efficacy of an mGlu<sub>2</sub> receptor PAM in this in vivo model, suggest potential utility for the treatment of nicotine dependence in humans.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div class="extra-info-sec articleNote"><h4><span>†</span> Author Contributions</h4><p class="last">These authors contributed equally to this work.</p></div><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_08262" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_08262" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Tobacco smoking causes significant preventable morbidity and mortality throughout the world.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1, 2)</a> Unfortunately, smoking cessation medications currently approved by the Food and Drug Administration (FDA) are not effective in the majority of tobacco smokers who attempt to quit.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Thus, there is a need to develop medications with novel mechanisms of action for smoking cessation. Nicotine is one of the major psychoactive components of tobacco that is considered to contribute to the initiation and maintenance of the tobacco smoking habit.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Thus, a compound that attenuates the reinforcing effects of nicotine may be effective as a smoking cessation medication.</div><div class="NLM_p">The excitatory neurotransmitter glutamate plays a critical role in mediating the reinforcing effects of nicotine.<a onclick="showRef(event, 'ref5 ref6 ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref5 ref6 ref7 ref8">(5-8)</a> Nicotine increases glutamatergic neurotransmission by activating excitatory nicotinic acetylcholine (nACh) receptors located on presynaptic glutamatergic terminals. Therefore, a drug which indirectly blocks the effects of nicotine by antagonizing nicotine-induced increases in glutamate release may be as effective as a more direct acting agent such as bupropion. Glutamatergic neurotransmission is negatively regulated by Group II metabotropic glutamate (mGlu) receptors consisting of the mGlu<sub>2</sub> and mGlu<sub>3</sub> receptor subtypes.<a onclick="showRef(event, 'ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref9 ref10">(9, 10)</a>The mGlu<sub>2</sub> and mGlu<sub>3</sub> receptors perform a modulatory role during synaptic transmission by coupling to G<sub>i/o</sub> proteins that negatively regulate the activity of adenylyl cyclase.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> There is ample evidence demonstrating that repeated exposure to cocaine or nicotine alters mGlu<sub>2</sub> receptor function.<a onclick="showRef(event, 'ref12 ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref12 ref13 ref14">(12-14)</a> Conversely, we have reported previously that the reinforcing effects of nicotine were attenuated by LY379268, a competitive agonist that binds to both the mGlu<sub>2</sub> and mGlu<sub>3</sub> receptor subtypes.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> In the same study, however, LY379268 also attenuated responding to a natural reward, food, indicating a lack of selectivity of the effects of this compound for nicotine-maintained behaviors. One possible reason for this lack of selectivity may relate to the site of action of LY379268, specifically the orthosteric (glutamate) binding site of mGlu<sub>2/3</sub> receptors. Compounds acting at the orthosteric site, such as LY379268, lack selectivity for mGlu<sub>2</sub> vs mGlu<sub>3</sub> receptors, presumably due to the high degree of sequence homology at the glutamate binding site.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Alternatively, mGlu<sub>2</sub> receptor selectivity may be achieved by targeting less conserved allosteric sites on the receptor. Thus, a mGlu<sub>2</sub> receptor-selective positive allosteric modulator (PAM), such as the prototypical compound 3′-((2-cyclopentyl-6,7-dimethyl-1-oxo-2,3-dihydro-1<i>H</i>-inden-5-yloxy)methyl)biphenyl-4-carboxylic acid (BINA, <b>1</b>), can noncompetitively potentiate the function of glutamate at mGlu<sub>2</sub> receptors.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3005306/production/images/medium/jm-2012-005306_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3005306/production/images/large/jm-2012-005306_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of recently reported mGlu<sub>2</sub> receptor PAMs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3005306/production/images/large/jm-2012-005306_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3005306&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Several pharmaceutical companies have investigated mGlu<sub>2</sub> receptor PAMs for the potential treatment of schizophrenia or anxiety (comprehensively reviewed in ref <a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">16</a>). For example, scientists at Lilly,<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> Merck,<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Pfizer,<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> and Janssen<a onclick="showRef(event, 'ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref20 ref21">(20, 21)</a> have recently disclosed their work on the discovery and optimization of mGlu<sub>2</sub> receptor PAMs (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>). We have reported our initial studies on the design, synthesis, and preliminary structure–activity relationships (SAR) around a series of mGlu<sub>2</sub> receptor PAMs that are systemically active following oral dosing in rats.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Our studies were prompted by the fact that while compound <b>1</b> is selective and brain penetrant following ip dosing, it lacks potency for mGlu2 receptors both in vitro and in vivo and has suboptimal pharmacokinetic (PK) properties. In the previous disclosure we described various modifications of the indanone ring of <b>1</b> including the incorporation of heteroatoms and expansion of the fused five-membered ring to a fused six-membered ring. In addition, it was found that the methyl substituents at positions 6 and 7 of the indanone moiety in compound <b>1</b> were not necessary for activity in the new series. Furthermore, compounds in the isoindolinone (<b>2</b>) and benzisothiazolone (<b>3</b>) series (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>) provided analogues with improved properties compared with BINA, including excellent brain levels after oral dosing in rats. In the present study, we investigated the effects on potency, efficacy, and druglike properties of different N-substituents (R<sup>1</sup>) in the benzisothiazolone series, and the effects of modifying the aryl substituents (R<sup>2</sup>) in the isoindolinone series (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). Our previous studies demonstrated that compounds <b>1</b><a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> and <b>3</b><a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>), unlike mGlu<sub>2/3</sub> receptor orthosteric agonists, decreased cocaine self-administration in rats at doses that did not affect responding for food.<a onclick="showRef(event, 'ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref22 ref23">(22, 23)</a> Herein, we report further investigations into the SAR around this series of compounds and the identification of additional potent mGlu<sub>2</sub> receptor PAMs with druglike properties. Importantly, in the present study we report for the first time the effects of an mGlu<sub>2</sub> receptor PAM in rats self-administering nicotine.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3005306/production/images/medium/jm-2012-005306_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3005306/production/images/large/jm-2012-005306_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structures of our mGlu<sub>2</sub> receptor PAMs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3005306/production/images/large/jm-2012-005306_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3005306&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3005306/production/images/medium/jm-2012-005306_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3005306/production/images/large/jm-2012-005306_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Areas of SAR investigation in the present study.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3005306/production/images/large/jm-2012-005306_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3005306&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div id="sec1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Chemistry</h3><div class="NLM_p">The synthesis of benzisothiazolone analogues <b>3a</b>-<b>f</b> is illustrated in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>. Methyl 4-methoxythiosalicylate <b>4</b> was converted to an amide derivative <b>5</b> by treatment with the corresponding amine in the presence of trimethylaluminum. Cyclization to access the benzisothiazol-3-one derivative <b>6</b>was accomplished by a PIFA-mediated in situ formation of an <i>N</i>-acylnitrenium ion and its intramolecular trapping by the thiol moiety. Demethylation of <b>6</b> was achieved with BBr<sub>3</sub> in hot benzene to afford intermediate <b>7</b>. O-Alkylation of <b>7</b> with methyl 3′-(bromomethyl)-4-chlorobiphenyl-3-carboxylate (<b>8</b>) gave compound <b>9</b> which was saponified with lithium iodide to provide the target carboxylic acid derivatives <b>3a</b>–<b>f</b>.</div><figure id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3005306/production/images/medium/jm-2012-005306_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3005306/production/images/large/jm-2012-005306_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of 3-Chloro-3′-((2-cyclopentyl-3-oxo-2,3-dihydrobenzo[<i>d</i>]isothiazol-6-yloxy)methyl)biphenyl-4-carboxylic Acid Derivatives <b>3a</b>–<b>f</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3005306/production/images/large/jm-2012-005306_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3005306&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) AlMe<sub>3</sub>, R<sup>1</sup>NH<sub>2</sub>, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C to 60 °C, 12 h; (b) PIFA, TFA, 0 °C, CH<sub>2</sub>Cl<sub>2</sub>, 1 h; (c) (i) BBr<sub>3</sub>, C<sub>6</sub>H<sub>6</sub>, 80 °C, 1 h; (ii) H<sub>2</sub>O, 100 °C, 1 h; (d) ArCH<sub>2</sub>Br, K<sub>2</sub>CO<sub>3</sub>, MeCN, 80 °C, 12 h; (e) LiI, pyridine, 110 °C, 12 h.</p></p></figure><div class="NLM_p">To access analogues in which various aryl substituents (R<sup>2</sup>, Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>) could be incorporated into the structure, we developedthe synthetic route shown in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>. Thus, reaction of 3-(bromomethyl)phenylboronic acid (<b>12</b>) with either <b>10</b> or <b>11</b> provided the key intermediates <b>13</b> and <b>14</b>, respectively. Compounds <b>13</b> and <b>14</b> were then subjected to Suzuki cross-coupling conditions with substituted aryl halides to yield the corresponding isoindolinone derivatives <b>15a</b>–<b>k</b> and benzoisothiazolone analogue <b>16a</b>.</div><figure id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3005306/production/images/medium/jm-2012-005306_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3005306/production/images/large/jm-2012-005306_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. General Synthetic Scheme for the Synthesis of Isoindolinones <b>15a</b>–<b>k</b> and Benzoisothiazolone Analogue <b>16a</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3005306/production/images/large/jm-2012-005306_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3005306&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) K<sub>2</sub>CO<sub>3</sub>, acetone, reflux; (b) when Y = CH<sub>2</sub>; RX, PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, toluene/MeOH, 80 °C or when Y = S; RX, Pd (PPh<sub>3</sub>)<sub>4</sub>, DME, 80 °C, 12 h.</p></p></figure><div class="NLM_p">An alternative synthetic route was employed for the synthesis of benzisothiazolone derivatives <b>16b</b> and <b>16c</b> which is shown in Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>. Thus, benzothiazolone derivative <b>11</b> was reacted with 1-bromo-3-(bromomethyl)benzene (<b>17</b>) to provide the corresponding ether derivative <b>18</b>. Intermediate <b>18</b> was then subjected to Suzuki cross-coupling conditions with the appropriate arylboronic acid derivatives to provide the target compounds <b>16b</b> and <b>16c</b>.</div><figure id="sch3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3005306/production/images/medium/jm-2012-005306_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3005306/production/images/large/jm-2012-005306_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Benzisothiazolone Derivatives <b>16b</b> and <b>16c</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3005306/production/images/large/jm-2012-005306_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3005306&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) K<sub>2</sub>CO<sub>3</sub>, CH<sub>3</sub>CN, 80 °C, 1 h; (b) RB(OH)<sub>2</sub>, Pd (PPh<sub>3</sub>)<sub>4</sub>, DME, 80 °C, 12 h.</p></p></figure><div class="NLM_p">In the benzothiazolone series, compound <b>3</b> was converted to the dimethylamide derivative <b>19</b> as shown in Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>. In addition, in the isoindolinone series the importance of the ether linker was investigated by preparing the analogue containing a triaryl moiety (<b>24</b>) (Scheme <a class="ref internalNav" href="#sch5" aria-label="5">5</a>). The synthesis began with commercially available 4-bromo-2-methylbenzoic acid (<b>20</b>), which was esterified to provide <b>21</b>, brominated at the benzylic position to provide <b>22</b>, and converted to 5-bromo-2-cyclopentylisoindolin-1-one (<b>23</b>) using a previously described procedure.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Finally, two consecutive Suzuki couplings yielded 4-chloro-3′-(2-cyclopentyl-1-oxoisoindolin-5-yl)biphenyl-3-carboxylic acid <b>24</b>.</div><figure id="sch4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3005306/production/images/medium/jm-2012-005306_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3005306/production/images/large/jm-2012-005306_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Amide Analogue  <b>19</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3005306/production/images/large/jm-2012-005306_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3005306&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) HOBt, EDC·HCl, Me<sub>2</sub>NH·HCl, Et<sub>3</sub>N, DMF, rt, 3 h.</p></p></figure><figure id="sch5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3005306/production/images/medium/jm-2012-005306_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3005306/production/images/large/jm-2012-005306_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of Isoindolinone Analogue <b>24</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3005306/production/images/large/jm-2012-005306_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3005306&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) MeOH, cat. H<sub>2</sub>SO<sub>4</sub>, reflux, 12 h; (b) NBS, cat. AIBN, CCl<sub>4</sub>, 68 °C, 12 h; (c) C<sub>5</sub>H<sub>9</sub>NH<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, CH<sub>3</sub>CN, reflux, 12 h; (d) (i) 3-bromophenylboronic acid, Pd(PPh<sub>3</sub>)<sub>4</sub>, 2 M Na<sub>2</sub>CO<sub>3</sub>, DME, reflux, 1 h; (ii) 5-borono-2-chlorobenzoic acid, Pd(PPh<sub>3</sub>)<sub>4</sub>, 2 M Na<sub>2</sub>CO<sub>3</sub>, DME, reflux, 2 h.</p></p></figure></div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_17663" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_17663" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The new analogues <b>3a</b>–<b>f</b>,<b> 15a</b>–<b>k</b>, <b>16a</b>–<b>c</b>,<b> 19</b>, and <b>24</b> were tested to determine in vitro activity, and the data are summarized in Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> and <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>. A thallium flux assay was performed in HEK-GIRK cells<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> expressing rat mGlu<sub>2</sub> receptors to determine potency and efficacy at the target receptors. The concentration–response relationship that potentiates the effect of an EC<sub>20</sub> concentration of glutamate was determined for each of the mGlu<sub>2</sub> receptor PAMs, and the potency is expressed as an EC<sub>50</sub> value. Efficacy for the potentiation of an EC<sub>20</sub> concentration of glutamate is presented as a percentage of the maximal glutamate response. Also shown in Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> and <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a> are in vitro absorption, distribution, metabolism, and excretion (ADME) data for the analogues. We determined the stability of compounds in vitro in rat plasma and rat liver microsomes, in addition to membrane permeability using a parallel artificial membrane assay (PAMPA) to aid in predicting their in vivo pharmacological profiles. Compounds with a permeability value (log <i>P</i><sub>e</sub>) of around −5.5 in the CNS PAMPA assay are likely to be brain penetrant.</div><div class="NLM_p">Analysis of the data in Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> and <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a> showed that in the benzisothiazolone series, variation of R<sup>1</sup> did not significantly improve potency compared with <b>3</b> (compounds <b>3a</b>–<b>f</b>, Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>); however, <b>3e</b> was slightly more potent and efficacious than <b>3</b> and had improved rat plasma and rat microsomal stability. In the isoindolinone series (compounds <b>15a</b>–<b>f</b>, Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>), introduction of methoxy or hydroxyl substituents into the R<sup>2</sup> benzoic acid moiety led to compounds with excellent potency and efficacy (<b>15a</b>–<b>c</b>). For example, replacement of the chloro substituent in compound <b>2</b> with a hydroxyl group, as in <b>15b</b>, resulted in improved mGlu<sub>2</sub> potency but with loss of microsomal stability (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). Introduction of halide or methyl substituents into the R<sup>2</sup> benzoic acid moiety (as in <b>15d</b>–<b>g</b>) provided analogues with good potency (100 nM range for EC<sub>50</sub>) and efficacy. In the benzothiazolone series, introduction of substituents into the R<sup>2</sup> benzoic acid moiety (as in <b>16a</b>–<b>c</b>) did not lead to a significant potency enhancement. Furthermore, conversion of the carboxylic acid moiety in <b>3</b> to the dimethylamide derivative (<b>19</b>) led to a 6-fold potency reduction. Isoindolinone analogues lacking the carboxylic acid moiety in R<sup>2</sup> (<b>15i</b>–<b>k</b>) were essentially inactive in vitro, demonstrating the importance of the carboxylic acid moiety in R<sup>2</sup> in this series. Finally, replacement of the oxymethylene bridge between the oxoisoindoline and biphenyl moieties of compound <b>2</b> with a single bond provided compound <b>24</b> with a 3-fold improvement in mGlu<sub>2</sub> potency and excellent plasma and microsomal stability in vitro.</div><div class="NLM_p">As shown in Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> and <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>, several of the new analogues displayed superior druglike properties compared with <b>1</b>, suggesting that these improvements may translate to in vivo efficacy. Compounds <b>3e</b>, <b>15a</b>, and <b>24</b> were selected for profiling against other mGlu receptor subtypes to determine the relative selectivity for mGlu<sub>2</sub> receptors (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). Overall the compounds were found to be highly selective for mGlu<sub>2</sub> receptors vs other subtypes. Thus, in general compounds <b>3e</b>, <b>15a</b> and <b>24</b> were >200-, >300-, and >1000-fold selective respectively for mGlu<sub>2</sub> compared with other mGlu receptor subtypes. The exceptions were compound <b>15a</b>, which exhibited weak PAM activity against mGlu<sub>3</sub>, and compound <b>24</b>, which exhibited weak PAM activity against mGlu<sub>7</sub>. As representatives of the respective series, compounds <b>2</b> and <b>3</b> were also profiled in binding assays against a comprehensive panel of CNS receptors through the NIMH Psychoactive Drug Screening Program (PDSP; see http://pdsp.med.unc.edu/indexR.html for details) and additional targets at Ricerca Biosciences. As shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>, at a concentration of 10 μM, overall neither <b>2</b> nor <b>3</b> exhibited significant activity against the majority of the targets. Compound <b>2</b> exhibited >50% activity at α<sub>1A</sub>, α<sub>1D</sub>, and H<sub>1</sub> receptors and the cytochrome P450 isozyme (CYP) 2C9. Testing in dose–response mode provided the following IC<sub>50</sub> values for compound <b>2</b>: α<sub>1A</sub> = 8.15 μM; α<sub>1D</sub> > 10 μM; H<sub>1</sub> = 8.15 μM; CYP 2C9 = 8.2 μM. On the other hand, compound <b>3</b> had a single significant interaction at rat brain benzodiazepine receptors (IC<sub>50</sub> = 2.35 μM) but at 10 μM inhibited all the CYPs tested except for CYP 2D6. Dose–response testing yielded the following IC<sub>50</sub> values for compound <b>3</b> in the CYP panel: 1A2 = 6.2 μM; 2C9 = 4.0 μM; 3A4 > 25 μM.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. In Vitro Data for Benzothiazolone mGlu<sub>2</sub> Receptor PAMs: Variation of R<sup>1</sup></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3005306/production/images/medium/jm-2012-005306_0010.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3005306/production/images/medium/jm-2012-005306_0011.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">mGlu<sub>2</sub> receptor PAM EC<sub>50</sub> (μM) data and % glutamate max data represent the mean ± SEM for at least three independent experiments performed in triplicate.</p></div><div class="footnote" id="t1fn2"><sup>Table b</sup><p class="last">Permeability is monitored by measuring the amount of compound that can diffuse through a polar brain lipid membrane to predict BBB permeability.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a></p></div><div class="footnote" id="t1fn3"><sup>Table c</sup><p class="last">Percent remaining after incubation for 60 min at 37 °C. NT = not tested.</p></div><div class="footnote" id="t1fn4"><sup>Table d</sup><p class="last">Species = rat.</p></div></div><div></div></div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. In Vitro Data for mGlu<sub>2</sub> Receptor PAMs</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3005306/production/images/medium/jm-2012-005306_0012.gif" alt="" id="fx3" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3005306/production/images/medium/jm-2012-005306_0013.gif" alt="" id="fx4" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>Table a</sup><p class="last">mGlu<sub>2</sub> receptor PAM EC<sub>50</sub> μM data and % glutamate max data represent the mean ± SEM for at least three independent experiments performed in triplicate.</p></div><div class="footnote" id="t2fn2"><sup>Table b</sup><p class="last">Permeability is monitored by measuring the amount of compound that can diffuse through a polar brain lipid membrane to predict BBB permeability.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a></p></div><div class="footnote" id="t2fn3"><sup>Table c</sup><p class="last">Percent remaining after incubation for 60 min at 37 °C. NT = not tested. ND = not determined.</p></div><div class="footnote" id="t2fn4"><sup>Table d</sup><p class="last">Species = rat.</p></div></div><div></div></div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. mGlu Receptor Subtype Selectivity<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">mGlu receptor subtype</th><th class="colsep0 rowsep0" align="center">compd <b>3e</b>(EC<sub>50</sub> μM)</th><th class="colsep0 rowsep0" align="center">compd <b>15a</b>(EC<sub>50</sub> μM)</th><th class="colsep0 rowsep0" align="center">compd <b>24</b>(EC<sub>50</sub> μM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">mGlu<sub>1</sub></td><td class="colsep0 rowsep0" align="left">>30</td><td class="colsep0 rowsep0" align="left">>30</td><td class="colsep0 rowsep0" align="left">>30</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">mGlu<sub>3</sub></td><td class="colsep0 rowsep0" align="left">>30</td><td class="colsep0 rowsep0" align="left">PAM</td><td class="colsep0 rowsep0" align="left">>30</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">mGlu<sub>4</sub></td><td class="colsep0 rowsep0" align="left">>30</td><td class="colsep0 rowsep0" align="left">>30</td><td class="colsep0 rowsep0" align="left">>30</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">mGlu<sub>5</sub></td><td class="colsep0 rowsep0" align="left">>30</td><td class="colsep0 rowsep0" align="left">>30</td><td class="colsep0 rowsep0" align="left">>30</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">mGlu<sub>6</sub></td><td class="colsep0 rowsep0" align="left">>30</td><td class="colsep0 rowsep0" align="left">>30</td><td class="colsep0 rowsep0" align="left">>30</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">mGlu<sub>7</sub></td><td class="colsep0 rowsep0" align="left">>30</td><td class="colsep0 rowsep0" align="left">>30</td><td class="colsep0 rowsep0" align="left">PAM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">mGlu<sub>8</sub></td><td class="colsep0 rowsep0" align="left">>30</td><td class="colsep0 rowsep0" align="left">>30</td><td class="colsep0 rowsep0" align="left">>30</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">In these selectivity experiments, for all receptors a full concentration-response of agonist was performed once in triplicate in the presence and absence of a 10 μM final concentration of each compound. Where 10 μM compound caused more than a 2 fold shift of the glutamate concentration–response curve, full concentration–response curves were performed in triplicate on three different days to assess potency of compounds. Compound <b>15a</b> showed weak potentiator activity at mGlu<sub>3</sub>, and compound <b>24</b> showed weak potentiator activity at mGlu<sub>7</sub>.</p></div></div></div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Off-Target Profiling Data for Compounds <b>2</b> and <b>3</b><a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">receptor/target</th><th class="colsep0 rowsep0" align="center">species</th><th class="colsep0 rowsep0" align="center">compd <b>2</b>, % inhibition<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">compd <b>3</b>, % inhibition<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">adrenergic α<sub>1A</sub></td><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="left">65 (8.15 μM)</td><td class="colsep0 rowsep0" align="left">2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">adrenergic α<sub>1B</sub></td><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="left">44</td><td class="colsep0 rowsep0" align="left">8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">adrenergic α<sub>1D</sub></td><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="left">52 (>10 μM)</td><td class="colsep0 rowsep0" align="left">3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">adrenergic α<sub>2A</sub></td><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="left">–1</td><td class="colsep0 rowsep0" align="left">31</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">adrenergic α<sub>2B</sub></td><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="left">22</td><td class="colsep0 rowsep0" align="left">18</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">adrenergic α<sub>2C</sub></td><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="left">24</td><td class="colsep0 rowsep0" align="left">30</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">adrenergic β<sub>1</sub></td><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="left">–2</td><td class="colsep0 rowsep0" align="left">–1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">adrenergic β<sub>2</sub></td><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="left">8</td><td class="colsep0 rowsep0" align="left">4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">adrenergic β<sub>3</sub></td><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="left">21</td><td class="colsep0 rowsep0" align="left">13</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">benzodiazepine (brain, [<sup>3</sup>H]flunitrazepam)</td><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="left">34</td><td class="colsep0 rowsep0" align="left">51 (2.35 μM)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">calcium channel L-type, dihydropyridine<a class="ref internalNav" href="#t4fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="left">–2</td><td class="colsep0 rowsep0" align="left">22</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">cytochrome P450, 1A2<a class="ref internalNav" href="#t4fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="left">14</td><td class="colsep0 rowsep0" align="left">100 (6.2 μM)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">cytochrome P450, 2C9<a class="ref internalNav" href="#t4fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="left">92 (8.2 μM)</td><td class="colsep0 rowsep0" align="left">93 (4.0 μM)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">cytochrome P450, 2D6<a class="ref internalNav" href="#t4fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">42</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">cytochrome P450, 3A4<a class="ref internalNav" href="#t4fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="left">40</td><td class="colsep0 rowsep0" align="left">94 (>25 μM)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">dopamine D<sub>1</sub></td><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="left">32</td><td class="colsep0 rowsep0" align="left">50 (>10 μM)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">dopamine D<sub>2</sub></td><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">dopamine D<sub>3</sub></td><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="left">–9</td><td class="colsep0 rowsep0" align="left">6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">dopamine D<sub>4</sub></td><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">dopamine D<sub>5</sub></td><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="left">15</td><td class="colsep0 rowsep0" align="left">28</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GABA<sub>A</sub>(brain, [<sup>3</sup>H]muscimol)</td><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="left">–14</td><td class="colsep0 rowsep0" align="left">–10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">histamine H<sub>1</sub></td><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="left">59 (8.15 μM)</td><td class="colsep0 rowsep0" align="left">56 (>10 μM)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">histamine H<sub>2</sub></td><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="left">27</td><td class="colsep0 rowsep0" align="left">29</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">histamine H<sub>3</sub></td><td class="colsep0 rowsep0" align="left">guinea pig</td><td class="colsep0 rowsep0" align="left">14</td><td class="colsep0 rowsep0" align="left">–9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">histamine H<sub>4</sub></td><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">muscarinic M<sub>1</sub></td><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">muscarinic M<sub>2</sub></td><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="left">–10</td><td class="colsep0 rowsep0" align="left">20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">muscarinic M<sub>3</sub></td><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="left">–2</td><td class="colsep0 rowsep0" align="left">7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">muscarinic M<sub>4</sub></td><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="left">–7</td><td class="colsep0 rowsep0" align="left">8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">muscarinic M<sub>5</sub></td><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="left">20</td><td class="colsep0 rowsep0" align="left">27</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">opiate δ (OP1, DOP)</td><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="left">37</td><td class="colsep0 rowsep0" align="left">23</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">opiate κ (OP2, KOP)</td><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="left">–23</td><td class="colsep0 rowsep0" align="left">–12</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">opiate μ (OP3, MOP)</td><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="left">41</td><td class="colsep0 rowsep0" align="left">38</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">serotonin (5-hydroxytryptamine) 5-HT<sub>1A</sub></td><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="left">0.1</td><td class="colsep0 rowsep0" align="left">6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">serotonin (5-hydroxytryptamine) 5-HT<sub>1B</sub></td><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="left">–7</td><td class="colsep0 rowsep0" align="left">–3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">serotonin (5-hydroxytryptamine) 5-HT<sub>1D</sub></td><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="left">–9</td><td class="colsep0 rowsep0" align="left">–14</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">serotonin (5-hydroxytryptamine) 5-HT<sub>1E</sub></td><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="left">6</td><td class="colsep0 rowsep0" align="left">–14</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">serotonin (5-hydroxytryptamine) 5-HT<sub>2A</sub></td><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="left">20</td><td class="colsep0 rowsep0" align="left">46</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">serotonin (5-hydroxytryptamine) 5-HT<sub>2B</sub></td><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="left">9</td><td class="colsep0 rowsep0" align="left">0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">serotonin (5-hydroxytryptamine) 5-HT<sub>2C</sub></td><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="left">18</td><td class="colsep0 rowsep0" align="left">–12</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">serotonin (5-hydroxytryptamine) 5-HT<sub>3</sub></td><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">–13</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">serotonin (5-hydroxytryptamine) 5-HT<sub>5A</sub></td><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="left">19</td><td class="colsep0 rowsep0" align="left">7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">serotonin (5-hydroxytryptamine) 5-HT<sub>6</sub></td><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="left">14</td><td class="colsep0 rowsep0" align="left">16</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">serotonin (5-hydroxytryptamine) 5-HT<sub>7</sub></td><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="left">11</td><td class="colsep0 rowsep0" align="left">10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">sigma σ<sub>1</sub></td><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="left">25</td><td class="colsep0 rowsep0" align="left">33</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">sigma σ<sub>2</sub></td><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="left">42</td><td class="colsep0 rowsep0" align="left">–2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">transporter, dopamine (DAT)</td><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="left">40</td><td class="colsep0 rowsep0" align="left">12</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">transporter, norepinephrine (NET)</td><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">–17</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">transporter, serotonin (5-hydroxytryptamine) (SERT)</td><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="left">6</td><td class="colsep0 rowsep0" align="left">8</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">Compounds were tested for displacement of radioligand binding activity at 10 μM. Assays were performed by the NIMH Psychoactive Drug Screening Program (UNC Chapel Hill) unless otherwise noted.</p></div><div class="footnote" id="t4fn2"><sup>b</sup><p class="last">Inhibition at 10 μM as a percentage of displacement of the respective radioligand at each target. IC<sub>50</sub> values where applicable are shown in parentheses.</p></div><div class="footnote" id="t4fn3"><sup>c</sup><p class="last">Assay screen at 10 μM performed by Ricerca Biosciences. Assays to determine IC<sub>50</sub> values were performed by the Sanford-Burnham Exploratory Pharmacology Core.</p></div></div></div><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> In Vivo Pharmacokinetics</h3><div class="NLM_p">On the basis of the overall in vitro profile of the compounds in Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>–<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>, isoindolinone derivatives (<b>2</b>, <b>15a</b>, <b>15b</b>, <b>24</b>) and a benzothiazolone derivative (<b>3e</b>) were selected for an in vivo assessment of their PK properties in rats. To optimize their solubility and improve gastrointestinal absorption, the compounds were converted to the corresponding sodium salts for the PK studies. The rat PK data for compounds <b>2</b>, <b>3e</b>, <b>15a, 15b</b>, and <b>24</b> are shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>(oral dosing) and Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a> (intravenous or intraperitoneal dosing). All compounds were found to be systemically bioavailable with a long half-life (<i>t</i><sub>1/2</sub>) when dosed orally (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). For example, compounds <b>2</b>, <b>3e</b>, <b>15a</b>, and <b>15b</b> exhibited micromolar plasma levels when dosed orally. Overall the PK data for compound <b>24</b>were inferior, with low <i>C</i><sub>max</sub> and AUC values, suggesting that this compound would be a poor choice for further studies. In addition, compound <b>15a</b> had high clearance (<i>C</i><sub>L</sub>) and volume of distribution (<i>V</i><sub>d</sub>) values, indicating rapid metabolism coupled with sequestration into other compartments (e.g., fatty tissue). On the other hand, compounds <b>2</b>,<b> 3e</b>, and <b>15b</b> had low <i>V</i><sub>d</sub> and <i>C</i><sub>L</sub> (<b>2</b> and <b>15b</b>) values, suggesting that these compounds might be promising candidates for in vivo studies. Furthermore, compounds <b>2</b>, <b>15a</b>, and <b>15b</b> possessed excellent oral bioavailability (%F). Consequently, brain levels were determined for compounds <b>2</b>, <b>3e</b>, <b>15a</b>, and <b>15b</b> following a 10 mg/kg oral dose and the brain concentrations were compared to the in vitro mGlu<sub>2</sub> PAM EC<sub>90</sub> values for each compound (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). These data revealed that only compound <b>2</b> achieved brain levels (236 nM at 10 mg/kg po) consistent with its mGlu<sub>2</sub> PAM EC<sub>90</sub> value (237 nM), suggesting that at this oral dose or above, the majority of the target receptors would be activated in the brain. Taking all the relevant data into account, compound <b>2</b> was therefore selected for behavioral studies in rats.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. In Vivo PK Data for mGlu<sub>2</sub> Receptor PAMs (as sodium salts) after Oral Administrationin Rats<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="left" /></col><col align="char" char="." /></col><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char="±"><i>C</i><sub>max</sub> (μM)</th><th class="colsep0 rowsep0" align="center"><i>T</i><sub>max</sub> (min)</th><th class="colsep0 rowsep0" align="center" char="."><i>V</i><sub>d</sub> (mL)</th><th class="colsep0 rowsep0" align="center">AUC (0–<i>t</i>) (μmol·min/mL)</th><th class="colsep0 rowsep0" align="center"><i>t</i><sub>1/2</sub> (h)</th><th class="colsep0 rowsep0" align="center">F (%)</th><th class="colsep0 rowsep0" align="center">mGlu<sub>2</sub> PAM EC<sub>90 (</sub>μM)</th><th class="colsep0 rowsep0" align="center">brain<a class="ref internalNav" href="#t5fn2" aria-label="b">b</a> (μM)</th><th class="colsep0 rowsep0" align="center">plasma<a class="ref internalNav" href="#t5fn2" aria-label="b">b</a> (μM)</th><th class="colsep0 rowsep0" align="center">brain:plasma ratio</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b><a class="ref internalNav" href="#t5fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="char" char="±">3 ± 0.1</td><td class="colsep0 rowsep0" align="left">120</td><td class="colsep0 rowsep0" align="char" char=".">3.0</td><td class="colsep0 rowsep0">2552</td><td class="colsep0 rowsep0">7</td><td class="colsep0 rowsep0">71.4 ± 2.3</td><td class="colsep0 rowsep0">0.237</td><td class="colsep0 rowsep0">0.236 ± 0.022</td><td class="colsep0 rowsep0">6.18 ± 0.869</td><td class="colsep0 rowsep0">0.039 ± 0.002</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3e</b><a class="ref internalNav" href="#t5fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="char" char="±">8.5 ± 3.04</td><td class="colsep0 rowsep0" align="left">60</td><td class="colsep0 rowsep0" align="char" char=".">4.1</td><td class="colsep0 rowsep0">3690</td><td class="colsep0 rowsep0">8.6</td><td class="colsep0 rowsep0">ND</td><td class="colsep0 rowsep0">0.664</td><td class="colsep0 rowsep0">0.03 ± 0.01</td><td class="colsep0 rowsep0">0.8 ± 0.2</td><td class="colsep0 rowsep0">0.04 ± 0.01</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15a</b><a class="ref internalNav" href="#t5fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="char" char="±">4 ± 2.9</td><td class="colsep0 rowsep0" align="left">30</td><td class="colsep0 rowsep0" align="char" char=".">10875.2</td><td class="colsep0 rowsep0">0.72</td><td class="colsep0 rowsep0">16.25</td><td class="colsep0 rowsep0">84.8 ± 8.9</td><td class="colsep0 rowsep0">0.248</td><td class="colsep0 rowsep0">0.18 ± 0.01</td><td class="colsep0 rowsep0">1.46 ± 0.29</td><td class="colsep0 rowsep0">0.13 ± 0.03</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15b</b><a class="ref internalNav" href="#t5fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="char" char="±">1.6 ± 0.4</td><td class="colsep0 rowsep0" align="left">30</td><td class="colsep0 rowsep0" align="char" char=".">28.0</td><td class="colsep0 rowsep0">426.0</td><td class="colsep0 rowsep0">10.6</td><td class="colsep0 rowsep0">109.2 ± 9.1</td><td class="colsep0 rowsep0">0.102</td><td class="colsep0 rowsep0">0.0071 ± 0.0004</td><td class="colsep0 rowsep0">0.21 ± 0.046</td><td class="colsep0 rowsep0">0.0335 ± 0.015</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>24</b><a class="ref internalNav" href="#t5fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="char" char="±">0.4 ± 0.2</td><td class="colsep0 rowsep0" align="left">30</td><td class="colsep0 rowsep0" align="char" char=".">96.2</td><td class="colsep0 rowsep0">0.16</td><td class="colsep0 rowsep0">3.06</td><td class="colsep0 rowsep0">ND</td><td class="colsep0 rowsep0">ND</td><td class="colsep0 rowsep0">ND</td><td class="colsep0 rowsep0">ND</td><td class="colsep0 rowsep0">ND</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>a</sup><p class="last">Oral dose: 10 mg/kg; vehicle: sterile water.</p></div><div class="footnote" id="t5fn2"><sup>b</sup><p class="last">Brains and plasma were harvested at or near the <i>T</i><sub>max</sub>.</p></div><div class="footnote" id="t5fn3"><sup>c</sup><p class="last">Number of animals used for <b>2</b>,<b> 3e</b>,<b> 15a</b>, and <b>24</b>, <i>n</i> = 3, for <b>15b</b>, <i>n</i> = 5. <i>C</i><sub>max</sub>: maximum concentration of the compound detected in plasma. <i>T</i><sub>max</sub>: time at <i>C</i><sub>max</sub>. <i>V</i><sub>d</sub>: volume of distribution. AUC: area under the curve. <i>t</i><sub>1/2</sub>: terminal half-life. <i>F</i>: oral bioavailability. ND: not determined.</p></div></div></div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. In Vivo PK Data for mGluR2 PAMs (as sodium salts) in Rats after Intravenous or Intraperitoneal Administration</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char="±"><i>C</i><sub>max</sub> (μM)</th><th class="colsep0 rowsep0" align="center" char="."><i>C</i><sub>L</sub>(mL/min)</th><th class="colsep0 rowsep0" align="center" char="."><i>V</i><sub>d</sub> (mL)</th><th class="colsep0 rowsep0" align="center" char=".">AUC (0–<i>t</i>) (μmol ·min/mL)</th><th class="colsep0 rowsep0" align="center" char="."><i>t</i><sub>1/2</sub> (h)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b><a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="char" char="±">28.2 ± 1.1</td><td class="colsep0 rowsep0" align="char" char=".">0.006</td><td class="colsep0 rowsep0" align="char" char=".">0.6</td><td class="colsep0 rowsep0" align="char" char=".">710.2</td><td class="colsep0 rowsep0" align="char" char=".">1.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3e</b><a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="char" char="±">9.6 ± 6.1</td><td class="colsep0 rowsep0" align="char" char=".">ND</td><td class="colsep0 rowsep0" align="char" char=".">2.4</td><td class="colsep0 rowsep0" align="char" char=".">1549.3</td><td class="colsep0 rowsep0" align="char" char=".">11.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15a</b><a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="char" char="±">5.6 ± 1.8</td><td class="colsep0 rowsep0" align="char" char=".">9.7</td><td class="colsep0 rowsep0" align="char" char=".">4620.0</td><td class="colsep0 rowsep0" align="char" char=".">0.4</td><td class="colsep0 rowsep0" align="char" char=".">0.51</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15b</b><a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="char" char="±">3.9 ± 0.6</td><td class="colsep0 rowsep0" align="char" char=".">0.028</td><td class="colsep0 rowsep0" align="char" char=".">4.3</td><td class="colsep0 rowsep0" align="char" char=".">154.4</td><td class="colsep0 rowsep0" align="char" char=".">1.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>24</b><a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="char" char="±">2.0 ± 0.2</td><td class="colsep0 rowsep0" align="char" char=".">ND</td><td class="colsep0 rowsep0" align="char" char=".">21.2</td><td class="colsep0 rowsep0" align="char" char=".">193.6</td><td class="colsep0 rowsep0" align="char" char=".">2.01</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup>a</sup><p class="last">Intravenous dose 2 mg/kg, vehicle used: sterile water.</p></div><div class="footnote" id="t6fn2"><sup>b</sup><p class="last">Intraperitoneal dose 10 mg/kg, vehicle used: sterile water. <i>C</i><sub>max</sub>: maximum concentration of compound detected in plasma. <i>C</i><sub>L</sub>: clearance. <i>V</i><sub>d</sub>: volume of distribution. AUC: area under the curve. <i>t</i><sub>1/2</sub>: terminal half-life.</p></div></div></div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Behavioral Studies</h3><div class="NLM_p">The in vivo model was designed to assess the effects of acute systemic (oral) administration of compound <b>2</b> as its sodium salt on the reinforcing effects of nicotine using the intravenous nicotine self-administration procedure in rats. This in vivo test is considered one of the most direct and reliable measures of the reinforcing properties of nicotine in an animal model.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Nicotine self-administration sessions were 1 h long (see Experimental Section for details). The results of the in vivo behavioral studies are shown in Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>. Oral administration of compound <b>2</b> significantly decreased nicotine self-administration in rats compared to vehicle treatment at doses of 10 and 20 mg/kg (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>). These results demonstrate that mGlu<sub>2</sub> receptor PAMs may be useful therapeutically for the treatment of nicotine dependence.</div><figure id="fig4" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3005306/production/images/medium/jm-2012-005306_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3005306/production/images/large/jm-2012-005306_0014.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Effects of compound <b>2</b> on nicotine self-administration in rats. Data are expressed as percent of baseline number of infusions earned (mean ± SEM). The number of baseline nicotine infusions was 13.88 ± 1.62 (mean ± SEM). *<i>p</i> < 0.05, **<i>p</i> < 0.01, significant differences from the corresponding vehicle condition (Newman–Keuls posthoc test after a significant main effect in the ANOVA).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3005306/production/images/large/jm-2012-005306_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3005306&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">In conclusion, expansion of the SAR around the prototypical mGlu<sub>2</sub> receptor PAM (<b>1</b>) led to additional potent and efficacious analogues. These compounds are highly selective for mGlu<sub>2</sub> vs other mGlu receptor subtypes and also vs other CNS receptors. Several analogues (<b>2</b>, <b>3e</b>, <b>15a</b>, and <b>15b</b>) have promising in vitro ADME and in vivo PK properties, providing compounds with excellent oral bioavailability and adequate brain penetration. The potent mGlu<sub>2</sub> receptor PAM (<b>2</b>) was shown to reduce nicotine infusions by 40% at a dose of 20 mg/kg po in a rat model, providing proof-of-concept for the use of an orally active mGlu<sub>2</sub> receptor PAM for the treatment of nicotine addiction.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_53166" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_53166" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> General Chemistry</h3><div class="NLM_p">All reactions were performed in oven-dried glassware under an atmosphere of argon with magnetic stirring. All solvents and chemicals used were purchased from Sigma-Aldrich or Acros and were used as received without further purification. Purity and characterization of compounds were established by a combination of liquid chromatography–mass spectroscopy (LC-MS) and NMR analytical techniques and was >95% for all tested compounds. Silica gel column chromatography was carried out using prepacked silica cartridges from RediSep (ISCO Ltd.) and eluted using an Isco Companion system. <sup>1</sup>H and <sup>13</sup>C NMR spectra were obtained on a Jeol 400 spectrometer at 400 and 100 MHz, respectively, unless otherwise mentioned. Chemical shifts are reported in δ (ppm) relative to residual solvent peaks or TMS as internal standards. Coupling constants are reported in hertz. High-resolution ESI-TOF mass spectra were acquired from the Mass Spectrometry Core at The Sanford-Burnham Medical Research Institute (Orlando, FL). HPLC-MS analyses were performed on a Shimadzu 2010EV LCMS using the following conditions: Kromisil C18 column (reverse phase, 4.6 mm ×50 mm); a linear gradient from 10% acetonitrile and 90% water to 95% acetonitrile and 5% water over 4.5 min; flow rate of 1 mL/min; UV photodiode array detection from 200 to 300 nm.</div><div class="NLM_p last">Compounds <b>3a</b>–<b>f</b> were prepared in a similar manner to the procedure previously described for 4-chloro-3′-((2-cyclopentyl-3-oxo-2,3-dihydro-benzo[<i>d</i>]isothiazol-6-yloxy)methyl)biphenyl-3-carboxylic acid.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a></div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> 4-Chloro-3′-((2-methyl-3-oxo-2,3-dihydrobenzo[<i>d</i>]isothiazol-6-yloxy)methyl)biphenyl-3-carboxylic Acid (<b>3a</b>)</h3><div class="NLM_p last">Colorless solid (70 mg, 52%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.01 (s, 1H), 7.84–7.79 (m, 3H), 7.72 (d, 1H, <i>J</i> = 8.5 Hz), 7.60 (s, 1H), 7.58 (d, 1H, <i>J</i> = 8.6 Hz), 7.49–7.47 (m, 2H), 7.05 (d, 1H, <i>J</i> = 8.5 Hz), 5.23 (s, 2H), 3.24 (s, 3H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 167.8, 164.8, 161.2, 144.1, 138.8, 138.3, 137.7, 132.1, 131.4, 130.9, 130.6, 129.5, 128.7, 127.6, 126.4, 126.2, 125.7, 115.5, 106.9, 70.8, 32.0. LC-MS (ESI) Calcd for C<sub>22</sub>H<sub>16</sub>ClNO<sub>4</sub>S [M + H]<sup>+</sup>: 426.05. Found: 425.90. HRMS (ESI) calcd for C<sub>22</sub>H<sub>16</sub>ClNO<sub>4</sub>S [M + H]<sup>+</sup>: 426.0561; found: 426.0553.</div></div><div id="sec3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> 4-Chloro-3′-((2-(cyclopropylmethyl)-3-oxo-2,3-dihydrobenzo[<i>d</i>]isothiazol-6-yloxy)methyl)biphenyl-3-carboxylic Acid (<b>3b</b>)</h3><div class="NLM_p last">Pale yellow solid (44 mg, 30%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.11 (s, 1H), 7.98 (d, 1H, <i>J</i> = 8.5 Hz), 7.80 (d, 1H, <i>J</i> = 8.6 Hz), 7.71–7.76 (m, 4H), 7.49–7.47 (m, 2H), 7.07 (d, 1H, <i>J</i> = 8.5 Hz), 5.23 (s, 2H), 3.33 (d, 2H, <i>J</i> = 6.9 Hz), 1.06–0.98 (m, 1H), 0.53–0.51 (m, 2H), 0.35–0.32 (m, 2H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 167.4, 164.4, 162.2, 144.4, 139.8, 138.8, 131.6, 131.2, 130.7, 129.9, 128.3, 127.3, 126.9, 126.0, 124.7, 115.6, 106.6, 70.2, 48.0, 11.3.6, 4.3. LC-MS (ESI) Calcd for C<sub>25</sub>H<sub>20</sub>ClNO<sub>4</sub>S [M + H]<sup>+</sup>: 466.08. Found: 465.95. HRMS (ESI) calcd for C<sub>25</sub>H<sub>20</sub>ClNO<sub>4</sub>S [3M + H]<sup>+</sup>:1398.2471; found:1398.2853.</div></div><div id="sec3_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> 4-Chloro-3′-((2-cyclobutyl-3-oxo-2,3-dihydrobenzo[<i>d</i>]isothiazol-6-yloxy)methyl)biphenyl-3-carboxylic Acid (<b>3c</b>)</h3><div class="NLM_p last">Pale yellow solid (53 mg, 35%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.01 (s, 1H), 7.82 (d, 1H, <i>J</i> = 8.5 Hz), 7.80 (d, 1H, <i>J</i> = 8.6 Hz), 7.71–7.76 (m, 4H), 7.49–7.47 (m, 2H), 7.05 (d, 1H, <i>J</i> = 8.5 Hz), 5.17 (s, 2H), 4.63–4.60 (m, 1H), 2.38–2.22 (m, 2H), 2.04–2.02 (m, 2H), 1.37–1.33 (m, 2H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 166.8, 165.2, 163.3, 147.0, 139.1, 138.8, 136.6, 132.2, 130.8, 129.0, 126.9, 126.5, 125.8, 119.8, 110.6, 70.3, 47.0, 29.7, 15.6. LC-MS (ESI) Calcd for C<sub>25</sub>H<sub>20</sub>ClNO<sub>4</sub>S [M + H]<sup>+</sup>: 466.08. Found: 465.90. HRMS (ESI) Calcd for C<sub>25</sub>H<sub>20</sub>ClNO<sub>4</sub>S [2M + H]<sup>+</sup>: 931.1676. Found: 931.1629.</div></div><div id="sec3_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> 4-Chloro-3′-((2-isobutyl-3-oxo-2,3-dihydrobenzo[<i>d</i>]isothiazol-6-yloxy)methyl)biphenyl-3-carboxylic Acid (<b>3d</b>)</h3><div class="NLM_p last">Pale yellow solid (97 mg, 65%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.05 (s, 1H), 7.84–7.80 (m, 1H), 7.56–7.38 (m, 6H), 7.21(d, 1H, <i>J</i> = 8.4 Hz), 6.98 (d, 1H, <i>J</i> = 8.5 Hz), 5.17 (s, 2H), 3.58 (d, 2H, <i>J</i> = 7.3 Hz), 2.07–1.96 (m, 1H), 0.88 (d, <i>J</i> = 6.7 Hz, 6H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 167.5, 165.5, 163.5, 147.9, 143.2, 139.7, 138.9, 131.5, 130.7, 130.2, 129.4, 127.8, 127.0, 126.0, 115.1, 110.6, 70.8, 51.1, 22.9. LC-MS (ESI) Calcd for C<sub>25</sub>H<sub>22</sub>ClNO<sub>4</sub>S [M + H]<sup>+</sup>: 468.09. Found: 467.90. HRMS (ESI) Calcd for C<sub>25</sub>H<sub>22</sub>ClNO<sub>4</sub>S [M + H]<sup>+</sup>: 468.1031. Found: 468.1012.</div></div><div id="sec3_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> 4-Chloro-3′-((2-cyclopropyl-3-oxo-2,3-dihydrobenzo[<i>d</i>]isothiazol-6-yloxy)methyl)biphenyl-3-carboxylic Acid (<b>3e</b>)</h3><div class="NLM_p last">Pale yellow solid (43 mg, 30%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.01 (s, 1H), 7.82–7.80 (m, 3H), 7.69 (d, 1H, <i>J</i> = 8.6 Hz), 7.60 (d, 1H, <i>J</i> = 8.5 Hz), 7.53–7.40 (m, 3H), 7.06 (d, 1H, <i>J</i> = 8.6 Hz), 5.23 (s, 2H), 3.00–2.98 (m, 1H), 0.96–0.92 (m, 2H), 0.87–0.83 (m, 2H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 167.7, 164.8, 161.2, 144.1, 138.8, 138.3, 137.7, 132.1, 131.4, 130.9, 130.6, 129.5, 128.7, 127.6, 126.4, 126.2, 125.7, 124.0, 115.5, 106.9, 70.2, 5.2. LC-MS (ESI) Calcd for C<sub>24</sub>H<sub>18</sub>ClNO<sub>4</sub>S [M + H]<sup>+</sup>: 452.06. Found: 451.85. HRMS (ESI) Calcd for C<sub>24</sub>H<sub>18</sub>ClNO<sub>4</sub>S [M + H]<sup>+</sup>: 452.0718. Found: 452.0716.</div></div><div id="sec3_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> 4-Chloro-3′-((2-isopentyl-3-oxo-2,3-dihydrobenzo[<i>d</i>]isothiazol-6-yloxy)methyl)biphenyl-3-carboxylic Acid (<b>3f</b>)</h3><div class="NLM_p last">Pale yellow solid (83 mg, 55%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.02 (s, 1H), 7.84–7.82 (m, 4H), 7.79 (d, 1H, <i>J</i> = 8.5 Hz), 7.58 (d, 1H, <i>J</i> = 8.6 Hz), 7.49–7.47 (m, 2H), 7.05 (d, 1H, <i>J</i> = 8.5 Hz), 5.32 (s, 2H), 3.76–3.72 (m, 2H), 1.51- 1.48 (m, 3H), 0.86 (d, <i>J</i> = 6.1 Hz, 6H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 167.8, 165.3, 149.7, 139.1, 137.8, 131.7, 131.0, 130.9, 129.9, 129.2, 127.5, 127.1, 126.9, 120.7, 112.0, 71.0, 54.8, 38.3, 25.7, 22.7. LC-MS (ESI) Calcd for C<sub>26</sub>H<sub>24</sub>ClNO<sub>4</sub>S [M + H]<sup>+</sup>: 482.11. Found: 482.00. HRMS (ESI) Calcd for C<sub>26</sub>H<sub>24</sub>ClNO<sub>4</sub>S [M + H]<sup>+</sup>: 482.1187. Found: 482.1173.</div></div><div id="sec3_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> 3-((2-Cyclopentyl-1-oxoisoindolin-5-yloxy)methyl)phenylboronic Acid (<b>13</b>)</h3><div class="NLM_p last">To a solution of 2-cyclopentyl-5-hydroxyisoindolin-1-one (500 mg, 2.3 mmol) in acetone (20 mL) were added K<sub>2</sub>CO<sub>3</sub> (1.2 g, 8.7 mmol) and 3-(bromomethyl)phenylboronic acid (650 mg, 3.0 mmol), and the mixture was heated with stirring at reflux for 3 h. The reaction mixture was filtered, and the solvent was evaporated in vacuo to obtain 3-((2-cyclopentyl-1-oxoisoindolin-5-yloxy)methyl)phenylboronic acid as a white solid (583 mg, 72%). The crude product was used for the next step without further purification. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.86 (s, 1H), 7.75–7.69 (m, 2H), 7.55–7.32 (m, 4H), 7.19 (s, 1H), 7.09–7.07 (m, 1H), 5.15 (s, 2H), 4.55–4.49 (m, 1H), 4.37 (s, 2H), 1.84–1.56 (m, 8H). LRMS calcd for C<sub>20</sub>H<sub>22</sub>BNO<sub>4</sub> [M + H]<sup>+</sup> 352 found: 352.</div></div><div id="sec3_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> 3-((2-Cyclopentyl-3-oxo-2,3-dihydrobenzo[<i>d</i>]isothiazol-6-yloxy)methyl)phenylboronic Acid (<b>14</b>)</h3><div class="NLM_p last">Potassium carbonate (166 mg, 1.2 mmol) was added to a solution of 2-cyclopentyl-7-hydroxy-3,4-dihydroisoquinolin-1(2<i>H</i>)-one (235 mg, 1 mmol) and 3-(bromomethyl)phenylboronic acid (257 mg, 1.2 mmol) in acetone (10 mL). After being stirred for 1 h at 60 °C, the reaction mixture was cooled to room temperature and filtered. The filtrate was evaporated under reduced pressure to give crude 3-((2-cyclopentyl-3-oxo-2,3-dihydrobenzo[<i>d</i>]isothiazol-6-yloxy)methyl)phenylboronic acid as a colorless solid (315 mg, 85%). The crude product was used for the next step without further purification. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.12 (s, 2H), 7.83 (s, 1H), 7.73–7.68 (m, 2H), 7.56 (s, 1H), 7.47 (d, 1H, <i>J</i> = 7.8 Hz), 7.32 (t, 1H, <i>J</i> = 7.8 Hz), 7.04 (d, 1H, <i>J</i> = 8.7 Hz), 5.25 (s, 2H), 4.85–4.81 (m, 1H), 2.01–1.98 (m, 2H), 1.75–1.59 (m, 6H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 164.4, 162.2, 143.3, 136.6, 134.4, 130.0, 128.8, 127.7, 115.6, 108.8, 70.8, 54.8, 32.2, 24.4. LC-MS (ESI) Calcd for C<sub>19</sub>H<sub>20</sub>BNO<sub>4</sub>S [M + H]<sup>+</sup>: 370.12. Found: 369.90.</div></div><div id="sec3_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> 3′-((2-Cyclopentyl-1-oxoisoindolin-5-yloxy)methyl)-6-methoxybiphenyl-3-carboxylic Acid (<b>15a</b>)</h3><div class="NLM_p last">3-((2-Cyclopentyl-1-oxoisoindolin-5-yloxy)methyl)phenylboronic acid (100 mg, 0.28 mmol), 3-iodo-4-methoxybenzoic acid (67 mg, 0.24 mmol), K<sub>2</sub>CO<sub>3</sub> (83 mg, 0.6 mmol), and PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub> (22 mg, 0.03 mmol) were dissolved in a mixture of toluene and MeOH (3.7:0.37 mL) and heated at 80 °C for 1.5 h. The mixture was filtered through Celite and washed with water, and the solvents were removed in vacuo. The resulting crude material was acidified with 2 M HCl, extracted into EtOAc, and dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>. The solvent was evaporated in vacuo to obtain the crude acid which was purified using automated preparative HPLC to yield the desired compound (33 mg, 30%) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.93 (d, <i>J</i> = 8.2 Hz, 1H), 7.82 (s, 1H), 7.55–7.42 (m, 5H), 7.21–7.18 (m, 2H), 7.10 (dd, <i>J</i> = 8.7 Hz, <i>J</i> = 2.3 Hz, 1H), 5.23 (s, 2H), 4.54–4.46 (m, 1H), 4.37 (s, 2H), 3.84 (s, 3H), 1.85–1.80 (m, 2H), 1.71–1.56 (m, 6H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 167.1, 166.8, 161.0, 159.5, 143.9, 137.5, 136.6, 131.5, 130.8, 129.2, 128.8, 128.4, 128.3, 126.6, 125.5, 123.9, 115.3, 111.5, 109.1, 69.5, 55.9, 51.9, 45.6, 29.6, 23.8. HRMS: calcd for C<sub>28</sub>H<sub>27</sub>NO<sub>5</sub> [M + H]<sup>+</sup> 458.1962; found 458.1947.</div></div><div id="sec3_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> 3′-((2-Cyclopentyl-1-oxoisoindolin-5-yloxy)methyl)-4-hydroxybiphenyl-3-carboxylic Acid (<b>15b</b>)</h3><div class="NLM_p last">White solid (18 mg, 20%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.03 (dd, <i>J</i> = 7.3 Hz, <i>J</i> = 2.3 Hz, 1H), 7.85–7.39 (m, 6H), 7.24–6.94 (m, 3H), 5.24 (s, 2H), 4.55–4.47 (m, 1H), 4.37 (s, 2H), 1.86–1.56 (m, 8H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 171.7, 166.8, 161.0, 160.6, 143.9, 139.2, 137.4, 133.9, 130.9, 129.2, 127.9, 126.4, 125.8, 125.5, 123.8, 117.9, 115.3, 109.1, 69.5, 51.9, 45.6, 29.6, 23.8. HRMS calcd for C<sub>27</sub>H<sub>25</sub>NO<sub>5</sub> [M + H]<sup>+</sup> 444.1805; found: 444.1800.</div></div><div id="sec3_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> 3′-((2-Cyclopentyl-1-oxoisoindolin-5-yloxy)methyl)-2,6-dimethoxybiphenyl-4-carboxylic Acid (<b>15c</b>)</h3><div class="NLM_p last">White solid (8 mg, 16%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.55 (d, <i>J</i> = 8.2 Hz, 1H), 7.40–7.09 (m, 8H), 5.19 (s, 2H), 4.56–4.48 (m, 1H), 4.39 (s, 2H), 3.69 (s, 6H), 2.02–1.54 (m, 8H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 167.1, 166.9, 161.1, 156.9, 143.9, 135.9, 133.5, 129.7, 127.8, 125.4, 123.8, 122.5, 115.6, 115.3, 109.1, 105.1, 69.6, 55.8, 51.9, 45.6, 29.6, 23.8. HRMS calcd for C<sub>29</sub>H<sub>29</sub>NO<sub>6</sub> [M + H]<sup>+</sup> 488.2068; found: 488.2061.</div></div><div id="sec3_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> 6-Chloro-3′-((2-cyclopentyl-1-oxoisoindolin-5-yloxy)methyl)biphenyl-3-carboxylic Acid (<b>15d</b>)</h3><div class="NLM_p last">White solid (8.2 mg, 14%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.05 (s, 1H), 7.99–7.97 (m, 1H), 7.75 (d, <i>J</i> = 8.2 Hz, 1H), 7.55–7.41 (m, 5H), 7.06–7.04 (m, 1H), 6.99 (s, 1H), 5.17 (s, 2H), 4.77–4.69 (m, 1H), 4.28 (s, 2H), 1.99–1.55 (m, 8H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 168.5, 161.2, 143.2, 136.8, 133.0, 130.3, 129.1, 128.4, 126.0, 124.9, 115.4, 108.8, 70.2, 52.6, 46.0, 30.0, 24.1. HRMS calcd for C<sub>27</sub>H<sub>24</sub>ClNO<sub>4</sub> [M + H]<sup>+</sup> 462.1467; found: 462.1466.</div></div><div id="sec3_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> 2-Chloro-3′-((2-cyclopentyl-1-oxoisoindolin-5-yloxy)methyl)biphenyl-4-carboxylic Acid (<b>15e</b>)</h3><div class="NLM_p last">White solid (14 mg, 15%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.00 (s, 1H), 7.94–7.91 (m, 1H), 7.55–7.51 (m, 5H), 7.45–7.43 (m, 1H), 7.21–7.09 (m, 2H), 5.25 (s, 2H), 4.55–4.47 (m, 1H), 4.37 (s, 2H), 1.86–1.56 (m, 8H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 167.1, 166.0, 160.9, 143.9, 137.0, 131.8, 130.4, 128.6, 128.2, 123.9, 115.3, 109.1, 69.3, 51.9, 45.2, 29.6, 23.8. HRMS calcd for C<sub>27</sub>H<sub>24</sub>ClNO<sub>4</sub> [M + H]<sup>+</sup> 462.1467; found: 462.1464.</div></div><div id="sec3_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> 3′-((2-Cyclopentyl-1-oxoisoindolin-5-yloxy)methyl)-6-methylbiphenyl-3-carboxylic Acid (<b>15f</b>)</h3><div class="NLM_p last">White solid (15 mg, 32%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.84–7.80 (m, 2H), 7.60–7.25 (m, 6H), 7.07–7.02 (m, 2H), 5.17 (s, 2H), 4.64–4.57 (m, 1H), 4.31 (s, 2H), 2.26 (s, 3H), 1.91–1.62 (m, 8H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 167.8, 167.6, 161.2, 143.4, 141.1, 141.0, 140.1, 136.4, 130.3, 128.8, 128.6, 128.4, 128.3, 127.9, 126.1, 125.8, 124.1, 115.3, 108.7, 69.8, 52.2, 45.8, 29.8, 23.9, 20.5. LRMS calcd for C<sub>28</sub>H<sub>27</sub>NO<sub>4</sub> [M + H]<sup>+</sup> 442 found: 442. HRMS calcd for C<sub>28</sub>H<sub>27</sub>NO<sub>4</sub> [M + H]<sup>+</sup> 442.2013 found: 442.2000.</div></div><div id="sec3_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> 3′-((2-Cyclopentyl-1-oxoisoindolin-5-yloxy)methyl)-5-fluorobiphenyl-3-carboxylic Acid (<b>15g</b>)</h3><div class="NLM_p last">White solid (9 mg, 27%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.05 (s, 1H), 7.85–7.51 (m, 7H), 7.24–7.11 (m, 2H), 5.28 (s, 2H), 4.56–4.48 (m, 1H), 4.39 (s, 2H), 1.87–1.57 (m, 8H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 166.8, 160.9, 144.0, 137.6, 129.3, 127.7, 126.5, 126.3, 125.5, 123.9, 123.3, 115.3, 109.1, 69.4, 51.9, 45.6, 29.6, 23.8. HRMS calcd for C<sub>27</sub>H<sub>24</sub>FNO<sub>4</sub> [M + H]<sup>+</sup> 446.1762; found: 446.1767.</div></div><div id="sec3_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> 3′-((2-Cyclopentyl-1-oxoisoindolin-5-yloxy)methyl)-4-methoxybiphenyl-3-carboxylic Acid (<b>15h</b>)</h3><div class="NLM_p last">White solid (12 mg, 21%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.45 (s, 1H), 7.81–7.39 (m, 7H), 7.15–7.01 (m, 2H), 5.17 (s, 2H), 4.76–4.70 (m, 1H), 4.29 (s, 2H), 4.12 (s, 3H), 1.99–1.57 (m, 8H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 168.3, 165.2, 161.4, 157.5, 143.3, 139.5, 137.2, 134.9, 133.4, 132.2, 129.6, 126.3, 125.8, 124.9, 117.9, 115.3, 112.2, 108.7, 70.19, 56.9, 52.5, 45.9, 30.0, 24.1. HRMS calcd for C<sub>28</sub>H<sub>27</sub>NO<sub>5</sub> [M + H]<sup>+</sup> 458.1962; found: 458.1954.</div></div><div id="sec3_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> 5-(Biphenyl-3-ylmethoxy)-2-cyclopentylisoindolin-1-one (<b>15i</b>)</h3><div class="NLM_p last">Pale yellow solid (18 mg, 26%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.75 (s, 1H), 7.68–7.35 (m, 9H), 7.23(d, <i>J</i> = 2.3 Hz, 1H), 7.13–7.11 (m, 1H), 5.26 (s, 2H), 4.56–4.48 (m, 1H), 4.38 (s, 2H), 1.87–1.57 (m, 8H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 166.9, 161.0, 144.0, 140.4, 139.9, 137.4, 129.2, 128.9, 127.6, 126.8, 126.7, 126.3, 126.1, 125.5, 123.9, 115.3, 109.1, 69.5, 51.9, 45.6, 29.6, 23.8. HRMS calcd for C<sub>26</sub>H<sub>25</sub>NO<sub>2</sub> [M + H]<sup>+</sup> 384.1958; found: 384.1937.</div></div><div id="sec3_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> 5-((4′-Chloro-2′-fluorobiphenyl-3-yl)methoxy)-2-cyclopentylisoindolin-1-one (<b>15j</b>)</h3><div class="NLM_p last">Yellow oil (50 mg, 32%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.62–7.51 (m, 7H), 7.41–7.38 (m, 1H), 7.22–7.09 (m, 2H), 5.25 (s, 2H), 4.55–4.47 (m, 1H), 4.38 (s, 2H), 1.84–1.57 (m, 8H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 167.1, 160.9, 144.0, 137.2, 134.2, 131.9, 128.9, 127.9, 127.5, 125.2, 123.9, 116.8, 116.6, 115.3, 109.1, 69.3, 51.9, 45.6, 29.6, 23.8. HRMS calcd for C<sub>26</sub>H<sub>23</sub>ClFNO<sub>2</sub> [M + H]<sup>+</sup> 436.1474 found: 436.1458.</div></div><div id="sec3_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> 2-Cyclopentyl-5-((2′-fluoro-4′-(trifluoromethyl)biphenyl-3-yl)methoxy)isoindolin-1-one (<b>15k</b>)</h3><div class="NLM_p last">Pale yellow solid (25 mg, 23%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.80–7.53 (m, 8H), 7.22–7.09 (m, 2H), 5.25 (s, 2H), 4.54–4.47 (m, 1H), 4.37 (s, 2H), 1.85–1.56 (m, 8H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 166.9, 160.9, 144.0, 137.3, 133.8, 132.1, 129.0, 128.6, 128.1, 125.6, 123.9, 121.8, 115.3, 109.1, 69.3, 51.9, 45.6, 29.6, 23.8. HRMS calcd for C<sub>27</sub>H<sub>23</sub>F<sub>4</sub>NO<sub>2</sub> [M + H]<sup>+</sup> 470.1738 found: 470.1713.</div></div><div id="sec3_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> (3′-((2-Cyclopentyl-3-oxo-2,3-dihydrobenzo[<i>d</i>]isothiazol-6-yloxy)methyl)-6-methylbiphenyl-3-carboxylic Acid (<b>16a</b>)</h3><div class="NLM_p last">A mixture of 3-((2-cyclopentyl-3-oxo-2,3-dihydrobenzo[<i>d</i>]isothiazol-6-yloxy)methyl)phenylboronic acid (50 mg, 0.14 mmol), 3-iodo-4-methylbenzoic acid (53 mg, 0.20 mmol), and tetrakis(triphenylphosphine)palladium(0) (0.016 mg, 0.014 mmol) were dissolved in DME (2 mL). To this solution was added 1 M Na<sub>2</sub>CO<sub>3</sub> (0.48 mmol), and the resulting mixture was heated at reflux under an atmosphere of N<sub>2</sub> for 12 h. The reaction mixture was cooled to room temperature, and the solvents were removed in vacuo. The solvents were evaporated, and the residue was dissolved in water and neutralized using 1 M HCl. The aqueous layer was extracted with ethyl acetate, and the organic layer was dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>. The solvent was evaporated in vacuo to obtain the crude acid as a yellow solid. The crude residue was purified using automated preparative HPLC to yield the desired compound as a pale yellow solid (23 mg, 36%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.01 (s, 1H), 7.90 (d, 1H, <i>J</i> = 8.5 Hz), 7.65–7.23 (m, 7H), 7.03 (s, 1H), 5.23 (s, 2H), 4.64–4.59 (m, 1H), 2.34 (s, 3H), 2.16–2.14 (m, 2H), 1.88–1.68 (m, 6H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 169.9, 165.5, 163.5, 142.2, 141.9, 136.6, 132.6, 132.0, 130.8, 129.3, 128.9, 128.3, 120.2, 110.4, 70.8, 55.8, 24.3, 23.7, 20.9. LC-MS (ESI) Calcd for C<sub>27</sub>H<sub>25</sub>NO<sub>4</sub>S [M + H]<sup>+</sup>: 460.15. Found: 460.00. HRMS (ESI) Calcd for C<sub>27</sub>H<sub>25</sub>NO<sub>4</sub>S [M + H]<sup>+</sup>: 460.1577. Found: 460.1565.</div></div><div id="sec3_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> 2-Cyclopentyl-3-oxo-2,3-dihydrobenzo[<i>d</i>]isothiazol-6-yloxy)methyl)-5-nitrobiphenyl-3-carboxylic Acid (<b>16b</b>)</h3><div class="NLM_p last">A mixture of 6-(3-bromobenzyloxy)-2-cyclopentylbenzo[<i>d</i>]isothiazol-3(2<i>H</i>)-one (43 mg, 0.1 mmol), 3-borono-5-nitrobenzoic acid (25 mg, 0.12 mmol), tetrakis(triphenylphosphine)palladium(0) (0.012 mg, 0.028 mmol), and 1 M Na<sub>2</sub>CO<sub>3</sub> (2 mmol) were heated in DME at reflux and processed according to the procedure described for 3′-((2-cyclopentyl-3-oxo-2,3-dihydrobenzo[<i>d</i>]isothiazol-6-yloxy)methyl)-6-methylbiphenyl-3-carboxylic acid to afford 3′-((2-cyclopentyl-3-oxo-2,3-dihydrobenzo[<i>d</i>]isothiazol-6-yloxy)methyl)-5-nitrobiphenyl-3-carboxylic acid as a pale yellow solid (23 mg, 47%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.87 (s, 1H), 8.65 (s, 1H), 8.61 (s, 1H), 7.87 (d, 1H, <i>J</i> = 8.7 Hz), 7.71–7.72 (m, 5H), 6.97 (d, 1H, <i>J</i> = 8.5 Hz), 5.24 (s, 2H), 4.63–4.59 (m, 1H), 2.19–2.03 (m, 2H), 1.99–1.66 (m, 6H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 167.5, 165.6, 163.4, 148.8, 143.4, 138.8, 136.0, 134.4, 130.1, 129.8, 128.8, 128.2, 127.2, 126.5, 123.0, 119.9, 110.4, 70.2, 55.8, 32.3, 23.7. LC-MS (ESI) Calcd for C<sub>26</sub>H<sub>22</sub>N<sub>2</sub>O<sub>6</sub>S [M + H]<sup>+</sup>: 491.11. Found: 491.00. HRMS (ESI) Calcd for C<sub>26</sub>H<sub>22</sub>N<sub>2</sub>O<sub>6</sub>S [M + Na]<sup>+</sup>: 512.1013. Found: 512.0889.</div></div><div id="sec3_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> 3′-((2-Cyclopentyl-3-oxo-2,3-dihydrobenzo[<i>d</i>]isothiazol-6-yloxy)methyl)-4-fluorobiphenyl-3-carboxylic Acid (<b>16c</b>)</h3><div class="NLM_p last">A mixture of 6-(3-bromobenzyloxy)-2-cyclopentylbenzo[<i>d</i>]isothiazol-3(2<i>H</i>)-one (113 mg, 0.28 mmol), 5-borono-2-fluorobenzoic acid (63 mg, 0.34 mmol), tetrakis(triphenylphosphine)palladium(0) (0.032 mg, 0.028 mmol), and 1 M Na<sub>2</sub>CO<sub>3</sub> (2 mmol) were heated in DME at reflux and processed according to the procedure described for 3′-((2-cyclopentyl-3-oxo-2,3-dihydrobenzo[<i>d</i>]isothiazol-6-yloxy)methyl)-6-methylbiphenyl-3-carboxylic acid to afford 3′-((2-cyclopentyl-3-oxo-2,3-dihydrobenzo[<i>d</i>]isothiazol-6-yloxy)methyl)-4-fluorobiphenyl-3-carboxylic acid as a pale yellow solid (54 mg, 42%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.23 (s, 1H), 7.86 (d, 1H, <i>J</i> = 8.7 Hz), 7.61 (s, 1H), 7.57–7.41 (m, 4H), 7.28–7.23 (m, 2H), 7.04 (d, 1H, <i>J</i> = 8.7 Hz), 5.25 (s, 2H), 4.61–4.59 (m, 1H), 2.19–2.02 (m, 2H), 1.99–1.65(m, 6H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 167.5, 165.6, 163.5, 147.9, 139.7, 137.7, 136.2, 135.6, 131.3, 129.6, 127.5, 127.3, 127.0, 126.2, 121.2, 117.8, 110.4, 70.8, 55.8, 32.2, 23.7. LC-MS (ESI) Calcd for C<sub>26</sub>H<sub>22</sub>FNO<sub>4</sub>S [M + H]<sup>+</sup>: 464.12. Found: 463.95. HRMS (ESI) Calcd for C<sub>26</sub>H<sub>22</sub>FNO<sub>4</sub>S [M + H]<sup>+</sup>: 464.1326. Found: 464.1304.</div></div><div id="sec3_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> 6-(3-Bromobenzyloxy)-2-cyclopentylbenzo[<i>d</i>]isothiazol-3(2<i>H</i>)-one (<b>18</b>)</h3><div class="NLM_p last">Potassium carbonate (94 mg, 0.66 mmol) was added to a solution of 2-cyclopentyl-7-hydroxy-3,4-dihydroisoquinolin-1(2<i>H</i>)-one (132 mg, 0.56 mmol) and 1-bromo-3-(bromomethyl)benzene (164 mg, 0.66 mmol) in CH<sub>3</sub>CN (10 mL). After being stirred for 1 h at 80 °C, the organic phase was evaporated under reduced pressure, and the crude material was partitioned between water and CH<sub>2</sub>Cl<sub>2</sub>. The aqueous layer was extracted with CH<sub>2</sub>Cl<sub>2</sub> (3 × 15 mL). The organic phase was dried using Na<sub>2</sub>SO<sub>4</sub> and evaporated to give 6-(3-bromobenzyloxy)-2-cyclopentylbenzo[<i>d</i>]isothiazol-3(2<i>H</i>)-one (223 mg, 98%). The crude product was used for the next step without further purification. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.90 (d, 1H, <i>J</i> = 9.6 Hz), 7.58 (s, 1H), 7.48 (d, 1H, <i>J</i> = 8.2 Hz), 7.33 (d, 1H, <i>J</i> = 7.8 Hz), 7.25 (t, 1H, <i>J</i> = 7.7 Hz)), 7.00–6.99 (overlapping singlet and doublet, 2H), 5.09 (s, 2H), 5.04–5.02 (m, 1H), 2.16–2.13 (m, 2H), 1.84–1.67 (m, 6H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 165.3, 162.3, 142.1, 138.4, 131.4, 130.4, 127.8, 125.9, 114.9, 104.3, 69.6, 55.1, 32.2, 24.4. LC-MS (ESI) Calcd for C<sub>19</sub>H<sub>18</sub>BrNO<sub>2</sub> [M + H]<sup>+</sup>: 404.02, 406.02. Found: 403.90, 405.80.</div></div><div id="sec3_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> 4-Chloro-3′-((2-cyclopentyl-3-oxo-2,3-dihydrobenzo[<i>d</i>]isothiazol-6-yloxy)methyl)-<i>N,N</i>-methylbiphenyl-3-carboxamide (<b>19</b>)</h3><div class="NLM_p last">The acid (48 mg, 0.1 mmol) was dissolved in DMF (2 mL) at room temperature. HOBt (16 mg, 0.12 mmol) was added in one portion followed by EDC·HCl (23 mg, 0.12 mmol). The resulting mixture was stirred at room temperature for 30 min. To this solution were added dimethylamine hydrochloride (10 mg, 0.12 mmol) and triethylamine (0.02 mL, 0.12 mmol), the mixture was stirred for 2 h, and the organic phase was evaporated under reduced pressure. The crude material was partitioned between water and ethyl acetate, and the aqueous layer was extracted with ethyl acetate (3 × 5 mL). The organic phase was dried using Na<sub>2</sub>SO<sub>4</sub> and evaporated to give 4-chloro-3′-((2-cyclopentyl-3-oxo-2,3-dihydrobenzo[<i>d</i>]isothiazol-6-yloxy)methyl)-<i>N,N</i>-dimethylbiphenyl-3-carboxamide. The crude product was purified by HPLC using 2-propanol:water as the solvent system to afford the amide as a colorless solid (40 mg, 80% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.87 (d, 1H, <i>J</i> = 8.7 Hz), 7.60 (s, 1H), 7.75–7.38 (m, 4H), 7.27–7.24 (m, 3H), 7.03 (d, 1H, <i>J</i> = 8.5 Hz), 5.25 (s, 2H), 4.63–4.59 (m, 1H), 3.15 (s, 3H), 2.91 (s, 3H), 2.16–2.03 (m, 2H), 1.62–1.60 (m, 6H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 168.4, 165.6, 163.5, 147.9, 140.0, 137.7, 136.6, 130.1, 129.6, 128.8, 127.5, 127.3, 127.1, 126.5, 126.1, 115.5, 110.2, 70.6, 55.8, 38.2, 34.9, 32.2. LC-MS (ESI) Calcd for C<sub>28</sub>H<sub>27</sub>ClNO<sub>3</sub>S [M + H]<sup>+</sup>: 507.14. Found: 507.05. HRMS (ESI) Calcd for C<sub>28</sub>H<sub>27</sub>ClNO<sub>3</sub>S [M + H]<sup>+</sup>: 507.1504. Found: 507.1519.</div></div><div id="sec3_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> 5-Bromo-2-cyclopentylisoindolin-1-one (23).<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a></h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.63–7.51 (m, 3H), 4.71–4.63 (m, 1H), 4.29 (s, 2H), 1.97–1.54 (m, 8H). LRMS calcd for C<sub>13</sub>H<sub>14</sub>BrNO [M + H]<sup>+</sup> 280 found: 280.</div></div><div id="sec3_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> 4-Chloro-3′-(2-cyclopentyl-1-oxoisoindolin-5-yl)biphenyl-3-carboxylic Acid (<b>24</b>)</h3><div class="NLM_p last">A solution of 3-bromophenylboronic acid (134 mg, 0.67 mmol) and 5-bromo-2-cyclopentylisoindolin-1-one (187 mg, 0.67 mmol) in DME (3.5 mL) was treated with 2 M Na<sub>2</sub>CO<sub>3</sub> (1.7 mL, 3.35 mmol) and Pd(PPh<sub>3</sub>)<sub>4</sub> (14 mg, 0.012 mmol) and heated at reflux under an atmosphere of N<sub>2</sub> for 1 h to obtain 5-(3-bromophenyl)-2-cyclopentylisoindolin-1-one. The reaction mixture was cooled, treated with 5-borono-2-chlorobenzoic acid (671 mg, 3.35 mmol), 2 M Na<sub>2</sub>CO<sub>3</sub> (1.7 mL, 3.35 mmol), DME (3.5 mL), and Pd(PPh<sub>3</sub>)<sub>4</sub>(14 mg, 0.012 mmol), and heated at reflux under an atmosphere of N<sub>2</sub> for 1.5 h. The mixture was cooled and filtered through Celite, and the solvent was evaporated in vacuo. The residue was acidified with 2 M HCl, and the resulting crude acid was purified using automated preparative HPLC to yield the desired product (34.5 mg, 12% over two steps) as a pale yellow solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.24 (d, <i>J</i> = 2.3 Hz, 1H), 7.94 (d, <i>J</i> = 8.0 Hz, 1H), 7.78–7.54 (m, 8H), 4.84–4.75 (m, 1H), 4.43 (s, 2H), 2.08–2.00 (m, 2H), 1.83–1.62 (m, 6H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 168.4, 144.0, 141.9, 141.5, 139.6, 133.6, 132.5, 131.8, 131.7, 130.8, 129.7, 127.5, 127.2, 126.5, 126.2, 124.1, 121.5, 52.7, 46.2, 30.1, 24.1. HRMS calcd for C<sub>26</sub>H<sub>22</sub>ClNO<sub>3</sub> [M + H]<sup>+</sup> 432.1361 found: 432.1363.</div></div><div id="sec3_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> mGlu<sub>2</sub> Receptor in Vitro Assay</h3><div class="NLM_p last">Human embryonic kidney (HEK-293) cell lines coexpressing rat mGlu receptors 2, 3, 4, 6, 7, or 8 and G protein inwardly rectifying potassium (GIRK) channels<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> were grown in growth media containing 45% DMEM, 45% F-12, 10% FBS, 20 mM HEPES, 2 mM <span class="smallcaps smallerCapital">l</span>-glutamine, antibiotic/antimycotic, nonessential amino acids, 700 μg/mL G418, and 0.6 μg/mL puromycin at 37 °C in the presence of 5% CO<sub>2</sub>. Cells expressing rat mGlu<sub>1</sub> and mGlu<sub>5</sub> receptors were cultured as described in Hemstapat et al.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> All cell culture reagents were purchased from Invitrogen Corp. (Carlsbad, CA) unless otherwise noted. Calcium assays were used to assess activity of compounds at mGlu<sub>1</sub> and mGlu<sub>5</sub>, as previously described in Engers et al.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Compound activity at the group II (mGlu<sub>2</sub> and mGlu<sub>3</sub>) and group III (mGlu<sub>4</sub>, mGlu<sub>6</sub>, mGlu<sub>7</sub>, and mGlu<sub>8</sub>) receptors was assessed using thallium flux through GIRK channels, a method that has been described in detail.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Briefly, cells were plated into 384-well, black-walled, clear-bottomed poly-<span class="smallcaps smallerCapital">d</span>-lysine-coated plates at a density of 15 000 cells/20 μL/well in DMEM containing 10% dialyzed FBS, 20 mM HEPES, and 100 units/mL penicillin/streptomycin (assay media). Plated cells were incubated overnight at 37 °C in the presence of 5% CO<sub>2</sub>. The following day the medium was exchanged from the cells to assay buffer [Hanks balanced salt solution (Invitrogen) containing 20 mM HEPES, pH 7.3] using an ELX405 microplate washer (BioTek), leaving 20 μL/well, followed by the addition of 20 μL/well FluoZin2-AM (330 nM final concentration) indicator dye (Invitrogen; prepared as a stock in DMSO and mixed in a 1:1 ratio with Pluronic acid F-127) in assay buffer. Cells were incubated for 1 h at room temperature, and the dye was exchanged to assay buffer using an ELX405, leaving 20 μL/well. Test compounds were diluted to 2 times their final desired concentration in assay buffer (0.3% DMSO final concentration). Agonists were diluted in thallium buffer [125 mM sodium bicarbonate (added fresh the morning of the experiment), 1 mM magnesium sulfate, 1.8 mM calcium sulfate, 5 mM glucose, 12 mM thallium sulfate, and 10 mM HEPES, pH 7.3] at 5 times the final concentration to be assayed. Cell plates and compound plates were loaded onto a kinetic imaging plate reader (FDSS 6000 or 7000; Hamamatsu Corporation, Bridgewater, NJ). Appropriate baseline readings were taken (10 images at 1 Hz; excitation, 470 ± 20 nm; emission, 540 ± 30 nm), and test compounds were added in a 20 μL volume and incubated for approximately 2.5 min before the addition of 10 μL of thallium buffer with or without agonist. After the addition of agonist, data were collected for approximately an additional 2.5 min. Data were analyzed using Excel (Microsoft Corp, Redmond, WA). The slope of the fluorescence increase beginning 5 s after thallium/agonist addition and ending 15 s after thallium/agonist addition was calculated, corrected to vehicle and maximal agonist control slope values, and plotted using either XLfit (ID Business Solutions Ltd.) or Prism software (GraphPad Software, San Diego, CA) to generate concentration–response curves. Potencies were calculated from fits using a four-point parameter logistic equation. For concentration–response curve experiments, compounds were serially diluted 1:3 into 10 point concentration–response curves and were transferred to daughter plates using an Echo acoustic plate reformatter (Labcyte, Sunnyvale, CA). Test compounds were applied and followed by EC<sub>20</sub> concentrations of glutamate. For selectivity experiments, full concentration–response curves of glutamate or L-AP4 (for mGlu<sub>7</sub>) were performed in the presence of a 10 μM concentration of compound, and compounds that affected the concentration–response by less than 2 fold in terms of potency or efficacy were designated as inactive.</div></div><div id="sec3_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> Microsomal Stability in Vitro Assay</h3><div class="NLM_p last">Pooled rat liver microsomes (BD Biosciences, # 452701) were preincubated with test compounds at 37.5 °C for 5 min in the absence of NADPH. The reaction was initiated by addition of NADPH and incubated under the same conditions. The final incubation concentrations were 4 μM test compound, 2 mM NADPH, and 1 mg/mL (total protein) liver microsomes in phosphate-buffered saline (PBS) at pH 7.4. One aliquot (100 μL) of the incubation mixture was withdrawn at 15 min time points and combined immediately with 100 μL of ACN/MeOH. After mixing, the sample was centrifuged at approximately 13 000 rpm for 12 min. The supernatant was filtered and transferred into an autosampler vial, and the amount of test compound was quantified using a Shimadzu LCMS 2010EV mass spectrometer. The change of the AUC (area under the curve) of the parent compound as a function of time was used as a measure of microsomal stability. Test compounds were run in duplicate with a positive control.</div></div><div id="sec3_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> Plasma Stability in Vitro Assay</h3><div class="NLM_p last">A 20 μL aliquot of a 10 mM solution in DMSO of the test compound was added to 2.0 mL of heparinized rat plasma (Lampire, P1-150N) to obtain a 100 μM final solution. The mixture was incubated for 1 h at 37.5 °C. Aliquots of 100 μL were taken at 15 min intervals and diluted with 100 μL of MeOH/ACN. After mixing, the sample was centrifuged at approximately 13 000 rpm for 12 min. The supernatant was filtered and transferred into an autosampler vial, and the amount of test compound was quantified using the Shimadzu LCMS-2010EV system. The change of the AUC of the parent compound as a function of time was used as a measure of plasma stability.</div></div><div id="sec3_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> Parallel Artificial Membrane Permeation Assay (PAMPA)</h3><div class="NLM_p last">A 96-well microtiter plate (Millipore, # MSSACCEPTOR) was completely filled with aqueous buffer solution (pH 7.4) and covered with a microtiter filterplate (Millipore, # MAPBMN310) to create a sort of sandwich construction.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> The hydrophobic filter material was impregnated with a 10% solution of polar brain lipid extract in chloroform (Avanti, Alabaster, AL) as the artificial membrane, and the organic solvent was allowed to completely evaporate. Permeation studies were started by the transfer of 200 μL of a 100 μM test compound solution on top of the filter plate. In general, phosphate pH 7.2 buffer was used. The maximum DMSO content of the stock solutions was <1.5%. In parallel, an equilibrium solution lacking a membrane was prepared using the exact concentrations and specifications but lacking the membrane. The concentrations of the acceptor and equilibrium solutions were determined using the Shimadzu LCMS-2010EV and AUC methods. The Acceptor plate and equilibrium plate concentrations were used to calculate the permeability rate (log <i>P</i><sub>e</sub>) of the compounds. The log <i>P</i><sub>e</sub> values were calculated using the following equation:<span class="NLM_disp-formula" id="ueq1"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3005306/production/images/jm-2012-005306_m001.gif" alt="" /></img></span>where <i>V</i><sub>D</sub> and <i>V</i><sub>A</sub> are the volumes of the donor and acceptor compartments<span class="NLM_disp-formula" id="ueq2"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3005306/production/images/jm-2012-005306_m002.gif" alt="" /></img></span></div></div><div id="sec3_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> Assays Measuring Inhibition of Drug-Metabolizing Enzymes CYP1A2, CYP2C9, and CYP3A4</h3><div class="NLM_p last">Evaluation of the compounds as inhibitors of the activity of CYP1A2, CYP2C9, or CYP3A4 was assessed using the P450-Glo CYP1A2 Assay kit (Promega, P/N V8422), the CYP2C9 Assay kit (Promega, P/N V8792), or the CYP3A4 Assay kit (Promega, P/N V8912) in the presence of human liver microsomes (XenoTech, P/N H0610, lot # 0810509). NADPH, a required cofactor for CYP450 metabolism, was provided by the NADPH Regenerating System, Solutions A (BD Biosciences, P/N 451220) and B (BD Biosciences, P/N 451200). Compound stock solutions were initially prepared in 100% DMSO and subsequently diluted in acetonitrile for the assay. The pH of the reactions was maintained at ∼7.4 with potassium phosphate buffer (BD Biosciences, P/N 451201). The reaction was started after adding NADPH and the corresponding CYP substrates (luciferin-1A2 for CYP1A2, luciferin-H for CYP2C9, or luciferin-PPXE for CYP3A4) to the reaction plate containing microsomes and compounds. The reaction was incubated for 10 min (CYP1A2), 30 min (CYP2C9), or 20 min (CYP3A4) at 37 °C with shaking. The Luciferin Detection Reagent was added after the incubation to stop the reaction and initiate a stable glow-type luminescent signal. The luminescence of the metabolite that was formed, luciferin, was recorded with the Infinite M200 (Tecan US). All reactions were run in duplicate, except negative controls (no NADPH) which were performed as single reactions. The background luminescence obtained from the negative control reactions was subtracted from the luminescence values obtained for the positive reaction duplicates.</div></div><div id="sec3_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> Behavioral Procedures</h3><div id="sec3_33_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> Apparatus</h4><div class="NLM_p last">Intravenous nicotine self-administration took place in 24 Plexiglas experimental chambers (25 × 31 × 24 cm; MED Associates, St. Albans, VT), each housed in a sound-attenuating box (San Diego Instruments, San Diego, CA). One wall of the chamber contained two levers, measuring approximately 3 cm in width and located approximately 3 cm above the metal grid floor of the chamber. There was also an opaque disk (2.5 cm diameter) mounted 10 cm above each lever which could be illuminated by a 2.5 W, 24 V white light bulb and served as a cue light paired with nicotine delivery. All data collection and test session functions were controlled by computers and MED-PC IV software (MED Associates).</div></div><div id="sec3_33_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> Nicotine Self-Administration Procedure</h4><div class="NLM_p last">Catheter construction and surgery and the nicotine self-administration procedure were performed as described previously.<a onclick="showRef(event, 'ref8 ref14'); return false;" href="javascript:void(0);" class="ref ref8 ref14">(8, 14)</a> Briefly, rats were initially trained to press a lever using food as a reward. Subsequently a jugular venous catheter was surgically inserted using isoflurane anesthesia (1–1.5% isoflurane/oxygen mixture). After one week of recovery from surgery, the animals were allowed to self-administer nicotine (0.03 mg/kg/infusion) during 1 h self-administration sessions. Self-administration sessions were initiated by extension of the two levers (active and inactive) in the chamber. Every five responses (FR5) on the active lever resulted in the delivery of a single infusion of nicotine (0.1 mL over 1 s). Each infusion of nicotine was paired with the presentation of a cue light located above the active lever for the duration of the infusion and for a period of 20 s termed the timeout period. During the timeout period responses on the active lever did not result in delivery of nicotine infusions. Responses on the inactive lever were recorded but did not result in any nicotine infusions. All rats were trained to self-administer nicotine for 3 weeks (5 days/week). All animals showed stable nicotine self-administration behavior over the three weeks of self-administration training (more than six infusions per session with less than 20% variation over three consecutive sessions).</div></div><div id="sec3_33_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> Experimental Design for Investigating the Effects of the mGlu<sub>2</sub> Receptor PAM on Nicotine Self-Administration</h4><div class="NLM_p last">After completion of the nicotine self-administration training, drug treatments were initiated. Compound <b>2</b> was administered to rats (<i>n</i> = 7) according to a within-subjects Latin-square design. The compound was administered orally at doses of 0, 10, and 20 mg/kg 2 h prior to nicotine self-administration sessions (pretreatment time). This pretreatment time was selected based on the PK data (see Tables <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a> and <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>). At least three days elapsed between drug/vehicle injections to re-establish stable self-administration behavior (less than 20% variation over three days).</div></div><div id="sec3_33_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> Statistical Analyses</h4><div class="NLM_p">Intravenous nicotine self-administration data were expressed as a percentage of the baseline number of rewards earned, with baseline defined as the mean number of rewards earned during the three days before each drug testing session. Data were expressed as percent values, as each animal served as its own control and conversion of data into percent of baseline best represented the data. Identical results were obtained when the data were analyzed as raw values. Acute effects of compound <b>2</b> on nicotine self-administration were analyzed using one-way repeated-measures ANOVA, and posthoc comparisons were conducted with the Newman–Keuls tests. The criterion for significance was set at 0.05.</div><div class="NLM_p last">A one-way ANOVA showed a significant main effect of dose (<i>F</i><sub>(2, 12)</sub> = 6.81; <i>p</i> < 0.01). Newman–Keuls posthoc test showed a significant dose-dependent decrease in nicotine self-administration after administration of compound <b>2</b> at 10 (<i>p</i> < 0.05) and 20 mg/kg (<i>p</i> < 0.01) compared to vehicle treatment.</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id=""></div><div class="testing" data-doi="10.1021/jm3005306" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_12161" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_12161" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nicholas D. P. Cosford</span> - <span class="hlFld-Affiliation affiliation">‡Apoptosis
and Cell Death Research Program and §Conrad Prebys Center for Chemical Genomics, Sanford-Burnham Medical Research Institute, 10901 N. Torrey Pines Road, La Jolla, California 92037, United
States, Departments of ∥Pharmacology, ⊥Pathology, Microbiology and Immunology, and #Vanderbilt Center for Neuroscience Drug
Discovery, Vanderbilt University Medical
Center, Nashville, Tennessee 37232, United States, and □Department of Psychiatry, School
of Medicine, University of California San
Diego, La Jolla, California 92093, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#bfd1dcd0ccd9d0cddbffccded1d9d0cddbddcacdd1d7ded291d0cdd8"><span class="__cf_email__" data-cfemail="3658555945505944527645575850594452544344585e575b18594451">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shyama Sidique</span> - <span class="hlFld-Affiliation affiliation">‡Apoptosis
and Cell Death Research Program and §Conrad Prebys Center for Chemical Genomics, Sanford-Burnham Medical Research Institute, 10901 N. Torrey Pines Road, La Jolla, California 92037, United
States, Departments of ∥Pharmacology, ⊥Pathology, Microbiology and Immunology, and #Vanderbilt Center for Neuroscience Drug
Discovery, Vanderbilt University Medical
Center, Nashville, Tennessee 37232, United States, and □Department of Psychiatry, School
of Medicine, University of California San
Diego, La Jolla, California 92093, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Raveendra-Panickar Dhanya</span> - <span class="hlFld-Affiliation affiliation">‡Apoptosis
and Cell Death Research Program and §Conrad Prebys Center for Chemical Genomics, Sanford-Burnham Medical Research Institute, 10901 N. Torrey Pines Road, La Jolla, California 92037, United
States, Departments of ∥Pharmacology, ⊥Pathology, Microbiology and Immunology, and #Vanderbilt Center for Neuroscience Drug
Discovery, Vanderbilt University Medical
Center, Nashville, Tennessee 37232, United States, and □Department of Psychiatry, School
of Medicine, University of California San
Diego, La Jolla, California 92093, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Douglas J. Sheffler</span> - <span class="hlFld-Affiliation affiliation">‡Apoptosis
and Cell Death Research Program and §Conrad Prebys Center for Chemical Genomics, Sanford-Burnham Medical Research Institute, 10901 N. Torrey Pines Road, La Jolla, California 92037, United
States, Departments of ∥Pharmacology, ⊥Pathology, Microbiology and Immunology, and #Vanderbilt Center for Neuroscience Drug
Discovery, Vanderbilt University Medical
Center, Nashville, Tennessee 37232, United States, and □Department of Psychiatry, School
of Medicine, University of California San
Diego, La Jolla, California 92093, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hilary Highfield Nickols</span> - <span class="hlFld-Affiliation affiliation">‡Apoptosis
and Cell Death Research Program and §Conrad Prebys Center for Chemical Genomics, Sanford-Burnham Medical Research Institute, 10901 N. Torrey Pines Road, La Jolla, California 92037, United
States, Departments of ∥Pharmacology, ⊥Pathology, Microbiology and Immunology, and #Vanderbilt Center for Neuroscience Drug
Discovery, Vanderbilt University Medical
Center, Nashville, Tennessee 37232, United States, and □Department of Psychiatry, School
of Medicine, University of California San
Diego, La Jolla, California 92093, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Li Yang</span> - <span class="hlFld-Affiliation affiliation">‡Apoptosis
and Cell Death Research Program and §Conrad Prebys Center for Chemical Genomics, Sanford-Burnham Medical Research Institute, 10901 N. Torrey Pines Road, La Jolla, California 92037, United
States, Departments of ∥Pharmacology, ⊥Pathology, Microbiology and Immunology, and #Vanderbilt Center for Neuroscience Drug
Discovery, Vanderbilt University Medical
Center, Nashville, Tennessee 37232, United States, and □Department of Psychiatry, School
of Medicine, University of California San
Diego, La Jolla, California 92093, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Russell Dahl</span> - <span class="hlFld-Affiliation affiliation">‡Apoptosis
and Cell Death Research Program and §Conrad Prebys Center for Chemical Genomics, Sanford-Burnham Medical Research Institute, 10901 N. Torrey Pines Road, La Jolla, California 92037, United
States, Departments of ∥Pharmacology, ⊥Pathology, Microbiology and Immunology, and #Vanderbilt Center for Neuroscience Drug
Discovery, Vanderbilt University Medical
Center, Nashville, Tennessee 37232, United States, and □Department of Psychiatry, School
of Medicine, University of California San
Diego, La Jolla, California 92093, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Arianna Mangravita-Novo</span> - <span class="hlFld-Affiliation affiliation">‡Apoptosis
and Cell Death Research Program and §Conrad Prebys Center for Chemical Genomics, Sanford-Burnham Medical Research Institute, 10901 N. Torrey Pines Road, La Jolla, California 92037, United
States, Departments of ∥Pharmacology, ⊥Pathology, Microbiology and Immunology, and #Vanderbilt Center for Neuroscience Drug
Discovery, Vanderbilt University Medical
Center, Nashville, Tennessee 37232, United States, and □Department of Psychiatry, School
of Medicine, University of California San
Diego, La Jolla, California 92093, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Layton H. Smith</span> - <span class="hlFld-Affiliation affiliation">‡Apoptosis
and Cell Death Research Program and §Conrad Prebys Center for Chemical Genomics, Sanford-Burnham Medical Research Institute, 10901 N. Torrey Pines Road, La Jolla, California 92037, United
States, Departments of ∥Pharmacology, ⊥Pathology, Microbiology and Immunology, and #Vanderbilt Center for Neuroscience Drug
Discovery, Vanderbilt University Medical
Center, Nashville, Tennessee 37232, United States, and □Department of Psychiatry, School
of Medicine, University of California San
Diego, La Jolla, California 92093, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Manoranjan S. D’Souza</span> - <span class="hlFld-Affiliation affiliation">‡Apoptosis
and Cell Death Research Program and §Conrad Prebys Center for Chemical Genomics, Sanford-Burnham Medical Research Institute, 10901 N. Torrey Pines Road, La Jolla, California 92037, United
States, Departments of ∥Pharmacology, ⊥Pathology, Microbiology and Immunology, and #Vanderbilt Center for Neuroscience Drug
Discovery, Vanderbilt University Medical
Center, Nashville, Tennessee 37232, United States, and □Department of Psychiatry, School
of Medicine, University of California San
Diego, La Jolla, California 92093, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Svetlana Semenova</span> - <span class="hlFld-Affiliation affiliation">‡Apoptosis
and Cell Death Research Program and §Conrad Prebys Center for Chemical Genomics, Sanford-Burnham Medical Research Institute, 10901 N. Torrey Pines Road, La Jolla, California 92037, United
States, Departments of ∥Pharmacology, ⊥Pathology, Microbiology and Immunology, and #Vanderbilt Center for Neuroscience Drug
Discovery, Vanderbilt University Medical
Center, Nashville, Tennessee 37232, United States, and □Department of Psychiatry, School
of Medicine, University of California San
Diego, La Jolla, California 92093, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">P. Jeffrey Conn</span> - <span class="hlFld-Affiliation affiliation">‡Apoptosis
and Cell Death Research Program and §Conrad Prebys Center for Chemical Genomics, Sanford-Burnham Medical Research Institute, 10901 N. Torrey Pines Road, La Jolla, California 92037, United
States, Departments of ∥Pharmacology, ⊥Pathology, Microbiology and Immunology, and #Vanderbilt Center for Neuroscience Drug
Discovery, Vanderbilt University Medical
Center, Nashville, Tennessee 37232, United States, and □Department of Psychiatry, School
of Medicine, University of California San
Diego, La Jolla, California 92093, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Athina Markou</span> - <span class="hlFld-Affiliation affiliation">‡Apoptosis
and Cell Death Research Program and §Conrad Prebys Center for Chemical Genomics, Sanford-Burnham Medical Research Institute, 10901 N. Torrey Pines Road, La Jolla, California 92037, United
States, Departments of ∥Pharmacology, ⊥Pathology, Microbiology and Immunology, and #Vanderbilt Center for Neuroscience Drug
Discovery, Vanderbilt University Medical
Center, Nashville, Tennessee 37232, United States, and □Department of Psychiatry, School
of Medicine, University of California San
Diego, La Jolla, California 92093, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d2214e4381-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i56">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_34780" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_34780" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was supported by National Institutes of Health grant R01 DA023926 to N.C., and DA011946 to A.M. The binding profiles for compounds <b>2</b> and <b>3</b> were generously provided by the National Institute of Mental Health’s Psychoactive Drug Screening Program, contract # HHSN-271-2008-00025-C (NIMH PDSP).</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i57" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i57"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i58" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i58"> Abbreviations Used</h2><tr><td class="NLM_term">mGlu<sub>2</sub> receptor</td><td class="NLM_def"><p class="first last">metabotropic glutamate receptor subtype 2</p></td></tr><tr><td class="NLM_term">PAM</td><td class="NLM_def"><p class="first last">positive allosteric modulator</p></td></tr><tr><td class="NLM_term">BINA</td><td class="NLM_def"><p class="first last">3′-((2-cyclopentyl-6,7-dimethyl-1-oxo-2,3-dihydro-1<i>H</i>-inden-5-yloxy)methyl)biphenyl-4-carboxylic acid</p></td></tr><tr><td class="NLM_term">HTS</td><td class="NLM_def"><p class="first last">high-throughput screening</p></td></tr><tr><td class="NLM_term">PK</td><td class="NLM_def"><p class="first last">pharmacokinetic</p></td></tr><tr><td class="NLM_term">PIFA</td><td class="NLM_def"><p class="first last">phenyliodine bis(trifluoroacetate)</p></td></tr><tr><td class="NLM_term">EDC</td><td class="NLM_def"><p class="first last">1-ethyl-3-(3-dimethylaminopropyl)carbodiimide</p></td></tr><tr><td class="NLM_term">AIBN</td><td class="NLM_def"><p class="first last">2,2′-azobis(isobutyronitrile)</p></td></tr><tr><td class="NLM_term">NBS</td><td class="NLM_def"><p class="first last"><i>N</i>-bromosuccinimide</p></td></tr><tr><td class="NLM_term">HEK</td><td class="NLM_def"><p class="first last">human embryonic kidney</p></td></tr><tr><td class="NLM_term">GIRK</td><td class="NLM_def"><p class="first last">G protein inwardly rectifying potassium</p></td></tr><tr><td class="NLM_term">PBS</td><td class="NLM_def"><p class="first last">phosphate-buffered saline</p></td></tr><tr><td class="NLM_term">DMEM</td><td class="NLM_def"><p class="first last">Dulbecco′s modified eagle medium</p></td></tr><tr><td class="NLM_term">HEPES</td><td class="NLM_def"><p class="first last">4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid</p></td></tr><tr><td class="NLM_term">FBS</td><td class="NLM_def"><p class="first last">fetal bovine serum</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i59">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_14280" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_14280" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 28 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">World Health Organization</span><span class="NLM_x">. </span> <span class="citation_source-book">WHO Report on the Global Tobacco Epidemic</span>; <span class="NLM_publisher-name">World Health Organization</span>: <span class="NLM_publisher-loc">Geneva</span>,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=World+Health+Organization&title=WHO+Report+on+the+Global+Tobacco+Epidemic"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3D%26btitle%3DWHO%2520Report%2520on%2520the%2520Global%2520Tobacco%2520Epidemic%26pub%3DWorld%2520Health%2520Organization%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Centers for Disease Control and Prevention</span><span class="NLM_x">. </span><span> </span><span class="NLM_article-title">Current cigarette smoking prevalence among working adults: United States, 2004–2010</span>.  <span class="citation_source-journal">Morbidity and Mortality Weekly Report</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">1305</span><span class="NLM_x">–</span> <span class="NLM_lpage">1309</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm3005306&amp;key=21956406" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2011&pages=1305-1309&author=Centers+for+Disease+Control+and+Prevention&title=Current+cigarette+smoking+prevalence+among+working+adults%3A+United+States%2C+2004%E2%80%932010"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3D%26atitle%3DCurrent%2520cigarette%2520smoking%2520prevalence%2520among%2520working%2520adults%253A%2520United%2520States%252C%25202004%25E2%2580%25932010%26jtitle%3DMorbidity%2520and%2520Mortality%2520Weekly%2520Report%26date%3D2011%26volume%3D60%26spage%3D1305%26epage%3D1309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Agboola, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNeill, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coleman, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonardi Bee, J.</span><span> </span><span class="NLM_article-title">A systematic review of the effectiveness of smoking relapse prevention interventions for abstinent smokers</span> <span class="citation_source-journal">Addiction</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">1362</span><span class="NLM_x">–</span> <span class="NLM_lpage">1380</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2010&pages=1362-1380&author=S.+Agboolaauthor=A.+McNeillauthor=T.+Colemanauthor=J.+Leonardi+Bee&title=A+systematic+review+of+the+effectiveness+of+smoking+relapse+prevention+interventions+for+abstinent+smokers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAgboola%26aufirst%3DS.%26aulast%3DMcNeill%26aufirst%3DA.%26aulast%3DColeman%26aufirst%3DT.%26aulast%3DLeonardi%2BBee%26aufirst%3DJ.%26atitle%3DA%2520systematic%2520review%2520of%2520the%2520effectiveness%2520of%2520smoking%2520relapse%2520prevention%2520interventions%2520for%2520abstinent%2520smokers%26jtitle%3DAddiction%26date%3D2010%26volume%3D105%26spage%3D1362%26epage%3D1380" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Stolerman, I. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jarvis, M. J.</span><span> </span><span class="NLM_article-title">The scientific case that nicotine is addictive</span> <span class="citation_source-journal">Psychopharmacology (Berlin, Ger.)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">117</span><span class="NLM_x">, </span> <span class="NLM_fpage">2</span><span class="NLM_x">–</span> <span class="NLM_lpage">10</span><div class="note"><p class="first last">; discussion 14–20</p></div></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm3005306&amp;key=10.1007%2FBF02245088" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm3005306&amp;key=7724697" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm3005306&amp;key=1%3ACAS%3A528%3ADyaK2MXkslSisrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=1995&pages=2-10&author=I.+P.+Stolermanauthor=M.+J.+Jarvis&title=The+scientific+case+that+nicotine+is+addictive"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">The scientific case that nicotine is addictive</span></div><div class="casAuthors">Stolerman, I. P.; Jarvis, M. J.</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology (Berlin)</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">2-10</span>CODEN:
                <span class="NLM_cas:coden">PSCHDL</span>;
        ISSN:<span class="NLM_cas:issn">0033-3158</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review with 96 refs.  Despite the wide-ranging and authoritative 1988 review by the US Surgeon General, views questioning the addictiveness of nicotine continue to be expressed in some quarters.  This lack of complete consensus is not unexpected, since no universally agreed scientific definition of addiction exists.  In this paper we briefly consider a no. of lines of evidence from both the human and animal literature bearing on the addictiveness of nicotine.  Patterns of use by smokers and the remarkable intractability of the smoking habit point to compulsive use as the norm.  Studies in both animal and human subjects have shown that nicotine can function as reinforcer, albeit under a more limited range of conditions than with some other drugs of abuse.  In drug discrimination paradigms, there is some cross-generalization between nicotine on the one hand, and amphetamine and cocaine on the other.  A well-defined nicotine withdrawal syndrome has been delineated which is alleviated by nicotine replacement.  Nicotine replacement also enhances outcomes in smoking cessation, roughly doubling success rates.  In total, the evidence clearly identifies nicotine as a powerful drug of addiction, comparable to heroin, cocaine and alc.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvNF8xLCCOyLVg90H21EOLACvtfcHk0lgjSssyP0nbmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXkslSisrw%253D&md5=6d53220302bf7ecfbe62ee488217ab4a</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1007%2FBF02245088&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF02245088%26sid%3Dliteratum%253Aachs%26aulast%3DStolerman%26aufirst%3DI.%2BP.%26aulast%3DJarvis%26aufirst%3DM.%2BJ.%26atitle%3DThe%2520scientific%2520case%2520that%2520nicotine%2520is%2520addictive%26jtitle%3DPsychopharmacology%2520%2528Berlin%252C%2520Ger.%2529%26date%3D1995%26volume%3D117%26spage%3D2%26epage%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Liechti, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markou, A.</span><span> </span><span class="NLM_article-title">Role of the glutamatergic system in nicotine dependence: implications for the discovery and development of new pharmacological smoking cessation therapies</span> <span class="citation_source-journal">CNS Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">705</span><span class="NLM_x">–</span> <span class="NLM_lpage">724</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2008&pages=705-724&author=M.+E.+Liechtiauthor=A.+Markou&title=Role+of+the+glutamatergic+system+in+nicotine+dependence%3A+implications+for+the+discovery+and+development+of+new+pharmacological+smoking+cessation+therapies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLiechti%26aufirst%3DM.%2BE.%26aulast%3DMarkou%26aufirst%3DA.%26atitle%3DRole%2520of%2520the%2520glutamatergic%2520system%2520in%2520nicotine%2520dependence%253A%2520implications%2520for%2520the%2520discovery%2520and%2520development%2520of%2520new%2520pharmacological%2520smoking%2520cessation%2520therapies%26jtitle%3DCNS%2520Drugs%26date%3D2008%26volume%3D22%26spage%3D705%26epage%3D724" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Markou, A.</span><span> </span><span class="NLM_article-title">Neurobiology of nicotine dependence</span> <span class="citation_source-journal">Philos. Trans R. Soc. London, Ser. B</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">363</span><span class="NLM_x">, </span> <span class="NLM_fpage">3159</span><span class="NLM_x">–</span> <span class="NLM_lpage">3168</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm3005306&amp;key=10.1098%2Frstb.2008.0095" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm3005306&amp;key=18640919" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=363&publication_year=2008&pages=3159-3168&author=A.+Markou&title=Neurobiology+of+nicotine+dependence"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1098%2Frstb.2008.0095&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1098%252Frstb.2008.0095%26sid%3Dliteratum%253Aachs%26aulast%3DMarkou%26aufirst%3DA.%26atitle%3DNeurobiology%2520of%2520nicotine%2520dependence%26jtitle%3DPhilos.%2520Trans%2520R.%2520Soc.%2520London%252C%2520Ser.%2520B%26date%3D2008%26volume%3D363%26spage%3D3159%26epage%3D3168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">D’Souza, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markou, A.</span><span> </span><span class="NLM_article-title">Neuronal mechanisms underlying development of nicotine dependence: implications for novel smoking-cessation treatments</span> <span class="citation_source-journal">Addict. Sci. Clin. Pract.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">4</span><span class="NLM_x">–</span> <span class="NLM_lpage">16</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm3005306&amp;key=22003417" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm3005306&amp;key=1%3ACAS%3A280%3ADC%252BC3Mbhs1Gjtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=4-16&author=M.+S.+D%E2%80%99Souzaauthor=A.+Markou&title=Neuronal+mechanisms+underlying+development+of+nicotine+dependence%3A+implications+for+novel+smoking-cessation+treatments"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Neuronal mechanisms underlying development of nicotine dependence: implications for novel smoking-cessation treatments</span></div><div class="casAuthors">D'Souza Manoranjan S; Markou Athina</div><div class="citationInfo"><span class="NLM_cas:title">Addiction science & clinical practice</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">4-16</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Tobacco smoking causes high rates of mortality and morbidity throughout the world.  Despite the availability of smoking-cessation medications, maintenance of long-term abstinence is difficult, and most individuals who attempt to quit smoking relapse.  Although tobacco smoke contains many substances, researchers and policymakers agree that nicotine is a major cause of tobacco dependence.  Understanding the neural substrates of nicotine dependence is essential for the development of more effective antismoking medications than those currently available.  This article focuses on the neural substrates, especially nicotinic acetylcholine receptors, that mediate the reinforcing effects of nicotine and the development of nicotine dependence.  Neuroadaptations in the function of the neurotransmitters dopamine, glutamate, and gamma-aminobutyric acid (GABA), which have been shown to be critically involved in nicotine dependence, are also reviewed.  Finally, the article discusses progress in the discovery and development of smoking-cessation medications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRnNF5GDChlcI3yKPtYViAGfW6udTcc2eYnc5NF7onyNLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3Mbhs1Gjtw%253D%253D&md5=45506372d3563c3a8ceeca32a7c3dbd2</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DD%25E2%2580%2599Souza%26aufirst%3DM.%2BS.%26aulast%3DMarkou%26aufirst%3DA.%26atitle%3DNeuronal%2520mechanisms%2520underlying%2520development%2520of%2520nicotine%2520dependence%253A%2520implications%2520for%2520novel%2520smoking-cessation%2520treatments%26jtitle%3DAddict.%2520Sci.%2520Clin.%2520Pract.%26date%3D2011%26volume%3D6%26spage%3D4%26epage%3D16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">D’Souza, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liechti, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramirez-Nino, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuczenski, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markou, A.</span><span> </span><span class="NLM_article-title">The metabotropic glutamate 2/3 receptor agonist LY379268 blocked nicotine-induced increases in nucleus accumbens shell dopamine only in the presence of a nicotine-associated context in rats</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">2111</span><span class="NLM_x">–</span> <span class="NLM_lpage">2124</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2011&pages=2111-2124&author=M.+S.+D%E2%80%99Souzaauthor=M.+E.+Liechtiauthor=A.+M.+Ramirez-Ninoauthor=R.+Kuczenskiauthor=A.+Markou&title=The+metabotropic+glutamate+2%2F3+receptor+agonist+LY379268+blocked+nicotine-induced+increases+in+nucleus+accumbens+shell+dopamine+only+in+the+presence+of+a+nicotine-associated+context+in+rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DD%25E2%2580%2599Souza%26aufirst%3DM.%2BS.%26aulast%3DLiechti%26aufirst%3DM.%2BE.%26aulast%3DRamirez-Nino%26aufirst%3DA.%2BM.%26aulast%3DKuczenski%26aufirst%3DR.%26aulast%3DMarkou%26aufirst%3DA.%26atitle%3DThe%2520metabotropic%2520glutamate%25202%252F3%2520receptor%2520agonist%2520LY379268%2520blocked%2520nicotine-induced%2520increases%2520in%2520nucleus%2520accumbens%2520shell%2520dopamine%2520only%2520in%2520the%2520presence%2520of%2520a%2520nicotine-associated%2520context%2520in%2520rats%26jtitle%3DNeuropsychopharmacology%26date%3D2011%26volume%3D36%26spage%3D2111%26epage%3D2124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Cartmell, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoepp, D. D.</span><span> </span><span class="NLM_article-title">Regulation of neurotransmitter release by metabotropic glutamate receptors</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">75</span><span class="NLM_x">, </span> <span class="NLM_fpage">889</span><span class="NLM_x">–</span> <span class="NLM_lpage">907</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm3005306&amp;key=10.1046%2Fj.1471-4159.2000.0750889.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm3005306&amp;key=10936169" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm3005306&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmtFykurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2000&pages=889-907&author=J.+Cartmellauthor=D.+D.+Schoepp&title=Regulation+of+neurotransmitter+release+by+metabotropic+glutamate+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of neurotransmitter release by metabotropic glutamate receptors</span></div><div class="casAuthors">Cartmell, Jayne; Schoepp, Darryle D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">889-907</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">A review, with ∼145 refs.  The G protein-coupled metabotropic glutamate (mGlu) receptors are differentially localized at various synapses throughout the brain.  Depending on the receptor subtype, they appear to be localized at presynaptic and/or postsynaptic sites, including glial as well as neuronal elements.  The heterogeneous distribution of these receptors on glutamate and nonglutamate neurons/cells thus allows modulation of synaptic transmission by a no. of different mechanisms.  Electrophysiol. studies have demonstrated that the activation of mGlu receptors can modulate the activity of Ca2+ or K+ channels, or interfere with release processes downstream of Ca2+ entry, and consequently regulate neuronal synaptic activity.  Such changes evoked by mGlu receptors can ultimately regulate transmitter release at both glutamatergic and nonglutamatergic synapses.  Increasing neurochem. evidence has emerged, obtained from in vitro and in vivo studies, showing modulation of the release of a variety of transmitters by mGlu receptors.  This review addresses the neurochem. evidence for mGlu receptor-mediated regulation of neurotransmitters, such as excitatory and inhibitory amino acids, monoamines, and neuropeptides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrRIHmsUn6YbVg90H21EOLACvtfcHk0lgzQYh3pKQ-xw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmtFykurY%253D&md5=15379bf75d0949789eeaeaf4f9485460</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1046%2Fj.1471-4159.2000.0750889.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1471-4159.2000.0750889.x%26sid%3Dliteratum%253Aachs%26aulast%3DCartmell%26aufirst%3DJ.%26aulast%3DSchoepp%26aufirst%3DD.%2BD.%26atitle%3DRegulation%2520of%2520neurotransmitter%2520release%2520by%2520metabotropic%2520glutamate%2520receptors%26jtitle%3DJ.%2520Neurochem.%26date%3D2000%26volume%3D75%26spage%3D889%26epage%3D907" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Xi, Z. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carson, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalivas, P. W.</span><span> </span><span class="NLM_article-title">Group II metabotropic glutamate receptors modulate extracellular glutamate in the nucleus accumbens</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">300</span><span class="NLM_x">, </span> <span class="NLM_fpage">162</span><span class="NLM_x">–</span> <span class="NLM_lpage">171</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm3005306&amp;key=10.1124%2Fjpet.300.1.162" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm3005306&amp;key=11752112" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm3005306&amp;key=1%3ACAS%3A528%3ADC%252BD38Xht1Wnug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=300&publication_year=2002&pages=162-171&author=Z.+X.+Xiauthor=D.+A.+Bakerauthor=H.+Shenauthor=D.+S.+Carsonauthor=P.+W.+Kalivas&title=Group+II+metabotropic+glutamate+receptors+modulate+extracellular+glutamate+in+the+nucleus+accumbens"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Group II metabotropic glutamate receptors modulate extracellular glutamate in the nucleus accumbens</span></div><div class="casAuthors">Xi, Zheng-Xiong; Baker, David A.; Shen, Hui; Carson, Daniel S.; Kalivas, Peter W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">300</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">162-171</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The regulation of extracellular glutamate in the nucleus accumbens by group II metabotropic glutamate receptors (mGluR2/3) was examd. in vivo.  Stimulation of mGluR2/3 with 2R,4R-4-aminopyrrolidine-2,4-dicarboxylate (APDC) or N-acetylaspartyl-glutamate reduced extracellular glutamate levels.  Conversely, blockade of mGluR2/3 by LY143495 or (RS)-1-amino-5-phosphonoindan-1-carboxylic acid (APICA) increased extracellular glutamate, an effect antagonized by the coadministration of APDC.  These effects likely involve both vesicular and nonvesicular glutamate, because the increase in glutamate by APICA or the decrease by APDC was prevented by blocking N-type calcium channels and the release of glutamate after potassium-induced membrane depolarization was antagonized by APDC.  In addn., blockade of the cystine-glutamate exchange, a major nonvesicular source of extracellular glutamate, by (S)-4-carboxyphenylglycine blocked the effects induced by either APDC or APICA.  However, blockade of Na+ channels by tetrodotoxin or Na+-dependent glutamate transporters by DL-threo-β-benzyloxyaspartate failed to affect the alterations in extracellular glutamate by APICA or APDC, resp.  Group II mGluRs are Gi-coupled and coperfusion with the cAMP-dependent protein kinase (PKA) activator Sp-cAMPS blocked the redn. in glutamate by APDC and the PKA inhibitor Rp-cAMPS prevented the elevation in glutamate by APICA.  Taken together, these data support three conclusions: (1) group II mGluRs regulate both vesicular and nonvesicular release of glutamate in the nucleus accumbens, (2) there is tonic in vivo stimulation of mGluR2/3 by endogenous glutamate, and (3) modulation of group II mGluRs of extracellular glutamate is Ca2+- and PKA-dependent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9O8HBxmVIjbVg90H21EOLACvtfcHk0lgzQYh3pKQ-xw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xht1Wnug%253D%253D&md5=4136e7de11a983e66e8b1cdf25494d38</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1124%2Fjpet.300.1.162&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.300.1.162%26sid%3Dliteratum%253Aachs%26aulast%3DXi%26aufirst%3DZ.%2BX.%26aulast%3DBaker%26aufirst%3DD.%2BA.%26aulast%3DShen%26aufirst%3DH.%26aulast%3DCarson%26aufirst%3DD.%2BS.%26aulast%3DKalivas%26aufirst%3DP.%2BW.%26atitle%3DGroup%2520II%2520metabotropic%2520glutamate%2520receptors%2520modulate%2520extracellular%2520glutamate%2520in%2520the%2520nucleus%2520accumbens%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2002%26volume%3D300%26spage%3D162%26epage%3D171" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Xi, Z. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramamoorthy, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samuvel, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalivas, P. W.</span><span> </span><span class="NLM_article-title">Modulation of group II metabotropic glutamate receptor signaling by chronic cocaine</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">303</span><span class="NLM_x">, </span> <span class="NLM_fpage">608</span><span class="NLM_x">–</span> <span class="NLM_lpage">615</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm3005306&amp;key=10.1124%2Fjpet.102.039735" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm3005306&amp;key=12388642" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm3005306&amp;key=1%3ACAS%3A528%3ADC%252BD38XotlCgu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=303&publication_year=2002&pages=608-615&author=Z.+X.+Xiauthor=S.+Ramamoorthyauthor=D.+A.+Bakerauthor=H.+Shenauthor=D.+J.+Samuvelauthor=P.+W.+Kalivas&title=Modulation+of+group+II+metabotropic+glutamate+receptor+signaling+by+chronic+cocaine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Modulation of group II metabotropic glutamate receptor signaling by chronic cocaine</span></div><div class="casAuthors">Xi, Zheng-Xiong; Ramamoorthy, Sammanda; Baker, David A.; Shen, Hui; Samuvel, Devadoss J.; Kalivas, Peter W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">303</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">608-615</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Repeated cocaine produces enduring neuroadaptations in glutamate transmission in the nucleus accumbens that are thought to contribute to addiction.  Group II metabotropic glutamate autoreceptors (mGluR2/3) regulate glutamate release, and this study investigates whether repeated cocaine injection produces long-lasting alterations in mGluR2/3 content, phosphorylation, and physiol.  Rats were administered cocaine daily for 1 wk, and 3 wk after the last injection, mGluR2/3 protein levels were altered in the accumbens and prefrontal cortex (PFC) but not in the dorsal striatum or ventral tegmental area.  The level of mGluR2/3 dimer was elevated in the accumbens and PFC and the monomer was reduced in the PFC only.  Furthermore, the relative Ser phosphorylation state of the monomer was elevated in both the accumbens and PFC of cocaine-pretreated subjects, whereas the dimer demonstrated negligible phosphorylation in either treatment group.  These changes in mGluR2/3 level and phosphorylation state were assocd. with reduced mGluR2/3 agonist-induced guanosine 5'-3-O -(thio)triphosphate binding in the accumbens and PFC, but not in the dorsal striatum.  Stimulation of mGluR2/3 reduces extracellular glutamate by inhibiting Ca2+-dependent and cystine/glutamate antiporter-mediated glutamate release.  The capacity of the mGluR2/3 agonist 2R,4R-4-aminopyrrolidine-2,4-dicarboxylate (APDC) to inhibit [35S]cystine uptake via cystine/glutamate antiporter in accumbens tissue slices was reduced by repeated cocaine.  Also, the capacity of APDC to reduce the basal and potassium-stimulated extrasynaptic glutamate was significantly blunted in the accumbens of cocaine-pretreated subjects.  Together, these data demonstrate that repeated cocaine produces an enduring redn. in mGluR2/3 function in the nucleus accumbens.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQspk27DAhJbVg90H21EOLACvtfcHk0lg9GOIz11csGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XotlCgu7k%253D&md5=3101c2c134f73ced1bcc0deee26befd0</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1124%2Fjpet.102.039735&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.102.039735%26sid%3Dliteratum%253Aachs%26aulast%3DXi%26aufirst%3DZ.%2BX.%26aulast%3DRamamoorthy%26aufirst%3DS.%26aulast%3DBaker%26aufirst%3DD.%2BA.%26aulast%3DShen%26aufirst%3DH.%26aulast%3DSamuvel%26aufirst%3DD.%2BJ.%26aulast%3DKalivas%26aufirst%3DP.%2BW.%26atitle%3DModulation%2520of%2520group%2520II%2520metabotropic%2520glutamate%2520receptor%2520signaling%2520by%2520chronic%2520cocaine%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2002%26volume%3D303%26spage%3D608%26epage%3D615" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Kalivas, P. W.</span><span> </span><span class="NLM_article-title">The glutamate homeostasis hypothesis of addiction</span> <span class="citation_source-journal">Nat. Rev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">561</span><span class="NLM_x">–</span> <span class="NLM_lpage">572</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm3005306&amp;key=10.1038%2Fnrn2515" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm3005306&amp;key=19571793" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm3005306&amp;key=1%3ACAS%3A528%3ADC%252BD1MXnvFans74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2009&pages=561-572&author=P.+W.+Kalivas&title=The+glutamate+homeostasis+hypothesis+of+addiction"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">The glutamate homeostasis hypothesis of addiction</span></div><div class="casAuthors">Kalivas, Peter W.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neuroscience</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">561-572</span>CODEN:
                <span class="NLM_cas:coden">NRNAAN</span>;
        ISSN:<span class="NLM_cas:issn">1471-003X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Addiction is assocd. with neuroplasticity in the corticostriatal brain circuitry that is important for guiding adaptive behavior.  The hierarchy of corticostriatal information processing that normally permits the prefrontal cortex to regulate reinforcement-seeking behaviors is impaired by chronic drug use.  A failure of the prefrontal cortex to control drug-seeking behaviors can be linked to an enduring imbalance between synaptic and non-synaptic glutamate, termed glutamate homeostasis.  The imbalance in glutamate homeostasis engenders changes in neuroplasticity that impair communication between the prefrontal cortex and the nucleus accumbens.  Some of these pathol. changes are amenable to new glutamate- and neuroplasticity-based pharmacotherapies for treating addiction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmzMH0MPPhgLVg90H21EOLACvtfcHk0lg9GOIz11csGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXnvFans74%253D&md5=1735bd00dc118bbd3438103f734a0394</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Fnrn2515&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrn2515%26sid%3Dliteratum%253Aachs%26aulast%3DKalivas%26aufirst%3DP.%2BW.%26atitle%3DThe%2520glutamate%2520homeostasis%2520hypothesis%2520of%2520addiction%26jtitle%3DNat.%2520Rev.%2520Neurosci.%26date%3D2009%26volume%3D10%26spage%3D561%26epage%3D572" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Semenova, S.; Markou, A.</span><span> </span><span class="NLM_article-title">Metabotropic glutamate receptors as targets for the treatment of drug and alcohol dependence</span>. In <i>Glutamate-based Therapies for Psychiatric Disorders</i>; <span class="NLM_contrib-group">Skolnick, P.</span>, Vol. Ed.; <span class="NLM_contrib-group">Parnham, M.J.; ; Bruinvels, J.</span>, Series Eds.;  <span class="citation_source-book">Milestones in Drug Therapy</span>; <span class="NLM_publisher-name">Springer Birkhauser</span>: <span class="NLM_publisher-loc">Basel</span>,<span class="NLM_x"> </span><span class="NLM_year">2010</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">133</span><span class="NLM_x">–</span> <span class="NLM_lpage">156</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm3005306&amp;key=10.1007%2F978-3-0346-0241-9_8" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&pages=133-156&author=S.+Semenova&author=A.+Markouauthor=P.+Skolnickauthor=M.J.+Parnham&author=J.+Bruinvels&title=Milestones+in+Drug+Therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1007%2F978-3-0346-0241-9_8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-3-0346-0241-9_8%26sid%3Dliteratum%253Aachs%26aulast%3DSemenova%26aufirst%3DS.%26atitle%3DMetabotropic%2520glutamate%2520receptors%2520as%2520targets%2520for%2520the%2520treatment%2520of%2520drug%2520and%2520alcohol%2520dependence%26aulast%3DSkolnick%26aufirst%3DP.%26aulast%3DParnham%26aufirst%3DM.J.%26btitle%3DMilestones%2520in%2520Drug%2520Therapy%26pub%3DSpringer%2520Birkhauser%26date%3D2010%26spage%3D133%26epage%3D156" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Liechti, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lhuillier, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaupmann, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markou, A.</span><span> </span><span class="NLM_article-title">Metabotropic glutamate 2/3 receptors in the ventral tegmental area and the nucleus accumbens shell are involved in behaviors relating to nicotine dependence</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">9077</span><span class="NLM_x">–</span> <span class="NLM_lpage">9085</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm3005306&amp;key=10.1523%2FJNEUROSCI.1766-07.2007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm3005306&amp;key=17715344" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm3005306&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVSnsLnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2007&pages=9077-9085&author=M.+E.+Liechtiauthor=L.+Lhuillierauthor=K.+Kaupmannauthor=A.+Markou&title=Metabotropic+glutamate+2%2F3+receptors+in+the+ventral+tegmental+area+and+the+nucleus+accumbens+shell+are+involved+in+behaviors+relating+to+nicotine+dependence"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Metabotropic glutamate 2/3 receptors in the ventral tegmental area and the nucleus accumbens shell are involved in behaviors relating to nicotine dependence</span></div><div class="casAuthors">Liechti, Matthias E.; Lhuillier, Loic; Kaupmann, Klemens; Markou, Athina</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">34</span>),
    <span class="NLM_cas:pages">9077-9085</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">The motivation to maintain nicotine self-administration and dependence may involve alterations in glutamatergic neurotransmission.  Metabotropic glutamate (mGlu) 2/3 receptors regulate glutamate and dopamine release in the ventral tegmental area (VTA) and the nucleus accumbens (NAc) shell, two brain areas critically involved in reward and motivational processes.  We found that acute systemic, as well as intra-VTA or intra-NAc, administration of the mGlu2/3 receptor agonist LY379268 [(-)-2-oxa-4-aminobicyclo[3.1.0]hexane-4,6-dicarboxylate] decreased nicotine, but not food, self-administration in rats.  In addn., nicotine self-administration downregulated mGlu2/3 receptor function in corticolimbic rat brain sites including the VTA and the NAc, demonstrated by decreased coupling of mGlu2/3 receptor to G-proteins in the [35S]GTPγS binding assay.  Furthermore, repeated treatment with LY379268 reduced nicotine self-administration at the beginning of a 14 d treatment period; however, the no. of nicotine infusions earned gradually returned to baseline levels, indicating tolerance to the effects of repeated LY379268 treatment.  Finally, LY379268 administration decreased both cue-induced reinstatement of nicotine- and food-seeking behavior.  Together, these findings indicate an important role for mGlu2/3 receptors in the posterior VTA and the NAc shell in the mediation of the rewarding effects of nicotine and potentially in cue-induced nicotine-seeking behavior.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQ7-uDyGc0jrVg90H21EOLACvtfcHk0lg9GOIz11csGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVSnsLnL&md5=73e420d3b66d2a6941302717dce4d988</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.1766-07.2007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.1766-07.2007%26sid%3Dliteratum%253Aachs%26aulast%3DLiechti%26aufirst%3DM.%2BE.%26aulast%3DLhuillier%26aufirst%3DL.%26aulast%3DKaupmann%26aufirst%3DK.%26aulast%3DMarkou%26aufirst%3DA.%26atitle%3DMetabotropic%2520glutamate%25202%252F3%2520receptors%2520in%2520the%2520ventral%2520tegmental%2520area%2520and%2520the%2520nucleus%2520accumbens%2520shell%2520are%2520involved%2520in%2520behaviors%2520relating%2520to%2520nicotine%2520dependence%26jtitle%3DJ.%2520Neurosci.%26date%3D2007%26volume%3D27%26spage%3D9077%26epage%3D9085" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Conn, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pin, J. P.</span><span> </span><span class="NLM_article-title">Pharmacology and functions of metabotropic glutamate receptors</span> <span class="citation_source-journal">Annu. Rev. Pharmacol. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">205</span><span class="NLM_x">–</span> <span class="NLM_lpage">237</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm3005306&amp;key=10.1146%2Fannurev.pharmtox.37.1.205" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm3005306&amp;key=9131252" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm3005306&amp;key=1%3ACAS%3A528%3ADyaK2sXisl2ktr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1997&pages=205-237&author=P.+J.+Connauthor=J.+P.+Pin&title=Pharmacology+and+functions+of+metabotropic+glutamate+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacology and functions of metabotropic glutamate receptors</span></div><div class="casAuthors">Conn, P. Jeffrey; Pin, Jean-Philippe</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Pharmacology and Toxicology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">205-237</span>CODEN:
                <span class="NLM_cas:coden">ARPTDI</span>;
        ISSN:<span class="NLM_cas:issn">0362-1642</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews</span>)
        </div><div class="casAbstract">A review, with 198 refs.  In the mid to late 1980s, studies were published that provided the first evidence for the existence of glutamate receptors that are not ligand-gated cation channels but are coupled to effector systems through GTP-binding proteins.  Since those initial reports, tremendous progress has been made in characterizing these metabotropic glutamate receptors (mGluRs), including cloning and characterization of cDNA that encodes a family of eight mGluR subtypes, several of which have multiple splice variants.  Also, tremendous progress has been made in developing new highly selective mGluR agonists and antagonists and toward detg. the physiol. roles of the mGluRs in mammalian brain.  These findings have exciting implications for drug development and suggest that the mGluRs provide a novel target for development of therapeutic agents that could have a significant impact on neuropharmacol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGph1fuaHYNvC7Vg90H21EOLACvtfcHk0liXUQ3kJdomxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXisl2ktr0%253D&md5=d9df228141c4747f80bbd9d2f0843a24</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1146%2Fannurev.pharmtox.37.1.205&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.pharmtox.37.1.205%26sid%3Dliteratum%253Aachs%26aulast%3DConn%26aufirst%3DP.%2BJ.%26aulast%3DPin%26aufirst%3DJ.%2BP.%26atitle%3DPharmacology%2520and%2520functions%2520of%2520metabotropic%2520glutamate%2520receptors%26jtitle%3DAnnu.%2520Rev.%2520Pharmacol.%2520Toxicol.%26date%3D1997%26volume%3D37%26spage%3D205%26epage%3D237" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Sheffler, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinkerton, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dahl, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markou, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cosford, N. D. P.</span><span> </span><span class="NLM_article-title">Recent progress in the synthesis and characterization of group II metabotropic glutamate receptor allosteric modulators</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">382</span><span class="NLM_x">–</span> <span class="NLM_lpage">393</span></span><div class="citationLinks">[<a href="/doi/10.1021/cn200008d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm3005306&amp;key=1%3ACAS%3A528%3ADC%252BC3MXksFaqtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=382-393&author=D.+J.+Shefflerauthor=A.+B.+Pinkertonauthor=R.+Dahlauthor=A.+Markouauthor=N.+D.+P.+Cosford&title=Recent+progress+in+the+synthesis+and+characterization+of+group+II+metabotropic+glutamate+receptor+allosteric+modulators"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Recent Progress in the Synthesis and Characterization of Group II Metabotropic Glutamate Receptor Allosteric Modulators</span></div><div class="casAuthors">Sheffler, Douglas J.; Pinkerton, Anthony B.; Dahl, Russell; Markou, Athina; Cosford, Nicholas D. P.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">382-393</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Group II metabotropic glutamate (mGlu) receptors consist of the metabotropic glutamate 2 (mGlu2) and metabotropic glutamate 3 (mGlu3) receptor subtypes which modulate glutamate transmission by second messenger activation to neg. regulate the activity of adenylyl cyclase.  Excessive accumulation of glutamate in the perisynaptic extracellular region triggers mGlu2 and mGlu3 receptors to inhibit further release of glutamate.  There is growing evidence that the modulation of glutamatergic neurotransmission by small mol. modulators of Group II mGlu receptors has significant potential for the treatment of several neuropsychiatric and neurodegenerative diseases.  This review provides an overview of recent progress on the synthesis and pharmacol. characterization of pos. and neg. allosteric modulators of the Group II mGlu receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpN3kTaVydOYbVg90H21EOLACvtfcHk0liXUQ3kJdomxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXksFaqtbg%253D&md5=98860a15e30c38b831332dcc82425f14</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fcn200008d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn200008d%26sid%3Dliteratum%253Aachs%26aulast%3DSheffler%26aufirst%3DD.%2BJ.%26aulast%3DPinkerton%26aufirst%3DA.%2BB.%26aulast%3DDahl%26aufirst%3DR.%26aulast%3DMarkou%26aufirst%3DA.%26aulast%3DCosford%26aufirst%3DN.%2BD.%2BP.%26atitle%3DRecent%2520progress%2520in%2520the%2520synthesis%2520and%2520characterization%2520of%2520group%2520II%2520metabotropic%2520glutamate%2520receptor%2520allosteric%2520modulators%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2011%26volume%3D2%26spage%3D382%26epage%3D393" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Fell, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witkin, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falcone, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katner, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perry, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hart, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rorick-Kehn, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Overshiner, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rasmussen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaney, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benvenga, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marlow, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luecke, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wafford, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seidel, W. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edgar, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quets, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felder, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heinz, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nikolayev, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, M.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayhugh, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khilevich, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ebert, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eckstein, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ackermann, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swanson, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catlow, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dean, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tauscher-Wisniewski, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marek, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schkeryantz, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svensson, K. A.</span><span> </span><span class="NLM_article-title">N-(4-((2-(Trifluoromethyl)-3-hydroxy-4-(isobutyryl)phenoxy) methyl)benzyl)-1-methyl-1H-imidazole-4-carboxamide (THIIC), a novel metabotropic glutamate 2 potentiator with potential anxiolytic/antidepressant properties: in vivo profiling suggests a link between behavioral and central nervous system neurochemical changes</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">336</span><span class="NLM_x">, </span> <span class="NLM_fpage">165</span><span class="NLM_x">–</span> <span class="NLM_lpage">177</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm3005306&amp;key=10.1124%2Fjpet.110.172957" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm3005306&amp;key=20947638" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm3005306&amp;key=1%3ACAS%3A528%3ADC%252BC3MXls1erug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=336&publication_year=2011&pages=165-177&author=M.+J.+Fellauthor=J.+M.+Witkinauthor=J.+F.+Falconeauthor=J.+S.+Katnerauthor=K.+W.+Perryauthor=J.+Hartauthor=L.+Rorick-Kehnauthor=C.+D.+Overshinerauthor=K.+Rasmussenauthor=S.+F.+Chaneyauthor=M.+J.+Benvengaauthor=X.+Liauthor=D.+L.+Marlowauthor=L.+K.+Thompsonauthor=S.+K.+Lueckeauthor=K.+A.+Waffordauthor=W.+F.+Seidelauthor=D.+M.+Edgarauthor=A.+T.+Quetsauthor=C.+C.+Felderauthor=X.+Wangauthor=B.+A.+Heinzauthor=A.+Nikolayevauthor=M.-S.+Kuoauthor=D.+Mayhughauthor=A.+Khilevichauthor=D.+Zhangauthor=P.+J.+Ebertauthor=J.+A.+Ecksteinauthor=B.+L.+Ackermannauthor=S.+P.+Swansonauthor=J.+T.+Catlowauthor=R.+A.+Deanauthor=K.+Jacksonauthor=S.+Tauscher-Wisniewskiauthor=G.+J.+Marekauthor=J.+M.+Schkeryantzauthor=K.+A.+Svensson&title=N-%284-%28%282-%28Trifluoromethyl%29-3-hydroxy-4-%28isobutyryl%29phenoxy%29+methyl%29benzyl%29-1-methyl-1H-imidazole-4-carboxamide+%28THIIC%29%2C+a+novel+metabotropic+glutamate+2+potentiator+with+potential+anxiolytic%2Fantidepressant+properties%3A+in+vivo+profiling+suggests+a+link+between+behavioral+and+central+nervous+system+neurochemical+changes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">N-(4-((2-(trifluoromethyl)-3-hydroxy-4-(isobutyryl)phenoxy)methyl)benzyl)-1-methyl-1H-imidazole-4-carboxamide (THIIC), a novel metabotropic glutamate 2 potentiator with potential anxiolytic/antidepressant properties: in vivo profiling suggests a link between behavioral and central nervous system neurochemical changes</span></div><div class="casAuthors">Fell, Matthew J.; Witkin, Jeffrey M.; Falcone, Julie F.; Katner, Jason S.; Perry, Kenneth W.; Hart, John; Rorick-Kehn, Linda; Overshiner, Carl D.; Rasmussen, Kurt; Chaney, Stephen F.; Benvenga, Mark J.; Li, Xia; Marlow, Deanna L.; Thompson, Linda K.; Luecke, Susan K.; Wafford, Keith A.; Seidel, Wesley F.; Edgar, Dale M.; Quets, Anne T.; Felder, Christian C.; Wang, XuShan; Heinz, Beverly A.; Nikolayev, Alexander; Kuo, Ming-Shang; Mayhugh, Daniel; Khilevich, Albert; Zhang, Deyi; Ebert, Philip J.; Eckstein, James A.; Ackermann, Bradley L.; Swanson, Steven P.; Catlow, John T.; Dean, Robert A.; Jackson, Kimberley; Tauscher-Wisniewski, Sitra; Marek, Gerard J.; Schkeryantz, Jeffrey M.; Svensson, Kjell A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">336</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">165-177</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The normalization of excessive glutamatergic neurotransmission through the activation of metabotropic glutamate 2 (mGlu2) receptors may have therapeutic potential in a variety of psychiatric disorders, including anxiety/depression and schizophrenia.  Here, we characterize the pharmacol. properties of N-(4-((2-(trifluoromethyl)-3-hydroxy-4-(isobutyryl)phenoxy)methyl)benzyl)-1-methyl-1H-imidazole-4-carboxamide (THIIC), a structurally novel, potent, and selective allosteric potentiator of human and rat mGlu2 receptors (EC50 = 23 and 13 nM, resp.).  THIIC produced anxiolytic-like efficacy in the rat stress-induced hyperthermia assay and the mouse stress-induced elevation of cerebellar cGMP and marble-burying assays.  THIIC also produced robust activity in three assays that detect antidepressant-like activity, including the mouse forced-swim test, the rat differential reinforcement of low rate 72-s assay, and the rat dominant-submissive test, with a maximal response similar to that of impiramine.  Effects of THIIC in the forced-swim test and marble burying were deleted in mGlu2 receptor null mice.  Anal. of sleep EEG showed that THIIC had a sleep-promoting profile with increased non-rapid eye movement (REM) and decreased REM sleep.  THIIC also decreased the dark phase increase in extracellular histamine in the medial prefrontal cortex and decreased levels of the histamine metabolite tele-methylhistamine (t-MeHA) in rat cerebrospinal fluid.  Collectively, these results indicate that the novel mGlu2-pos. allosteric modulator THIIC has robust activity in models used to predict anxiolytic/antidepressant efficacy, substantiating, at least with this mol., differentiation in the biol. impact of mGlu2 potentiation vs. mGlu2/3 orthosteric agonism.  In addn., we provide evidence that sleep EEG and CSF t-MeHA might function as viable biomarker approaches to facilitate the translational development of THIIC and other mGlu2 potentiators.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocfm6DC8ijJrVg90H21EOLACvtfcHk0liXUQ3kJdomxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXls1erug%253D%253D&md5=ab138f946460f041067c5330a1b5217a</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1124%2Fjpet.110.172957&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.110.172957%26sid%3Dliteratum%253Aachs%26aulast%3DFell%26aufirst%3DM.%2BJ.%26aulast%3DWitkin%26aufirst%3DJ.%2BM.%26aulast%3DFalcone%26aufirst%3DJ.%2BF.%26aulast%3DKatner%26aufirst%3DJ.%2BS.%26aulast%3DPerry%26aufirst%3DK.%2BW.%26aulast%3DHart%26aufirst%3DJ.%26aulast%3DRorick-Kehn%26aufirst%3DL.%26aulast%3DOvershiner%26aufirst%3DC.%2BD.%26aulast%3DRasmussen%26aufirst%3DK.%26aulast%3DChaney%26aufirst%3DS.%2BF.%26aulast%3DBenvenga%26aufirst%3DM.%2BJ.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DMarlow%26aufirst%3DD.%2BL.%26aulast%3DThompson%26aufirst%3DL.%2BK.%26aulast%3DLuecke%26aufirst%3DS.%2BK.%26aulast%3DWafford%26aufirst%3DK.%2BA.%26aulast%3DSeidel%26aufirst%3DW.%2BF.%26aulast%3DEdgar%26aufirst%3DD.%2BM.%26aulast%3DQuets%26aufirst%3DA.%2BT.%26aulast%3DFelder%26aufirst%3DC.%2BC.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DHeinz%26aufirst%3DB.%2BA.%26aulast%3DNikolayev%26aufirst%3DA.%26aulast%3DKuo%26aufirst%3DM.-S.%26aulast%3DMayhugh%26aufirst%3DD.%26aulast%3DKhilevich%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DD.%26aulast%3DEbert%26aufirst%3DP.%2BJ.%26aulast%3DEckstein%26aufirst%3DJ.%2BA.%26aulast%3DAckermann%26aufirst%3DB.%2BL.%26aulast%3DSwanson%26aufirst%3DS.%2BP.%26aulast%3DCatlow%26aufirst%3DJ.%2BT.%26aulast%3DDean%26aufirst%3DR.%2BA.%26aulast%3DJackson%26aufirst%3DK.%26aulast%3DTauscher-Wisniewski%26aufirst%3DS.%26aulast%3DMarek%26aufirst%3DG.%2BJ.%26aulast%3DSchkeryantz%26aufirst%3DJ.%2BM.%26aulast%3DSvensson%26aufirst%3DK.%2BA.%26atitle%3DN-%25284-%2528%25282-%2528Trifluoromethyl%2529-3-hydroxy-4-%2528isobutyryl%2529phenoxy%2529%2520methyl%2529benzyl%2529-1-methyl-1H-imidazole-4-carboxamide%2520%2528THIIC%2529%252C%2520a%2520novel%2520metabotropic%2520glutamate%25202%2520potentiator%2520with%2520potential%2520anxiolytic%252Fantidepressant%2520properties%253A%2520in%2520vivo%2520profiling%2520suggests%2520a%2520link%2520between%2520behavioral%2520and%2520central%2520nervous%2520system%2520neurochemical%2520changes%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2011%26volume%3D336%26spage%3D165%26epage%3D177" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Garbaccio, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brnardic, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fraley, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartman, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutson, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magliaro, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uslaner, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huszar, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fillgrove, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Small, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, M. A.</span><span> </span><span class="NLM_article-title">Discovery of oxazolobenzimidazoles as positive allosteric modulators for the mGluR2 receptor</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">406</span><span class="NLM_x">–</span> <span class="NLM_lpage">410</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml100115a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=406-410&author=R.+M.+Garbaccioauthor=E.+J.+Brnardicauthor=M.+E.+Fraleyauthor=G.+D.+Hartmanauthor=P.+H.+Hutsonauthor=J.+A.+O%E2%80%99Brienauthor=B.+C.+Magliaroauthor=J.+M.+Uslanerauthor=S.+L.+Huszarauthor=K.+L.+Fillgroveauthor=J.+H.+Smallauthor=C.+Tangauthor=Y.+Kuoauthor=M.+A.+Jacobson&title=Discovery+of+oxazolobenzimidazoles+as+positive+allosteric+modulators+for+the+mGluR2+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fml100115a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml100115a%26sid%3Dliteratum%253Aachs%26aulast%3DGarbaccio%26aufirst%3DR.%2BM.%26aulast%3DBrnardic%26aufirst%3DE.%2BJ.%26aulast%3DFraley%26aufirst%3DM.%2BE.%26aulast%3DHartman%26aufirst%3DG.%2BD.%26aulast%3DHutson%26aufirst%3DP.%2BH.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DJ.%2BA.%26aulast%3DMagliaro%26aufirst%3DB.%2BC.%26aulast%3DUslaner%26aufirst%3DJ.%2BM.%26aulast%3DHuszar%26aufirst%3DS.%2BL.%26aulast%3DFillgrove%26aufirst%3DK.%2BL.%26aulast%3DSmall%26aufirst%3DJ.%2BH.%26aulast%3DTang%26aufirst%3DC.%26aulast%3DKuo%26aufirst%3DY.%26aulast%3DJacobson%26aufirst%3DM.%2BA.%26atitle%3DDiscovery%2520of%2520oxazolobenzimidazoles%2520as%2520positive%2520allosteric%2520modulators%2520for%2520the%2520mGluR2%2520receptor%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D1%26spage%3D406%26epage%3D410" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brodney, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Candler, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doran, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duplantier, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Efremov, I. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evrard, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kraus, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganong, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haas, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanks, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenza, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lazzaro, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maklad, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarthy, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, B. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rottas, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siuciak, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tingley, F. D.,  III</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, A. Q.</span><span> </span><span class="NLM_article-title">1-[(1-Methyl-1<i>H</i>-imidazol-2-yl)methyl]-4-phenylpiperidines as mGluR2 positive allosteric modulators for the treatment of psychosis</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">1724</span><span class="NLM_x">–</span> <span class="NLM_lpage">1739</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm101414h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=1724-1739&author=L.+Zhangauthor=M.+A.+Brodneyauthor=J.+Candlerauthor=A.+C.+Doranauthor=A.+J.+Duplantierauthor=I.+V.+Efremovauthor=E.+Evrardauthor=K.+Krausauthor=A.+H.+Ganongauthor=J.+A.+Haasauthor=A.+N.+Hanksauthor=K.+Jenzaauthor=J.+T.+Lazzaroauthor=N.+Makladauthor=S.+A.+McCarthyauthor=W.+Qianauthor=B.+N.+Rogersauthor=M.+D.+Rottasauthor=C.+J.+Schmidtauthor=J.+A.+Siuciakauthor=F.+D.+Tingleyauthor=A.+Q.+Zhang&title=1-%5B%281-Methyl-1H-imidazol-2-yl%29methyl%5D-4-phenylpiperidines+as+mGluR2+positive+allosteric+modulators+for+the+treatment+of+psychosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm101414h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101414h%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DBrodney%26aufirst%3DM.%2BA.%26aulast%3DCandler%26aufirst%3DJ.%26aulast%3DDoran%26aufirst%3DA.%2BC.%26aulast%3DDuplantier%26aufirst%3DA.%2BJ.%26aulast%3DEfremov%26aufirst%3DI.%2BV.%26aulast%3DEvrard%26aufirst%3DE.%26aulast%3DKraus%26aufirst%3DK.%26aulast%3DGanong%26aufirst%3DA.%2BH.%26aulast%3DHaas%26aufirst%3DJ.%2BA.%26aulast%3DHanks%26aufirst%3DA.%2BN.%26aulast%3DJenza%26aufirst%3DK.%26aulast%3DLazzaro%26aufirst%3DJ.%2BT.%26aulast%3DMaklad%26aufirst%3DN.%26aulast%3DMcCarthy%26aufirst%3DS.%2BA.%26aulast%3DQian%26aufirst%3DW.%26aulast%3DRogers%26aufirst%3DB.%2BN.%26aulast%3DRottas%26aufirst%3DM.%2BD.%26aulast%3DSchmidt%26aufirst%3DC.%2BJ.%26aulast%3DSiuciak%26aufirst%3DJ.%2BA.%26aulast%3DTingley%26aufirst%3DF.%2BD.%26aulast%3DZhang%26aufirst%3DA.%2BQ.%26atitle%3D1-%255B%25281-Methyl-1H-imidazol-2-yl%2529methyl%255D-4-phenylpiperidines%2520as%2520mGluR2%2520positive%2520allosteric%2520modulators%2520for%2520the%2520treatment%2520of%2520psychosis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D1724%26epage%3D1739" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Cid, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duvey, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tresadern, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nhem, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furnari, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cluzeau, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Lucas, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matesanz, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alonso, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linares, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrés, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poli, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vega, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lutjens, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Himogai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rocher, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macdonald, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oehlrich, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavreysen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahnaou, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drinkenburg, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackie, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trabanco, A. A.</span><span> </span><span class="NLM_article-title">Discovery of 1,4-disubstituted 3-cyano-2-pyridones: A new class of positive allosteric modulators of the metabotropic glutamate 2 receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">2388</span><span class="NLM_x">–</span> <span class="NLM_lpage">2405</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm2016864" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=2388-2405&author=J.+M.+Cidauthor=G.+Duveyauthor=G.+Tresadernauthor=V.+Nhemauthor=R.+Furnariauthor=P.+Cluzeauauthor=A.+I.+de+Lucasauthor=E.+Matesanzauthor=J.+M.+Alonsoauthor=M.+L.+Linaresauthor=J.+I.+Andr%C3%A9sauthor=S.+M.+Poliauthor=J.+A.+Vegaauthor=R.+Lutjensauthor=H.+Himogaiauthor=J.-P.+Rocherauthor=G.+J.+Macdonaldauthor=D.+Oehlrichauthor=H.+Lavreysenauthor=A.+Ahnaouauthor=W.+Drinkenburgauthor=C.+Mackieauthor=A.+A.+Trabanco&title=Discovery+of+1%2C4-disubstituted+3-cyano-2-pyridones%3A+A+new+class+of+positive+allosteric+modulators+of+the+metabotropic+glutamate+2+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm2016864&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2016864%26sid%3Dliteratum%253Aachs%26aulast%3DCid%26aufirst%3DJ.%2BM.%26aulast%3DDuvey%26aufirst%3DG.%26aulast%3DTresadern%26aufirst%3DG.%26aulast%3DNhem%26aufirst%3DV.%26aulast%3DFurnari%26aufirst%3DR.%26aulast%3DCluzeau%26aufirst%3DP.%26aulast%3Dde%2BLucas%26aufirst%3DA.%2BI.%26aulast%3DMatesanz%26aufirst%3DE.%26aulast%3DAlonso%26aufirst%3DJ.%2BM.%26aulast%3DLinares%26aufirst%3DM.%2BL.%26aulast%3DAndr%25C3%25A9s%26aufirst%3DJ.%2BI.%26aulast%3DPoli%26aufirst%3DS.%2BM.%26aulast%3DVega%26aufirst%3DJ.%2BA.%26aulast%3DLutjens%26aufirst%3DR.%26aulast%3DHimogai%26aufirst%3DH.%26aulast%3DRocher%26aufirst%3DJ.-P.%26aulast%3DMacdonald%26aufirst%3DG.%2BJ.%26aulast%3DOehlrich%26aufirst%3DD.%26aulast%3DLavreysen%26aufirst%3DH.%26aulast%3DAhnaou%26aufirst%3DA.%26aulast%3DDrinkenburg%26aufirst%3DW.%26aulast%3DMackie%26aufirst%3DC.%26aulast%3DTrabanco%26aufirst%3DA.%2BA.%26atitle%3DDiscovery%2520of%25201%252C4-disubstituted%25203-cyano-2-pyridones%253A%2520A%2520new%2520class%2520of%2520positive%2520allosteric%2520modulators%2520of%2520the%2520metabotropic%2520glutamate%25202%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D2388%26epage%3D2405" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Trabanco, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tresadern, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macdonald, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vega, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Lucas, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matesanz, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">García, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linares, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Diego, S. A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alonso, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oehlrich, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahnaou, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drinkenburg, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackie, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrés, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavreysen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cid, J. M.</span><span> </span><span class="NLM_article-title">Imidazo[1,2-<i>a</i>]pyridines: Orally active positive allosteric modulators of the metabotropic glutamate 2 receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">2688</span><span class="NLM_x">–</span> <span class="NLM_lpage">2701</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm201561r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=2688-2701&author=A.+A.+Trabancoauthor=G.+Tresadernauthor=G.+J.+Macdonaldauthor=J.+A.+Vegaauthor=A.+I.+de+Lucasauthor=E.+Matesanzauthor=A.+Garc%C3%ADaauthor=M.+L.+Linaresauthor=S.+A.+A.+de+Diegoauthor=J.+M.+Alonsoauthor=D.+Oehlrichauthor=A.+Ahnaouauthor=W.+Drinkenburgauthor=C.+Mackieauthor=J.+I.+Andr%C3%A9sauthor=H.+Lavreysenauthor=J.+M.+Cid&title=Imidazo%5B1%2C2-a%5Dpyridines%3A+Orally+active+positive+allosteric+modulators+of+the+metabotropic+glutamate+2+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm201561r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201561r%26sid%3Dliteratum%253Aachs%26aulast%3DTrabanco%26aufirst%3DA.%2BA.%26aulast%3DTresadern%26aufirst%3DG.%26aulast%3DMacdonald%26aufirst%3DG.%2BJ.%26aulast%3DVega%26aufirst%3DJ.%2BA.%26aulast%3Dde%2BLucas%26aufirst%3DA.%2BI.%26aulast%3DMatesanz%26aufirst%3DE.%26aulast%3DGarc%25C3%25ADa%26aufirst%3DA.%26aulast%3DLinares%26aufirst%3DM.%2BL.%26aulast%3Dde%2BDiego%26aufirst%3DS.%2BA.%2BA.%26aulast%3DAlonso%26aufirst%3DJ.%2BM.%26aulast%3DOehlrich%26aufirst%3DD.%26aulast%3DAhnaou%26aufirst%3DA.%26aulast%3DDrinkenburg%26aufirst%3DW.%26aulast%3DMackie%26aufirst%3DC.%26aulast%3DAndr%25C3%25A9s%26aufirst%3DJ.%2BI.%26aulast%3DLavreysen%26aufirst%3DH.%26aulast%3DCid%26aufirst%3DJ.%2BM.%26atitle%3DImidazo%255B1%252C2-a%255Dpyridines%253A%2520Orally%2520active%2520positive%2520allosteric%2520modulators%2520of%2520the%2520metabotropic%2520glutamate%25202%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D2688%26epage%3D2701" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Dhanya, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sidique, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheffler, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nickols, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herath, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dahl, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ardecky, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Semenova, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markou, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cosford, N. D. P.</span><span> </span><span class="NLM_article-title">Design and synthesis of an orally active metabotropic glutamate receptor subtype-2 (mGluR2) positive allosteric modulator (PAM) that decreases cocaine self-administration in rats</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">342</span><span class="NLM_x">–</span> <span class="NLM_lpage">353</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm1012165" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm3005306&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFGlt7bO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=342-353&author=R.+Dhanyaauthor=S.+Sidiqueauthor=D.+J.+Shefflerauthor=H.+H.+Nickolsauthor=A.+Herathauthor=L.+Yangauthor=R.+Dahlauthor=R.+Ardeckyauthor=S.+Semenovaauthor=A.+Markouauthor=P.+J.+Connauthor=N.+D.+P.+Cosford&title=Design+and+synthesis+of+an+orally+active+metabotropic+glutamate+receptor+subtype-2+%28mGluR2%29+positive+allosteric+modulator+%28PAM%29+that+decreases+cocaine+self-administration+in+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Design and synthesis of an orally active metabotropic glutamate receptor subtype-2 (mGluR2) positive allosteric modulator (PAM) that decreases cocaine self-administration in rats</span></div><div class="casAuthors">Dhanya, Raveendra-Panickar; Sidique, Shyama; Sheffler, Douglas J.; Nickols, Hilary Highfield; Herath, Ananda; Yang, Li; Dahl, Russell; Ardecky, Robert; Semenova, Svetlana; Markou, Athina; Conn, P. Jeffrey; Cosford, Nicholas D. P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">342-353</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The modification of 3'-((2-cyclopentyl-6,7-dimethyl-1-oxo-2,3-dihydro-1H-inden-5-yloxy)methyl)biphenyl-4-carboxylic acid (BINA, I) by incorporating heteroatoms into the structure and replacing the cyclopentyl moiety led to the development of new mGluR2 pos. allosteric modulators (PAMs) with optimized potency and superior druglike properties.  These analogs are more potent than I in vitro and are highly selective for mGluR2 vs other mGluR subtypes.  They have significantly improved pharmacokinetic (PK) properties, with excellent oral bioavailability and brain penetration.  The benzisothiazol-3-one deriv. II decreased cocaine self-administration in rats, providing proof-of-concept for the use of mGluR2 PAMs for the treatment of cocaine dependence.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRmO8DAzKVg7Vg90H21EOLACvtfcHk0liKsfHJxa9Dog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFGlt7bO&md5=402c4f95aa11618fe07c8d146ffc2a8e</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjm1012165&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1012165%26sid%3Dliteratum%253Aachs%26aulast%3DDhanya%26aufirst%3DR.%26aulast%3DSidique%26aufirst%3DS.%26aulast%3DSheffler%26aufirst%3DD.%2BJ.%26aulast%3DNickols%26aufirst%3DH.%2BH.%26aulast%3DHerath%26aufirst%3DA.%26aulast%3DYang%26aufirst%3DL.%26aulast%3DDahl%26aufirst%3DR.%26aulast%3DArdecky%26aufirst%3DR.%26aulast%3DSemenova%26aufirst%3DS.%26aulast%3DMarkou%26aufirst%3DA.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26aulast%3DCosford%26aufirst%3DN.%2BD.%2BP.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520an%2520orally%2520active%2520metabotropic%2520glutamate%2520receptor%2520subtype-2%2520%2528mGluR2%2529%2520positive%2520allosteric%2520modulator%2520%2528PAM%2529%2520that%2520decreases%2520cocaine%2520self-administration%2520in%2520rats%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D342%26epage%3D353" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Jin, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Semenova, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ardecky, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheffler, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dahl, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cosford, N. D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markou, M.</span><span> </span><span class="NLM_article-title">The mGluR2 positive allosteric modulator BINA decreases cocaine self-administration, cue-induced cocaine-seeking and counteracts cocaine-induced enhancement of brain reward function in rats</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">2021</span><span class="NLM_x">–</span> <span class="NLM_lpage">2036</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2010&pages=2021-2036&author=X.+Jinauthor=S.+Semenovaauthor=L.+Yangauthor=A.+Ardeckyauthor=D.+J.+Shefflerauthor=R.+Dahlauthor=J.+P.+Connauthor=N.+D.+P.+Cosfordauthor=M.+Markou&title=The+mGluR2+positive+allosteric+modulator+BINA+decreases+cocaine+self-administration%2C+cue-induced+cocaine-seeking+and+counteracts+cocaine-induced+enhancement+of+brain+reward+function+in+rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJin%26aufirst%3DX.%26aulast%3DSemenova%26aufirst%3DS.%26aulast%3DYang%26aufirst%3DL.%26aulast%3DArdecky%26aufirst%3DA.%26aulast%3DSheffler%26aufirst%3DD.%2BJ.%26aulast%3DDahl%26aufirst%3DR.%26aulast%3DConn%26aufirst%3DJ.%2BP.%26aulast%3DCosford%26aufirst%3DN.%2BD.%2BP.%26aulast%3DMarkou%26aufirst%3DM.%26atitle%3DThe%2520mGluR2%2520positive%2520allosteric%2520modulator%2520BINA%2520decreases%2520cocaine%2520self-administration%252C%2520cue-induced%2520cocaine-seeking%2520and%2520counteracts%2520cocaine-induced%2520enhancement%2520of%2520brain%2520reward%2520function%2520in%2520rats%26jtitle%3DNeuropsychopharmacology%26date%3D2010%26volume%3D35%26spage%3D2021%26epage%3D2036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Van Wagenen, B.; Ukkiramapandian, R.; Clayton, J.; Egle, I.; Empfield, J.; Isaac, M.; Ma, F.; Slassi, A.; Steelman, G.; Urbanek, R.; Walsh, S.</span><span> </span><span class="NLM_article-title">Metabotropic glutamate receptor potentiating isoindolinones</span>. WO/2007/021308, Feb 22,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=B.+Van+Wagenen&author=R.+Ukkiramapandian&author=J.+Clayton&author=I.+Egle&author=J.+Empfield&author=M.+Isaac&author=F.+Ma&author=A.+Slassi&author=G.+Steelman&author=R.+Urbanek&author=S.+Walsh&title=Metabotropic+glutamate+receptor+potentiating+isoindolinones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BWagenen%26aufirst%3DB.%26atitle%3DMetabotropic%2520glutamate%2520receptor%2520potentiating%2520isoindolinones%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Niswender, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayala, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weaver, C. D.</span><span> </span><span class="NLM_article-title">A novel assay of Gi/o-linked G protein-coupled receptor coupling to potassium channels provides new insights into the pharmacology of the group III metabotropic glutamate receptors</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">1213</span><span class="NLM_x">–</span> <span class="NLM_lpage">1224</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2008&pages=1213-1224&author=C.+M.+Niswenderauthor=K.+A.+Johnsonauthor=Q.+Luoauthor=J.+E.+Ayalaauthor=C.+Kimauthor=P.+J.+Connauthor=C.+D.+Weaver&title=A+novel+assay+of+Gi%2Fo-linked+G+protein-coupled+receptor+coupling+to+potassium+channels+provides+new+insights+into+the+pharmacology+of+the+group+III+metabotropic+glutamate+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNiswender%26aufirst%3DC.%2BM.%26aulast%3DJohnson%26aufirst%3DK.%2BA.%26aulast%3DLuo%26aufirst%3DQ.%26aulast%3DAyala%26aufirst%3DJ.%2BE.%26aulast%3DKim%26aufirst%3DC.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26aulast%3DWeaver%26aufirst%3DC.%2BD.%26atitle%3DA%2520novel%2520assay%2520of%2520Gi%252Fo-linked%2520G%2520protein-coupled%2520receptor%2520coupling%2520to%2520potassium%2520channels%2520provides%2520new%2520insights%2520into%2520the%2520pharmacology%2520of%2520the%2520group%2520III%2520metabotropic%2520glutamate%2520receptors%26jtitle%3DMol.%2520Pharmacol.%26date%3D2008%26volume%3D73%26spage%3D1213%26epage%3D1224" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Di, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerns, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McConnell, O. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, G. T.</span><span> </span><span class="NLM_article-title">High throughput artificial membrane permeability assay for blood-brain barrier</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">223</span><span class="NLM_x">–</span> <span class="NLM_lpage">232</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm3005306&amp;key=10.1016%2FS0223-5234%2803%2900012-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm3005306&amp;key=12667689" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm3005306&amp;key=1%3ACAS%3A528%3ADC%252BD3sXitlKju7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2003&pages=223-232&author=L.+Diauthor=E.+H.+Kernsauthor=K.+Fanauthor=O.+J.+McConnellauthor=G.+T.+Carter&title=High+throughput+artificial+membrane+permeability+assay+for+blood-brain+barrier"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">High throughput artificial membrane permeability assay for blood-brain barrier</span></div><div class="casAuthors">Di, Li; Kerns, Edward H.; Fan, Kristi; McConnell, Oliver J.; Carter, Guy T.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">223-232</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Editions Scientifiques et Medicales Elsevier</span>)
        </div><div class="casAbstract">The recent advances in high throughput screening for biol. activities and combinatorial chem. have greatly expanded the no. of drug candidates.  Rapid screening for BBB penetration potential early in drug discovery programs provides important information for compd. selection and guidance of synthesis for desirable CNS properties.  In this paper, we discuss a modification of the parallel artificial membrane permeation assay (PAMPA) for the prediction of blood-brain barrier penetration (PAMPA-BBB).  The assay was developed with 30 structurally diverse com. drugs and validated with 14 Wyeth Research compds.  The PAMPA-BBB assay has the advantages of: predicting passive blood-brain barrier penetration with high success, high throughput, low cost, and reproducibility.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZCg9Ka4mziLVg90H21EOLACvtfcHk0liKsfHJxa9Dog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXitlKju7c%253D&md5=d228d5808ba8df23deed92c5e2bf3863</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2FS0223-5234%2803%2900012-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0223-5234%252803%252900012-6%26sid%3Dliteratum%253Aachs%26aulast%3DDi%26aufirst%3DL.%26aulast%3DKerns%26aufirst%3DE.%2BH.%26aulast%3DFan%26aufirst%3DK.%26aulast%3DMcConnell%26aufirst%3DO.%2BJ.%26aulast%3DCarter%26aufirst%3DG.%2BT.%26atitle%3DHigh%2520throughput%2520artificial%2520membrane%2520permeability%2520assay%2520for%2520blood-brain%2520barrier%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2003%26volume%3D38%26spage%3D223%26epage%3D232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Hemstapat, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Da Costa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nong, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brady, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niswender, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamagnan, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, P. J.</span><span> </span><span class="NLM_article-title">A novel family of potent negative allosteric modulators of group II metabotropic glutamate receptors</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">322</span><span class="NLM_x">, </span> <span class="NLM_fpage">254</span><span class="NLM_x">–</span> <span class="NLM_lpage">264</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm3005306&amp;key=10.1124%2Fjpet.106.117093" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm3005306&amp;key=17416742" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm3005306&amp;key=1%3ACAS%3A528%3ADC%252BD2sXntl2jtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=322&publication_year=2007&pages=254-264&author=K.+Hemstapatauthor=H.+Da+Costaauthor=Y.+Nongauthor=A.+E.+Bradyauthor=Q.+Luoauthor=C.+M.+Niswenderauthor=G.+D.+Tamagnanauthor=P.+J.+Conn&title=A+novel+family+of+potent+negative+allosteric+modulators+of+group+II+metabotropic+glutamate+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">A novel family of potent negative allosteric modulators of group II metabotropic glutamate receptors</span></div><div class="casAuthors">Hemstapat, Kamondanai; Da Costa, Herve; Nong, Yi; Brady, Ashley E.; Luo, Qingwei; Niswender, Colleen M.; Tamagnan, Gilles D.; Conn, P. Jeffrey</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">322</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">254-264</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Group II metabotropic glutamate receptors (mGluRs), mGluR2 and mGluR3, play a no. of important roles in mammalian brain and represent exciting new targets for certain central nervous system disorders.  We now report synthesis and characterization of a novel family of derivs. of dihydrobenzo[1,4]diazepin-2-one that are selective neg. allosteric modulators for group II mGluRs.  These compds. inhibit both mGluR2 and mGluR3 but have no activity at group I and III mGluRs.  The novel mGluR2/3 antagonists also potently block mGluR2/3-mediated inhibition of the field excitatory postsynaptic potentials at the perforant path synapse in hippocampal slices.  These compds. induce a rightward shift and decrease the maximal response in the glutamate concn.-response relation, consistent with a noncompetitive antagonist mechanism of action.  Furthermore, radioligand binding studies revealed no effect on binding of the orthosteric antagonist [3H]LY341495 [2S-2-amino-2-(1S,2S-2-carboxycyclopropan-1-yl)-3-(xanth-9-yl)propionic acid].  Site-directed mutagenesis revealed that a single point mutation in transmembrane V (N735D), previously shown to be an important residue for potentiation activity of the mGluR2 allosteric potentiator LY487379 [N-(4-(2-methoxyphenoxy)phenyl)-N-(2,2,2-trifluoroethylsulfonyl)pyrid-3-ylmethylamine], is not crit. for the inhibitory activity of neg. allosteric modulators of group II mGluRs.  However, this single mutation in human GluR2 almost completely blocked the enhancing activity of biphenyl-indanone A, a novel allosteric potentiator of mGluR2.  Our data suggest that these two pos. allosteric modulators of mGluR2 may share a common binding site and that this site may be distinct from the binding site for the new neg. allosteric modulators of group II mGluRs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqo14LJ7WYXzLVg90H21EOLACvtfcHk0lglkqPJMcuOzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXntl2jtLw%253D&md5=f0bc1e67558e269bdd389a35b3acba75</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1124%2Fjpet.106.117093&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.106.117093%26sid%3Dliteratum%253Aachs%26aulast%3DHemstapat%26aufirst%3DK.%26aulast%3DDa%2BCosta%26aufirst%3DH.%26aulast%3DNong%26aufirst%3DY.%26aulast%3DBrady%26aufirst%3DA.%2BE.%26aulast%3DLuo%26aufirst%3DQ.%26aulast%3DNiswender%26aufirst%3DC.%2BM.%26aulast%3DTamagnan%26aufirst%3DG.%2BD.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26atitle%3DA%2520novel%2520family%2520of%2520potent%2520negative%2520allosteric%2520modulators%2520of%2520group%2520II%2520metabotropic%2520glutamate%2520receptors%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2007%26volume%3D322%26spage%3D254%26epage%3D264" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Engers, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niswender, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weaver, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jadhav, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menon, U. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zamorano, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hopkins, C. R.</span><span> </span><span class="NLM_article-title">Synthesis and evaluation of a series of heterobiaryl amides that are centrally penetrant metabotropic glutamate receptor 4 (mGluR4) positive allosteric modulators (PAMs)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">4115</span><span class="NLM_x">–</span> <span class="NLM_lpage">4118</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9005065" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=4115-4118&author=D.+W.+Engersauthor=C.+M.+Niswenderauthor=C.+D.+Weaverauthor=S.+Jadhavauthor=U.+N.+Menonauthor=R.+Zamoranoauthor=P.+J.+Connauthor=C.+W.+Lindsleyauthor=C.+R.+Hopkins&title=Synthesis+and+evaluation+of+a+series+of+heterobiaryl+amides+that+are+centrally+penetrant+metabotropic+glutamate+receptor+4+%28mGluR4%29+positive+allosteric+modulators+%28PAMs%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjm9005065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9005065%26sid%3Dliteratum%253Aachs%26aulast%3DEngers%26aufirst%3DD.%2BW.%26aulast%3DNiswender%26aufirst%3DC.%2BM.%26aulast%3DWeaver%26aufirst%3DC.%2BD.%26aulast%3DJadhav%26aufirst%3DS.%26aulast%3DMenon%26aufirst%3DU.%2BN.%26aulast%3DZamorano%26aufirst%3DR.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DHopkins%26aufirst%3DC.%2BR.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520a%2520series%2520of%2520heterobiaryl%2520amides%2520that%2520are%2520centrally%2520penetrant%2520metabotropic%2520glutamate%2520receptor%25204%2520%2528mGluR4%2529%2520positive%2520allosteric%2520modulators%2520%2528PAMs%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D4115%26epage%3D4118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 21 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Tomoteru Yamasaki, Xiaofei Zhang, Katsushi Kumata, Yiding Zhang, Xiaoyun Deng, Masayuki Fujinaga, Zhen Chen, Wakana Mori, Kuan Hu, Hidekatsu Wakizaka, Akiko Hatori, Lin Xie, Masanao Ogawa, Nobuki Nengaki, Richard Van, Yihan Shao, Douglas J. Sheffler, Nicholas D. P. Cosford, Steven H. Liang, <span class="NLM_string-name hlFld-ContribAuthor">Ming-Rong Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Identification and Development of a New Positron Emission Tomography Ligand 4-(2-Fluoro-4-[11C]methoxyphenyl)-5-((1-methyl-1H-pyrazol-3-yl)methoxy)picolinamide for Imaging Metabotropic Glutamate Receptor Subtype 2 (mGlu2). </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (20)
                                     , 11469-11483. <a href="https://doi.org/10.1021/acs.jmedchem.9b01991" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01991</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01991&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01991%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIdentification%252Band%252BDevelopment%252Bof%252Ba%252BNew%252BPositron%252BEmission%252BTomography%252BLigand%252B4-%2525282-Fluoro-4-%25255B11C%25255Dmethoxyphenyl%252529-5-%252528%2525281-methyl-1H-pyrazol-3-yl%252529methoxy%252529picolinamide%252Bfor%252BImaging%252BMetabotropic%252BGlutamate%252BReceptor%252BSubtype%252B2%252B%252528mGlu2%252529%26aulast%3DYamasaki%26aufirst%3DTomoteru%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D29112019%26date%3D22092020%26volume%3D63%26issue%3D20%26spage%3D11469%26epage%3D11483" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaofei  Zhang</span>, <span class="hlFld-ContribAuthor ">Katsushi  Kumata</span>, <span class="hlFld-ContribAuthor ">Tomoteru  Yamasaki</span>, <span class="hlFld-ContribAuthor ">Ran  Cheng</span>, <span class="hlFld-ContribAuthor ">Akiko  Hatori</span>, <span class="hlFld-ContribAuthor ">Longle  Ma</span>, <span class="hlFld-ContribAuthor ">Yiding  Zhang</span>, <span class="hlFld-ContribAuthor ">Lin  Xie</span>, <span class="hlFld-ContribAuthor ">Lu  Wang</span>, <span class="hlFld-ContribAuthor ">Hye Jin  Kang</span>, <span class="hlFld-ContribAuthor ">Douglas J.  Sheffler</span>, <span class="hlFld-ContribAuthor ">Nicholas D. P.  Cosford</span>, <span class="hlFld-ContribAuthor ">Ming-Rong  Zhang</span>, and <span class="hlFld-ContribAuthor ">Steven H.  Liang</span>  . </span><span class="cited-content_cbyCitation_article-title">Synthesis and Preliminary Studies of a Novel Negative Allosteric Modulator, 7-((2,5-Dioxopyrrolidin-1-yl)methyl)-4-(2-fluoro-4-[11C]methoxyphenyl) quinoline-2-carboxamide, for Imaging of Metabotropic Glutamate Receptor 2. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2017,</strong> <em>8 </em>
                                    (9)
                                     , 1937-1948. <a href="https://doi.org/10.1021/acschemneuro.7b00098" title="DOI URL">https://doi.org/10.1021/acschemneuro.7b00098</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.7b00098&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.7b00098%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DSynthesis%252Band%252BPreliminary%252BStudies%252Bof%252Ba%252BNovel%252BNegative%252BAllosteric%252BModulator%25252C%252B7-%252528%2525282%25252C5-Dioxopyrrolidin-1-yl%252529methyl%252529-4-%2525282-fluoro-4-%25255B11C%25255Dmethoxyphenyl%252529%252Bquinoline-2-carboxamide%25252C%252Bfor%252BImaging%252Bof%252BMetabotropic%252BGlutamate%252BReceptor%252B2%26aulast%3DZhang%26aufirst%3DXiaofei%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D13032017%26date%3D31052017%26date%3D13062017%26date%3D20092017%26date%3D31052017%26volume%3D8%26issue%3D9%26spage%3D1937%26epage%3D1948" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Craig W.  Lindsley</span>, <span class="hlFld-ContribAuthor ">Kyle A.  Emmitte</span>, <span class="hlFld-ContribAuthor ">Corey R.  Hopkins</span>, <span class="hlFld-ContribAuthor ">Thomas M.  Bridges</span>, <span class="hlFld-ContribAuthor ">Karen J.  Gregory</span>, <span class="hlFld-ContribAuthor ">Colleen M.  Niswender</span>, and <span class="hlFld-ContribAuthor ">P. Jeffrey  Conn</span>  . </span><span class="cited-content_cbyCitation_article-title">Practical Strategies and Concepts in GPCR Allosteric Modulator Discovery: Recent Advances with Metabotropic Glutamate Receptors. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2016,</strong> <em>116 </em>
                                    (11)
                                     , 6707-6741. <a href="https://doi.org/10.1021/acs.chemrev.5b00656" title="DOI URL">https://doi.org/10.1021/acs.chemrev.5b00656</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.chemrev.5b00656&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.chemrev.5b00656%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DPractical%252BStrategies%252Band%252BConcepts%252Bin%252BGPCR%252BAllosteric%252BModulator%252BDiscovery%25253A%252BRecent%252BAdvances%252Bwith%252BMetabotropic%252BGlutamate%252BReceptors%26aulast%3DLindsley%26aufirst%3DCraig%2BW.%26date%3D2016%26date%3D2016%26date%3D2015%26date%3D06112015%26date%3D16022016%26date%3D08062016%26volume%3D116%26issue%3D11%26spage%3D6707%26epage%3D6741" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Raveendra-Panickar  Dhanya</span>, <span class="hlFld-ContribAuthor ">Douglas J.  Sheffler</span>, <span class="hlFld-ContribAuthor ">Russell  Dahl</span>, <span class="hlFld-ContribAuthor ">Melinda  Davis</span>, <span class="hlFld-ContribAuthor ">Pooi San  Lee</span>, <span class="hlFld-ContribAuthor ">Li  Yang</span>, <span class="hlFld-ContribAuthor ">Hilary Highfield  Nickols</span>, <span class="hlFld-ContribAuthor ">Hyekyung P.  Cho</span>, <span class="hlFld-ContribAuthor ">Layton H.  Smith</span>, <span class="hlFld-ContribAuthor ">Manoranjan S.  D’Souza</span>, <span class="hlFld-ContribAuthor ">P. Jeffrey  Conn</span>, <span class="hlFld-ContribAuthor ">Andre  Der-Avakian</span>, <span class="hlFld-ContribAuthor ">Athina  Markou</span>, and <span class="hlFld-ContribAuthor ">Nicholas D. P.  Cosford</span>  . </span><span class="cited-content_cbyCitation_article-title">Design and Synthesis of Systemically Active Metabotropic Glutamate Subtype-2 and -3 (mGlu2/3) Receptor Positive Allosteric Modulators (PAMs): Pharmacological Characterization and Assessment in a Rat Model of Cocaine Dependence. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (10)
                                     , 4154-4172. <a href="https://doi.org/10.1021/jm5000563" title="DOI URL">https://doi.org/10.1021/jm5000563</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm5000563&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm5000563%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Band%252BSynthesis%252Bof%252BSystemically%252BActive%252BMetabotropic%252BGlutamate%252BSubtype-2%252Band%252B-3%252B%252528mGlu2%25252F3%252529%252BReceptor%252BPositive%252BAllosteric%252BModulators%252B%252528PAMs%252529%25253A%252BPharmacological%252BCharacterization%252Band%252BAssessment%252Bin%252Ba%252BRat%252BModel%252Bof%252BCocaine%252BDependence%26aulast%3DDhanya%26aufirst%3DRaveendra-Panickar%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D10012014%26date%3D09052014%26date%3D22052014%26date%3D15042014%26volume%3D57%26issue%3D10%26spage%3D4154%26epage%3D4172" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Roberto  Frutos-Pedreño</span>, <span class="hlFld-ContribAuthor ">Pablo  González-Herrero</span>, and <span class="hlFld-ContribAuthor ">José  Vicente</span>  , <span class="hlFld-ContribAuthor ">Peter G.  Jones</span>  . </span><span class="cited-content_cbyCitation_article-title">Reactivity of Ortho-Palladated Benzamides toward CO, Isocyanides, and Alkynes. Synthesis of Functionalized Isoindolin-1-ones and 4,5-Disubstituted Benzo[c]azepine-1,3-diones. </span><span class="cited-content_cbyCitation_journal-name">Organometallics</span><span> <strong>2013,</strong> <em>32 </em>
                                    (16)
                                     , 4664-4676. <a href="https://doi.org/10.1021/om4006406" title="DOI URL">https://doi.org/10.1021/om4006406</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/om4006406&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fom4006406%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganometallics%26atitle%3DReactivity%252Bof%252BOrtho-Palladated%252BBenzamides%252Btoward%252BCO%25252C%252BIsocyanides%25252C%252Band%252BAlkynes.%252BSynthesis%252Bof%252BFunctionalized%252BIsoindolin-1-ones%252Band%252B4%25252C5-Disubstituted%252BBenzo%25255Bc%25255Dazepine-1%25252C3-diones%26aulast%3DFrutos-Pedre%25C3%25B1o%26aufirst%3DRoberto%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D01072013%26date%3D08082013%26date%3D26082013%26volume%3D32%26issue%3D16%26spage%3D4664%26epage%3D4676" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniele  Caprioli</span>, <span class="hlFld-ContribAuthor ">Zuzana  Justinova</span>, <span class="hlFld-ContribAuthor ">Marco  Venniro</span>, <span class="hlFld-ContribAuthor ">Yavin  Shaham</span>. </span><span class="cited-content_cbyCitation_article-title">Effect of Novel Allosteric Modulators of Metabotropic Glutamate Receptors on Drug Self-administration and Relapse: A Review of Preclinical Studies and Their Clinical Implications. </span><span class="cited-content_cbyCitation_journal-name">Biological Psychiatry</span><span> <strong>2018,</strong> <em>84 </em>
                                    (3)
                                     , 180-192. <a href="https://doi.org/10.1016/j.biopsych.2017.08.018" title="DOI URL">https://doi.org/10.1016/j.biopsych.2017.08.018</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.biopsych.2017.08.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.biopsych.2017.08.018%26sid%3Dliteratum%253Aachs%26jtitle%3DBiological%2520Psychiatry%26atitle%3DEffect%252Bof%252BNovel%252BAllosteric%252BModulators%252Bof%252BMetabotropic%252BGlutamate%252BReceptors%252Bon%252BDrug%252BSelf-administration%252Band%252BRelapse%25253A%252BA%252BReview%252Bof%252BPreclinical%252BStudies%252Band%252BTheir%252BClinical%252BImplications%26aulast%3DCaprioli%26aufirst%3DDaniele%26date%3D2018%26volume%3D84%26issue%3D3%26spage%3D180%26epage%3D192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anthony G.  Phillips</span>, <span class="hlFld-ContribAuthor ">Mark A.  Geyer</span>, <span class="hlFld-ContribAuthor ">Trevor W.  Robbins</span>. </span><span class="cited-content_cbyCitation_article-title">Effective Use of Animal Models for Therapeutic Development in Psychiatric and Substance Use Disorders. </span><span class="cited-content_cbyCitation_journal-name">Biological Psychiatry</span><span> <strong>2018,</strong> <em>83 </em>
                                    (11)
                                     , 915-923. <a href="https://doi.org/10.1016/j.biopsych.2018.01.014" title="DOI URL">https://doi.org/10.1016/j.biopsych.2018.01.014</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.biopsych.2018.01.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.biopsych.2018.01.014%26sid%3Dliteratum%253Aachs%26jtitle%3DBiological%2520Psychiatry%26atitle%3DEffective%252BUse%252Bof%252BAnimal%252BModels%252Bfor%252BTherapeutic%252BDevelopment%252Bin%252BPsychiatric%252Band%252BSubstance%252BUse%2525C2%2525A0Disorders%26aulast%3DPhillips%26aufirst%3DAnthony%2BG.%26date%3D2018%26volume%3D83%26issue%3D11%26spage%3D915%26epage%3D923" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paul J.  Kenny</span>, <span class="hlFld-ContribAuthor ">Daniel  Hoyer</span>, <span class="hlFld-ContribAuthor ">George F.  Koob</span>. </span><span class="cited-content_cbyCitation_article-title">Animal Models of Addiction and Neuropsychiatric Disorders and Their Role in Drug Discovery: Honoring the Legacy of Athina Markou. </span><span class="cited-content_cbyCitation_journal-name">Biological Psychiatry</span><span> <strong>2018,</strong> <em>83 </em>
                                    (11)
                                     , 940-946. <a href="https://doi.org/10.1016/j.biopsych.2018.02.009" title="DOI URL">https://doi.org/10.1016/j.biopsych.2018.02.009</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.biopsych.2018.02.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.biopsych.2018.02.009%26sid%3Dliteratum%253Aachs%26jtitle%3DBiological%2520Psychiatry%26atitle%3DAnimal%252BModels%252Bof%252BAddiction%252Band%252BNeuropsychiatric%252BDisorders%252Band%252BTheir%252BRole%252Bin%252BDrug%252BDiscovery%25253A%252BHonoring%252Bthe%252BLegacy%252Bof%252BAthina%252BMarkou%26aulast%3DKenny%26aufirst%3DPaul%2BJ.%26date%3D2018%26volume%3D83%26issue%3D11%26spage%3D940%26epage%3D946" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alan J.  Cross</span>, <span class="hlFld-ContribAuthor ">Robert  Anthenelli</span>, <span class="hlFld-ContribAuthor ">Xia  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Metabotropic Glutamate Receptors 2 and 3 as Targets for Treating Nicotine Addiction. </span><span class="cited-content_cbyCitation_journal-name">Biological Psychiatry</span><span> <strong>2018,</strong> <em>83 </em>
                                    (11)
                                     , 947-954. <a href="https://doi.org/10.1016/j.biopsych.2017.11.021" title="DOI URL">https://doi.org/10.1016/j.biopsych.2017.11.021</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.biopsych.2017.11.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.biopsych.2017.11.021%26sid%3Dliteratum%253Aachs%26jtitle%3DBiological%2520Psychiatry%26atitle%3DMetabotropic%252BGlutamate%252BReceptors%252B2%252Band%252B3%252Bas%252BTargets%252Bfor%252BTreating%252BNicotine%252BAddiction%26aulast%3DCross%26aufirst%3DAlan%2BJ.%26date%3D2018%26volume%3D83%26issue%3D11%26spage%3D947%26epage%3D954" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jane B.  Acri</span>, <span class="hlFld-ContribAuthor ">Alan J.  Cross</span>, <span class="hlFld-ContribAuthor ">Phil  Skolnick</span>. </span><span class="cited-content_cbyCitation_article-title">From bench to bedside: mGluR2 positive allosteric modulators as medications to treat substance use disorders. </span><span class="cited-content_cbyCitation_journal-name">Psychopharmacology</span><span> <strong>2017,</strong> <em>234 </em>
                                    (9-10)
                                     , 1347-1355. <a href="https://doi.org/10.1007/s00213-016-4501-9" title="DOI URL">https://doi.org/10.1007/s00213-016-4501-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00213-016-4501-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00213-016-4501-9%26sid%3Dliteratum%253Aachs%26jtitle%3DPsychopharmacology%26atitle%3DFrom%252Bbench%252Bto%252Bbedside%25253A%252BmGluR2%252Bpositive%252Ballosteric%252Bmodulators%252Bas%252Bmedications%252Bto%252Btreat%252Bsubstance%252Buse%252Bdisorders%26aulast%3DAcri%26aufirst%3DJane%2BB.%26date%3D2017%26date%3D2016%26volume%3D234%26issue%3D9-10%26spage%3D1347%26epage%3D1355" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chaobin  Jin</span>, <span class="hlFld-ContribAuthor ">Shutao  Ma</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advances in the medicinal chemistry of group II and group III mGlu receptors. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2017,</strong> <em>8 </em>
                                    (3)
                                     , 501-515. <a href="https://doi.org/10.1039/C6MD00612D" title="DOI URL">https://doi.org/10.1039/C6MD00612D</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C6MD00612D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC6MD00612D%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DRecent%252Badvances%252Bin%252Bthe%252Bmedicinal%252Bchemistry%252Bof%252Bgroup%252BII%252Band%252Bgroup%252BIII%252BmGlu%252Breceptors%26aulast%3DJin%26aufirst%3DChaobin%26date%3D2017%26date%3D2017%26volume%3D8%26issue%3D3%26spage%3D501%26epage%3D515" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kathryn E.  Price</span>, <span class="hlFld-ContribAuthor ">Christopher M.  Armstrong</span>, <span class="hlFld-ContribAuthor ">Leah S.  Imlay</span>, <span class="hlFld-ContribAuthor ">Dana M.  Hodge</span>, <span class="hlFld-ContribAuthor ">C.  Pidathala</span>, <span class="hlFld-ContribAuthor ">Natalie J.  Roberts</span>, <span class="hlFld-ContribAuthor ">Jooyoung  Park</span>, <span class="hlFld-ContribAuthor ">Marwa  Mikati</span>, <span class="hlFld-ContribAuthor ">Raman  Sharma</span>, <span class="hlFld-ContribAuthor ">Alexandre S.  Lawrenson</span>, <span class="hlFld-ContribAuthor ">Niraj H.  Tolia</span>, <span class="hlFld-ContribAuthor ">Neil G.  Berry</span>, <span class="hlFld-ContribAuthor ">Paul M.  O’Neill</span>, <span class="hlFld-ContribAuthor ">Audrey R. Odom  John</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular Mechanism of Action of Antimalarial Benzoisothiazolones: Species-Selective Inhibitors of the Plasmodium spp. MEP Pathway enzyme, IspD. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2016,</strong> <em>6 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/srep36777" title="DOI URL">https://doi.org/10.1038/srep36777</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/srep36777&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fsrep36777%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DMolecular%252BMechanism%252Bof%252BAction%252Bof%252BAntimalarial%252BBenzoisothiazolones%25253A%252BSpecies-Selective%252BInhibitors%252Bof%252Bthe%252BPlasmodium%252Bspp.%252BMEP%252BPathway%252Benzyme%25252C%252BIspD%26aulast%3DPrice%26aufirst%3DKathryn%2BE.%26date%3D2016%26date%3D2016%26volume%3D6%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xia  Li</span>, <span class="hlFld-ContribAuthor ">Manoranjan S.  D’Souza</span>, <span class="hlFld-ContribAuthor ">Ana M.  Niño</span>, <span class="hlFld-ContribAuthor ">James  Doherty</span>, <span class="hlFld-ContribAuthor ">Alan  Cross</span>, <span class="hlFld-ContribAuthor ">Athina  Markou</span>. </span><span class="cited-content_cbyCitation_article-title">Attenuation of nicotine-taking and nicotine-seeking behavior by the mGlu2 receptor positive allosteric modulators AZD8418 and AZD8529 in rats. </span><span class="cited-content_cbyCitation_journal-name">Psychopharmacology</span><span> <strong>2016,</strong> <em>233 </em>
                                    (10)
                                     , 1801-1814. <a href="https://doi.org/10.1007/s00213-016-4220-2" title="DOI URL">https://doi.org/10.1007/s00213-016-4220-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00213-016-4220-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00213-016-4220-2%26sid%3Dliteratum%253Aachs%26jtitle%3DPsychopharmacology%26atitle%3DAttenuation%252Bof%252Bnicotine-taking%252Band%252Bnicotine-seeking%252Bbehavior%252Bby%252Bthe%252BmGlu2%252Breceptor%252Bpositive%252Ballosteric%252Bmodulators%252BAZD8418%252Band%252BAZD8529%252Bin%252Brats%26aulast%3DLi%26aufirst%3DXia%26date%3D2016%26date%3D2016%26volume%3D233%26issue%3D10%26spage%3D1801%26epage%3D1814" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fawaz  Alasmari</span>, <span class="hlFld-ContribAuthor ">Salim S.  Al-Rejaie</span>, <span class="hlFld-ContribAuthor ">Shakir D.  AlSharari</span>, <span class="hlFld-ContribAuthor ">Youssef  Sari</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting glutamate homeostasis for potential treatment of nicotine dependence. </span><span class="cited-content_cbyCitation_journal-name">Brain Research Bulletin</span><span> <strong>2016,</strong> <em>121 </em>, 1-8. <a href="https://doi.org/10.1016/j.brainresbull.2015.11.010" title="DOI URL">https://doi.org/10.1016/j.brainresbull.2015.11.010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.brainresbull.2015.11.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.brainresbull.2015.11.010%26sid%3Dliteratum%253Aachs%26jtitle%3DBrain%2520Research%2520Bulletin%26atitle%3DTargeting%252Bglutamate%252Bhomeostasis%252Bfor%252Bpotential%252Btreatment%252Bof%252Bnicotine%252Bdependence%26aulast%3DAlasmari%26aufirst%3DFawaz%26date%3D2016%26volume%3D121%26spage%3D1%26epage%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yue  Zheng</span>, <span class="hlFld-ContribAuthor ">Genichiro  Tsuji</span>, <span class="hlFld-ContribAuthor ">Clement  Opoku-Temeng</span>, <span class="hlFld-ContribAuthor ">Herman O.  Sintim</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibition of P. aeruginosa c-di-GMP phosphodiesterase RocR and swarming motility by a benzoisothiazolinone derivative. </span><span class="cited-content_cbyCitation_journal-name">Chemical Science</span><span> <strong>2016,</strong> <em>7 </em>
                                    (9)
                                     , 6238-6244. <a href="https://doi.org/10.1039/C6SC02103D" title="DOI URL">https://doi.org/10.1039/C6SC02103D</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C6SC02103D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC6SC02103D%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Science%26atitle%3DInhibition%252Bof%252BP.%252Baeruginosa%252Bc-di-GMP%252Bphosphodiesterase%252BRocR%252Band%252Bswarming%252Bmotility%252Bby%252Ba%252Bbenzoisothiazolinone%252Bderivative%26aulast%3DZheng%26aufirst%3DYue%26date%3D2016%26date%3D2016%26volume%3D7%26issue%3D9%26spage%3D6238%26epage%3D6244" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Manoranjan S.  D'Souza</span>. </span><span class="cited-content_cbyCitation_article-title">Glutamatergic transmission in drug reward: implications for drug addiction. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Neuroscience</span><span> <strong>2015,</strong> <em>9 </em><a href="https://doi.org/10.3389/fnins.2015.00404" title="DOI URL">https://doi.org/10.3389/fnins.2015.00404</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fnins.2015.00404&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffnins.2015.00404%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Neuroscience%26atitle%3DGlutamatergic%252Btransmission%252Bin%252Bdrug%252Breward%25253A%252Bimplications%252Bfor%252Bdrug%252Baddiction%26aulast%3DD%2527Souza%26aufirst%3DManoranjan%2BS.%26date%3D2015%26date%3D2015%26volume%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kalynda K.  Gonzales</span>, <span class="hlFld-ContribAuthor ">Yoland  Smith</span>. </span><span class="cited-content_cbyCitation_article-title">Cholinergic interneurons in the dorsal and ventral striatum: anatomical and functional considerations in normal and diseased conditions. </span><span class="cited-content_cbyCitation_journal-name">Annals of the New York Academy of Sciences</span><span> <strong>2015,</strong> <em>1349 </em>
                                    (1)
                                     , 1-45. <a href="https://doi.org/10.1111/nyas.12762" title="DOI URL">https://doi.org/10.1111/nyas.12762</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/nyas.12762&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fnyas.12762%26sid%3Dliteratum%253Aachs%26jtitle%3DAnnals%2520of%2520the%2520New%2520York%2520Academy%2520of%2520Sciences%26atitle%3DCholinergic%252Binterneurons%252Bin%252Bthe%252Bdorsal%252Band%252Bventral%252Bstriatum%25253A%252Banatomical%252Band%252Bfunctional%252Bconsiderations%252Bin%252Bnormal%252Band%252Bdiseased%252Bconditions%26aulast%3DGonzales%26aufirst%3DKalynda%2BK.%26date%3D2015%26date%3D2015%26volume%3D1349%26issue%3D1%26spage%3D1%26epage%3D45" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daxin  Shi</span>, <span class="hlFld-ContribAuthor ">Jiarong  Li</span>, <span class="hlFld-ContribAuthor ">Mingxing  Liu</span>, <span class="hlFld-ContribAuthor ">Qi  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">CoCl2•6H2O-Promoted Pinner-Dimroth Tandem Reaction: Facile Synthesis of 3-Substituted Isoindolinones. </span><span class="cited-content_cbyCitation_journal-name">HETEROCYCLES</span><span> <strong>2015,</strong> <em>91 </em>
                                    (7)
                                     , 1465. <a href="https://doi.org/10.3987/COM-15-13247" title="DOI URL">https://doi.org/10.3987/COM-15-13247</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3987/COM-15-13247&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3987%2FCOM-15-13247%26sid%3Dliteratum%253Aachs%26jtitle%3DHETEROCYCLES%26atitle%3DCoCl2%2525E2%252580%2525A26H2O-Promoted%252BPinner-Dimroth%252BTandem%252BReaction%25253A%252BFacile%252BSynthesis%252Bof%252B3-Substituted%252BIsoindolinones%26aulast%3DShi%26aufirst%3DDaxin%26date%3D2015%26volume%3D91%26issue%3D7%26spage%3D1465" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">José M.  Cid</span>, <span class="hlFld-ContribAuthor ">Andrés A.  Trabanco</span>, <span class="hlFld-ContribAuthor ">Hilde  Lavreysen</span>. </span><span class="cited-content_cbyCitation_article-title">Metabotropic Glutamate Receptor 2 Activators. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2014,</strong>,, 101-142. <a href="https://doi.org/10.1007/7355_2014_48" title="DOI URL">https://doi.org/10.1007/7355_2014_48</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/7355_2014_48&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F7355_2014_48%26sid%3Dliteratum%253Aachs%26atitle%3DMetabotropic%252BGlutamate%252BReceptor%252B2%252BActivators%26aulast%3DCid%26aufirst%3DJos%25C3%25A9%2BM.%26date%3D2014%26date%3D2014%26spage%3D101%26epage%3D142%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DSmall%252BMolecule%252BTherapeutics%252Bfor%252BSchizophrenia%26aulast%3DCelanire%26aufirst%3DSylvain%26date%3D2015%26volume%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xia  Li</span>, <span class="hlFld-ContribAuthor ">Svetlana  Semenova</span>, <span class="hlFld-ContribAuthor ">Manoranjan S.  D'Souza</span>, <span class="hlFld-ContribAuthor ">Astrid K.  Stoker</span>, <span class="hlFld-ContribAuthor ">Athina  Markou</span>. </span><span class="cited-content_cbyCitation_article-title">Involvement of glutamatergic and GABAergic systems in nicotine dependence: Implications for novel pharmacotherapies for smoking cessation. </span><span class="cited-content_cbyCitation_journal-name">Neuropharmacology</span><span> <strong>2014,</strong> <em>76 </em>, 554-565. <a href="https://doi.org/10.1016/j.neuropharm.2013.05.042" title="DOI URL">https://doi.org/10.1016/j.neuropharm.2013.05.042</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.neuropharm.2013.05.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.neuropharm.2013.05.042%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuropharmacology%26atitle%3DInvolvement%252Bof%252Bglutamatergic%252Band%252BGABAergic%252Bsystems%252Bin%252Bnicotine%252Bdependence%25253A%252BImplications%252Bfor%252Bnovel%252Bpharmacotherapies%252Bfor%252Bsmoking%252Bcessation%26aulast%3DLi%26aufirst%3DXia%26date%3D2014%26volume%3D76%26spage%3D554%26epage%3D565" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrés A  Trabanco</span>, <span class="hlFld-ContribAuthor ">José María  Cid</span>. </span><span class="cited-content_cbyCitation_article-title">mGluR2 positive allosteric modulators: a patent review (2009 – present). </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2013,</strong> <em>23 </em>
                                    (5)
                                     , 629-647. <a href="https://doi.org/10.1517/13543776.2013.777043" title="DOI URL">https://doi.org/10.1517/13543776.2013.777043</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/13543776.2013.777043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F13543776.2013.777043%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DmGluR2%252Bpositive%252Ballosteric%252Bmodulators%25253A%252Ba%252Bpatent%252Breview%252B%2525282009%252B%2525E2%252580%252593%252Bpresent%252529%26aulast%3DTrabanco%26aufirst%3DAndr%25C3%25A9s%2BA%26date%3D2013%26date%3D2013%26volume%3D23%26issue%3D5%26spage%3D629%26epage%3D647" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3005306/production/images/medium/jm-2012-005306_0015.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3005306/production/images/large/jm-2012-005306_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3005306&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3005306/production/images/medium/jm-2012-005306_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3005306/production/images/large/jm-2012-005306_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of recently reported mGlu<sub>2</sub> receptor PAMs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3005306/production/images/large/jm-2012-005306_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3005306&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3005306/production/images/medium/jm-2012-005306_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3005306/production/images/large/jm-2012-005306_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structures of our mGlu<sub>2</sub> receptor PAMs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3005306/production/images/large/jm-2012-005306_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3005306&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3005306/production/images/medium/jm-2012-005306_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3005306/production/images/large/jm-2012-005306_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Areas of SAR investigation in the present study.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3005306/production/images/large/jm-2012-005306_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3005306&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3005306/production/images/medium/jm-2012-005306_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3005306/production/images/large/jm-2012-005306_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of 3-Chloro-3′-((2-cyclopentyl-3-oxo-2,3-dihydrobenzo[<i>d</i>]isothiazol-6-yloxy)methyl)biphenyl-4-carboxylic Acid Derivatives <b>3a</b>–<b>f</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3005306/production/images/large/jm-2012-005306_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3005306&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) AlMe<sub>3</sub>, R<sup>1</sup>NH<sub>2</sub>, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C to 60 °C, 12 h; (b) PIFA, TFA, 0 °C, CH<sub>2</sub>Cl<sub>2</sub>, 1 h; (c) (i) BBr<sub>3</sub>, C<sub>6</sub>H<sub>6</sub>, 80 °C, 1 h; (ii) H<sub>2</sub>O, 100 °C, 1 h; (d) ArCH<sub>2</sub>Br, K<sub>2</sub>CO<sub>3</sub>, MeCN, 80 °C, 12 h; (e) LiI, pyridine, 110 °C, 12 h.</p></p></figure><figure data-id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3005306/production/images/medium/jm-2012-005306_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3005306/production/images/large/jm-2012-005306_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. General Synthetic Scheme for the Synthesis of Isoindolinones <b>15a</b>–<b>k</b> and Benzoisothiazolone Analogue <b>16a</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3005306/production/images/large/jm-2012-005306_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3005306&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) K<sub>2</sub>CO<sub>3</sub>, acetone, reflux; (b) when Y = CH<sub>2</sub>; RX, PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, toluene/MeOH, 80 °C or when Y = S; RX, Pd (PPh<sub>3</sub>)<sub>4</sub>, DME, 80 °C, 12 h.</p></p></figure><figure data-id="sch3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3005306/production/images/medium/jm-2012-005306_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3005306/production/images/large/jm-2012-005306_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Benzisothiazolone Derivatives <b>16b</b> and <b>16c</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3005306/production/images/large/jm-2012-005306_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3005306&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) K<sub>2</sub>CO<sub>3</sub>, CH<sub>3</sub>CN, 80 °C, 1 h; (b) RB(OH)<sub>2</sub>, Pd (PPh<sub>3</sub>)<sub>4</sub>, DME, 80 °C, 12 h.</p></p></figure><figure data-id="sch4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3005306/production/images/medium/jm-2012-005306_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3005306/production/images/large/jm-2012-005306_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Amide Analogue  <b>19</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3005306/production/images/large/jm-2012-005306_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3005306&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) HOBt, EDC·HCl, Me<sub>2</sub>NH·HCl, Et<sub>3</sub>N, DMF, rt, 3 h.</p></p></figure><figure data-id="sch5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3005306/production/images/medium/jm-2012-005306_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3005306/production/images/large/jm-2012-005306_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of Isoindolinone Analogue <b>24</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3005306/production/images/large/jm-2012-005306_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3005306&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) MeOH, cat. H<sub>2</sub>SO<sub>4</sub>, reflux, 12 h; (b) NBS, cat. AIBN, CCl<sub>4</sub>, 68 °C, 12 h; (c) C<sub>5</sub>H<sub>9</sub>NH<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, CH<sub>3</sub>CN, reflux, 12 h; (d) (i) 3-bromophenylboronic acid, Pd(PPh<sub>3</sub>)<sub>4</sub>, 2 M Na<sub>2</sub>CO<sub>3</sub>, DME, reflux, 1 h; (ii) 5-borono-2-chlorobenzoic acid, Pd(PPh<sub>3</sub>)<sub>4</sub>, 2 M Na<sub>2</sub>CO<sub>3</sub>, DME, reflux, 2 h.</p></p></figure><figure data-id="fig4" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3005306/production/images/medium/jm-2012-005306_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3005306/production/images/large/jm-2012-005306_0014.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Effects of compound <b>2</b> on nicotine self-administration in rats. Data are expressed as percent of baseline number of infusions earned (mean ± SEM). The number of baseline nicotine infusions was 13.88 ± 1.62 (mean ± SEM). *<i>p</i> < 0.05, **<i>p</i> < 0.01, significant differences from the corresponding vehicle condition (Newman–Keuls posthoc test after a significant main effect in the ANOVA).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm3005306/production/images/large/jm-2012-005306_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3005306&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i59">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_73146" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_73146" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 28 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">World Health Organization</span><span class="NLM_x">. </span> <span class="citation_source-book">WHO Report on the Global Tobacco Epidemic</span>; <span class="NLM_publisher-name">World Health Organization</span>: <span class="NLM_publisher-loc">Geneva</span>,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=World+Health+Organization&title=WHO+Report+on+the+Global+Tobacco+Epidemic"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3D%26btitle%3DWHO%2520Report%2520on%2520the%2520Global%2520Tobacco%2520Epidemic%26pub%3DWorld%2520Health%2520Organization%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Centers for Disease Control and Prevention</span><span class="NLM_x">. </span><span> </span><span class="NLM_article-title">Current cigarette smoking prevalence among working adults: United States, 2004–2010</span>.  <span class="citation_source-journal">Morbidity and Mortality Weekly Report</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">1305</span><span class="NLM_x">–</span> <span class="NLM_lpage">1309</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm3005306&amp;key=21956406" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2011&pages=1305-1309&author=Centers+for+Disease+Control+and+Prevention&title=Current+cigarette+smoking+prevalence+among+working+adults%3A+United+States%2C+2004%E2%80%932010"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3D%26atitle%3DCurrent%2520cigarette%2520smoking%2520prevalence%2520among%2520working%2520adults%253A%2520United%2520States%252C%25202004%25E2%2580%25932010%26jtitle%3DMorbidity%2520and%2520Mortality%2520Weekly%2520Report%26date%3D2011%26volume%3D60%26spage%3D1305%26epage%3D1309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Agboola, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNeill, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coleman, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonardi Bee, J.</span><span> </span><span class="NLM_article-title">A systematic review of the effectiveness of smoking relapse prevention interventions for abstinent smokers</span> <span class="citation_source-journal">Addiction</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">1362</span><span class="NLM_x">–</span> <span class="NLM_lpage">1380</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2010&pages=1362-1380&author=S.+Agboolaauthor=A.+McNeillauthor=T.+Colemanauthor=J.+Leonardi+Bee&title=A+systematic+review+of+the+effectiveness+of+smoking+relapse+prevention+interventions+for+abstinent+smokers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAgboola%26aufirst%3DS.%26aulast%3DMcNeill%26aufirst%3DA.%26aulast%3DColeman%26aufirst%3DT.%26aulast%3DLeonardi%2BBee%26aufirst%3DJ.%26atitle%3DA%2520systematic%2520review%2520of%2520the%2520effectiveness%2520of%2520smoking%2520relapse%2520prevention%2520interventions%2520for%2520abstinent%2520smokers%26jtitle%3DAddiction%26date%3D2010%26volume%3D105%26spage%3D1362%26epage%3D1380" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Stolerman, I. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jarvis, M. J.</span><span> </span><span class="NLM_article-title">The scientific case that nicotine is addictive</span> <span class="citation_source-journal">Psychopharmacology (Berlin, Ger.)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">117</span><span class="NLM_x">, </span> <span class="NLM_fpage">2</span><span class="NLM_x">–</span> <span class="NLM_lpage">10</span><div class="note"><p class="first last">; discussion 14–20</p></div></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm3005306&amp;key=10.1007%2FBF02245088" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm3005306&amp;key=7724697" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm3005306&amp;key=1%3ACAS%3A528%3ADyaK2MXkslSisrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=1995&pages=2-10&author=I.+P.+Stolermanauthor=M.+J.+Jarvis&title=The+scientific+case+that+nicotine+is+addictive"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">The scientific case that nicotine is addictive</span></div><div class="casAuthors">Stolerman, I. P.; Jarvis, M. J.</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology (Berlin)</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">2-10</span>CODEN:
                <span class="NLM_cas:coden">PSCHDL</span>;
        ISSN:<span class="NLM_cas:issn">0033-3158</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review with 96 refs.  Despite the wide-ranging and authoritative 1988 review by the US Surgeon General, views questioning the addictiveness of nicotine continue to be expressed in some quarters.  This lack of complete consensus is not unexpected, since no universally agreed scientific definition of addiction exists.  In this paper we briefly consider a no. of lines of evidence from both the human and animal literature bearing on the addictiveness of nicotine.  Patterns of use by smokers and the remarkable intractability of the smoking habit point to compulsive use as the norm.  Studies in both animal and human subjects have shown that nicotine can function as reinforcer, albeit under a more limited range of conditions than with some other drugs of abuse.  In drug discrimination paradigms, there is some cross-generalization between nicotine on the one hand, and amphetamine and cocaine on the other.  A well-defined nicotine withdrawal syndrome has been delineated which is alleviated by nicotine replacement.  Nicotine replacement also enhances outcomes in smoking cessation, roughly doubling success rates.  In total, the evidence clearly identifies nicotine as a powerful drug of addiction, comparable to heroin, cocaine and alc.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvNF8xLCCOyLVg90H21EOLACvtfcHk0lhURtmnP1P21g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXkslSisrw%253D&md5=6d53220302bf7ecfbe62ee488217ab4a</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1007%2FBF02245088&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF02245088%26sid%3Dliteratum%253Aachs%26aulast%3DStolerman%26aufirst%3DI.%2BP.%26aulast%3DJarvis%26aufirst%3DM.%2BJ.%26atitle%3DThe%2520scientific%2520case%2520that%2520nicotine%2520is%2520addictive%26jtitle%3DPsychopharmacology%2520%2528Berlin%252C%2520Ger.%2529%26date%3D1995%26volume%3D117%26spage%3D2%26epage%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Liechti, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markou, A.</span><span> </span><span class="NLM_article-title">Role of the glutamatergic system in nicotine dependence: implications for the discovery and development of new pharmacological smoking cessation therapies</span> <span class="citation_source-journal">CNS Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">705</span><span class="NLM_x">–</span> <span class="NLM_lpage">724</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2008&pages=705-724&author=M.+E.+Liechtiauthor=A.+Markou&title=Role+of+the+glutamatergic+system+in+nicotine+dependence%3A+implications+for+the+discovery+and+development+of+new+pharmacological+smoking+cessation+therapies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLiechti%26aufirst%3DM.%2BE.%26aulast%3DMarkou%26aufirst%3DA.%26atitle%3DRole%2520of%2520the%2520glutamatergic%2520system%2520in%2520nicotine%2520dependence%253A%2520implications%2520for%2520the%2520discovery%2520and%2520development%2520of%2520new%2520pharmacological%2520smoking%2520cessation%2520therapies%26jtitle%3DCNS%2520Drugs%26date%3D2008%26volume%3D22%26spage%3D705%26epage%3D724" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Markou, A.</span><span> </span><span class="NLM_article-title">Neurobiology of nicotine dependence</span> <span class="citation_source-journal">Philos. Trans R. Soc. London, Ser. B</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">363</span><span class="NLM_x">, </span> <span class="NLM_fpage">3159</span><span class="NLM_x">–</span> <span class="NLM_lpage">3168</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm3005306&amp;key=10.1098%2Frstb.2008.0095" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm3005306&amp;key=18640919" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=363&publication_year=2008&pages=3159-3168&author=A.+Markou&title=Neurobiology+of+nicotine+dependence"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1098%2Frstb.2008.0095&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1098%252Frstb.2008.0095%26sid%3Dliteratum%253Aachs%26aulast%3DMarkou%26aufirst%3DA.%26atitle%3DNeurobiology%2520of%2520nicotine%2520dependence%26jtitle%3DPhilos.%2520Trans%2520R.%2520Soc.%2520London%252C%2520Ser.%2520B%26date%3D2008%26volume%3D363%26spage%3D3159%26epage%3D3168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">D’Souza, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markou, A.</span><span> </span><span class="NLM_article-title">Neuronal mechanisms underlying development of nicotine dependence: implications for novel smoking-cessation treatments</span> <span class="citation_source-journal">Addict. Sci. Clin. Pract.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">4</span><span class="NLM_x">–</span> <span class="NLM_lpage">16</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm3005306&amp;key=22003417" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm3005306&amp;key=1%3ACAS%3A280%3ADC%252BC3Mbhs1Gjtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=4-16&author=M.+S.+D%E2%80%99Souzaauthor=A.+Markou&title=Neuronal+mechanisms+underlying+development+of+nicotine+dependence%3A+implications+for+novel+smoking-cessation+treatments"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Neuronal mechanisms underlying development of nicotine dependence: implications for novel smoking-cessation treatments</span></div><div class="casAuthors">D'Souza Manoranjan S; Markou Athina</div><div class="citationInfo"><span class="NLM_cas:title">Addiction science & clinical practice</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">4-16</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Tobacco smoking causes high rates of mortality and morbidity throughout the world.  Despite the availability of smoking-cessation medications, maintenance of long-term abstinence is difficult, and most individuals who attempt to quit smoking relapse.  Although tobacco smoke contains many substances, researchers and policymakers agree that nicotine is a major cause of tobacco dependence.  Understanding the neural substrates of nicotine dependence is essential for the development of more effective antismoking medications than those currently available.  This article focuses on the neural substrates, especially nicotinic acetylcholine receptors, that mediate the reinforcing effects of nicotine and the development of nicotine dependence.  Neuroadaptations in the function of the neurotransmitters dopamine, glutamate, and gamma-aminobutyric acid (GABA), which have been shown to be critically involved in nicotine dependence, are also reviewed.  Finally, the article discusses progress in the discovery and development of smoking-cessation medications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRnNF5GDChlcI3yKPtYViAGfW6udTcc2ebmEy0RvwvlJLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3Mbhs1Gjtw%253D%253D&md5=45506372d3563c3a8ceeca32a7c3dbd2</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DD%25E2%2580%2599Souza%26aufirst%3DM.%2BS.%26aulast%3DMarkou%26aufirst%3DA.%26atitle%3DNeuronal%2520mechanisms%2520underlying%2520development%2520of%2520nicotine%2520dependence%253A%2520implications%2520for%2520novel%2520smoking-cessation%2520treatments%26jtitle%3DAddict.%2520Sci.%2520Clin.%2520Pract.%26date%3D2011%26volume%3D6%26spage%3D4%26epage%3D16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">D’Souza, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liechti, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramirez-Nino, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuczenski, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markou, A.</span><span> </span><span class="NLM_article-title">The metabotropic glutamate 2/3 receptor agonist LY379268 blocked nicotine-induced increases in nucleus accumbens shell dopamine only in the presence of a nicotine-associated context in rats</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">2111</span><span class="NLM_x">–</span> <span class="NLM_lpage">2124</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2011&pages=2111-2124&author=M.+S.+D%E2%80%99Souzaauthor=M.+E.+Liechtiauthor=A.+M.+Ramirez-Ninoauthor=R.+Kuczenskiauthor=A.+Markou&title=The+metabotropic+glutamate+2%2F3+receptor+agonist+LY379268+blocked+nicotine-induced+increases+in+nucleus+accumbens+shell+dopamine+only+in+the+presence+of+a+nicotine-associated+context+in+rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DD%25E2%2580%2599Souza%26aufirst%3DM.%2BS.%26aulast%3DLiechti%26aufirst%3DM.%2BE.%26aulast%3DRamirez-Nino%26aufirst%3DA.%2BM.%26aulast%3DKuczenski%26aufirst%3DR.%26aulast%3DMarkou%26aufirst%3DA.%26atitle%3DThe%2520metabotropic%2520glutamate%25202%252F3%2520receptor%2520agonist%2520LY379268%2520blocked%2520nicotine-induced%2520increases%2520in%2520nucleus%2520accumbens%2520shell%2520dopamine%2520only%2520in%2520the%2520presence%2520of%2520a%2520nicotine-associated%2520context%2520in%2520rats%26jtitle%3DNeuropsychopharmacology%26date%3D2011%26volume%3D36%26spage%3D2111%26epage%3D2124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Cartmell, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoepp, D. D.</span><span> </span><span class="NLM_article-title">Regulation of neurotransmitter release by metabotropic glutamate receptors</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">75</span><span class="NLM_x">, </span> <span class="NLM_fpage">889</span><span class="NLM_x">–</span> <span class="NLM_lpage">907</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm3005306&amp;key=10.1046%2Fj.1471-4159.2000.0750889.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm3005306&amp;key=10936169" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm3005306&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmtFykurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2000&pages=889-907&author=J.+Cartmellauthor=D.+D.+Schoepp&title=Regulation+of+neurotransmitter+release+by+metabotropic+glutamate+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of neurotransmitter release by metabotropic glutamate receptors</span></div><div class="casAuthors">Cartmell, Jayne; Schoepp, Darryle D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">889-907</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">A review, with ∼145 refs.  The G protein-coupled metabotropic glutamate (mGlu) receptors are differentially localized at various synapses throughout the brain.  Depending on the receptor subtype, they appear to be localized at presynaptic and/or postsynaptic sites, including glial as well as neuronal elements.  The heterogeneous distribution of these receptors on glutamate and nonglutamate neurons/cells thus allows modulation of synaptic transmission by a no. of different mechanisms.  Electrophysiol. studies have demonstrated that the activation of mGlu receptors can modulate the activity of Ca2+ or K+ channels, or interfere with release processes downstream of Ca2+ entry, and consequently regulate neuronal synaptic activity.  Such changes evoked by mGlu receptors can ultimately regulate transmitter release at both glutamatergic and nonglutamatergic synapses.  Increasing neurochem. evidence has emerged, obtained from in vitro and in vivo studies, showing modulation of the release of a variety of transmitters by mGlu receptors.  This review addresses the neurochem. evidence for mGlu receptor-mediated regulation of neurotransmitters, such as excitatory and inhibitory amino acids, monoamines, and neuropeptides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrRIHmsUn6YbVg90H21EOLACvtfcHk0lgFWB3rJW0aKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmtFykurY%253D&md5=15379bf75d0949789eeaeaf4f9485460</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1046%2Fj.1471-4159.2000.0750889.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1471-4159.2000.0750889.x%26sid%3Dliteratum%253Aachs%26aulast%3DCartmell%26aufirst%3DJ.%26aulast%3DSchoepp%26aufirst%3DD.%2BD.%26atitle%3DRegulation%2520of%2520neurotransmitter%2520release%2520by%2520metabotropic%2520glutamate%2520receptors%26jtitle%3DJ.%2520Neurochem.%26date%3D2000%26volume%3D75%26spage%3D889%26epage%3D907" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Xi, Z. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carson, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalivas, P. W.</span><span> </span><span class="NLM_article-title">Group II metabotropic glutamate receptors modulate extracellular glutamate in the nucleus accumbens</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">300</span><span class="NLM_x">, </span> <span class="NLM_fpage">162</span><span class="NLM_x">–</span> <span class="NLM_lpage">171</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm3005306&amp;key=10.1124%2Fjpet.300.1.162" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm3005306&amp;key=11752112" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm3005306&amp;key=1%3ACAS%3A528%3ADC%252BD38Xht1Wnug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=300&publication_year=2002&pages=162-171&author=Z.+X.+Xiauthor=D.+A.+Bakerauthor=H.+Shenauthor=D.+S.+Carsonauthor=P.+W.+Kalivas&title=Group+II+metabotropic+glutamate+receptors+modulate+extracellular+glutamate+in+the+nucleus+accumbens"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Group II metabotropic glutamate receptors modulate extracellular glutamate in the nucleus accumbens</span></div><div class="casAuthors">Xi, Zheng-Xiong; Baker, David A.; Shen, Hui; Carson, Daniel S.; Kalivas, Peter W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">300</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">162-171</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The regulation of extracellular glutamate in the nucleus accumbens by group II metabotropic glutamate receptors (mGluR2/3) was examd. in vivo.  Stimulation of mGluR2/3 with 2R,4R-4-aminopyrrolidine-2,4-dicarboxylate (APDC) or N-acetylaspartyl-glutamate reduced extracellular glutamate levels.  Conversely, blockade of mGluR2/3 by LY143495 or (RS)-1-amino-5-phosphonoindan-1-carboxylic acid (APICA) increased extracellular glutamate, an effect antagonized by the coadministration of APDC.  These effects likely involve both vesicular and nonvesicular glutamate, because the increase in glutamate by APICA or the decrease by APDC was prevented by blocking N-type calcium channels and the release of glutamate after potassium-induced membrane depolarization was antagonized by APDC.  In addn., blockade of the cystine-glutamate exchange, a major nonvesicular source of extracellular glutamate, by (S)-4-carboxyphenylglycine blocked the effects induced by either APDC or APICA.  However, blockade of Na+ channels by tetrodotoxin or Na+-dependent glutamate transporters by DL-threo-β-benzyloxyaspartate failed to affect the alterations in extracellular glutamate by APICA or APDC, resp.  Group II mGluRs are Gi-coupled and coperfusion with the cAMP-dependent protein kinase (PKA) activator Sp-cAMPS blocked the redn. in glutamate by APDC and the PKA inhibitor Rp-cAMPS prevented the elevation in glutamate by APICA.  Taken together, these data support three conclusions: (1) group II mGluRs regulate both vesicular and nonvesicular release of glutamate in the nucleus accumbens, (2) there is tonic in vivo stimulation of mGluR2/3 by endogenous glutamate, and (3) modulation of group II mGluRs of extracellular glutamate is Ca2+- and PKA-dependent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9O8HBxmVIjbVg90H21EOLACvtfcHk0lgFWB3rJW0aKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xht1Wnug%253D%253D&md5=4136e7de11a983e66e8b1cdf25494d38</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1124%2Fjpet.300.1.162&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.300.1.162%26sid%3Dliteratum%253Aachs%26aulast%3DXi%26aufirst%3DZ.%2BX.%26aulast%3DBaker%26aufirst%3DD.%2BA.%26aulast%3DShen%26aufirst%3DH.%26aulast%3DCarson%26aufirst%3DD.%2BS.%26aulast%3DKalivas%26aufirst%3DP.%2BW.%26atitle%3DGroup%2520II%2520metabotropic%2520glutamate%2520receptors%2520modulate%2520extracellular%2520glutamate%2520in%2520the%2520nucleus%2520accumbens%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2002%26volume%3D300%26spage%3D162%26epage%3D171" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Xi, Z. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramamoorthy, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samuvel, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalivas, P. W.</span><span> </span><span class="NLM_article-title">Modulation of group II metabotropic glutamate receptor signaling by chronic cocaine</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">303</span><span class="NLM_x">, </span> <span class="NLM_fpage">608</span><span class="NLM_x">–</span> <span class="NLM_lpage">615</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm3005306&amp;key=10.1124%2Fjpet.102.039735" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm3005306&amp;key=12388642" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm3005306&amp;key=1%3ACAS%3A528%3ADC%252BD38XotlCgu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=303&publication_year=2002&pages=608-615&author=Z.+X.+Xiauthor=S.+Ramamoorthyauthor=D.+A.+Bakerauthor=H.+Shenauthor=D.+J.+Samuvelauthor=P.+W.+Kalivas&title=Modulation+of+group+II+metabotropic+glutamate+receptor+signaling+by+chronic+cocaine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Modulation of group II metabotropic glutamate receptor signaling by chronic cocaine</span></div><div class="casAuthors">Xi, Zheng-Xiong; Ramamoorthy, Sammanda; Baker, David A.; Shen, Hui; Samuvel, Devadoss J.; Kalivas, Peter W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">303</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">608-615</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Repeated cocaine produces enduring neuroadaptations in glutamate transmission in the nucleus accumbens that are thought to contribute to addiction.  Group II metabotropic glutamate autoreceptors (mGluR2/3) regulate glutamate release, and this study investigates whether repeated cocaine injection produces long-lasting alterations in mGluR2/3 content, phosphorylation, and physiol.  Rats were administered cocaine daily for 1 wk, and 3 wk after the last injection, mGluR2/3 protein levels were altered in the accumbens and prefrontal cortex (PFC) but not in the dorsal striatum or ventral tegmental area.  The level of mGluR2/3 dimer was elevated in the accumbens and PFC and the monomer was reduced in the PFC only.  Furthermore, the relative Ser phosphorylation state of the monomer was elevated in both the accumbens and PFC of cocaine-pretreated subjects, whereas the dimer demonstrated negligible phosphorylation in either treatment group.  These changes in mGluR2/3 level and phosphorylation state were assocd. with reduced mGluR2/3 agonist-induced guanosine 5'-3-O -(thio)triphosphate binding in the accumbens and PFC, but not in the dorsal striatum.  Stimulation of mGluR2/3 reduces extracellular glutamate by inhibiting Ca2+-dependent and cystine/glutamate antiporter-mediated glutamate release.  The capacity of the mGluR2/3 agonist 2R,4R-4-aminopyrrolidine-2,4-dicarboxylate (APDC) to inhibit [35S]cystine uptake via cystine/glutamate antiporter in accumbens tissue slices was reduced by repeated cocaine.  Also, the capacity of APDC to reduce the basal and potassium-stimulated extrasynaptic glutamate was significantly blunted in the accumbens of cocaine-pretreated subjects.  Together, these data demonstrate that repeated cocaine produces an enduring redn. in mGluR2/3 function in the nucleus accumbens.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQspk27DAhJbVg90H21EOLACvtfcHk0lg_ML5rq1R8fA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XotlCgu7k%253D&md5=3101c2c134f73ced1bcc0deee26befd0</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1124%2Fjpet.102.039735&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.102.039735%26sid%3Dliteratum%253Aachs%26aulast%3DXi%26aufirst%3DZ.%2BX.%26aulast%3DRamamoorthy%26aufirst%3DS.%26aulast%3DBaker%26aufirst%3DD.%2BA.%26aulast%3DShen%26aufirst%3DH.%26aulast%3DSamuvel%26aufirst%3DD.%2BJ.%26aulast%3DKalivas%26aufirst%3DP.%2BW.%26atitle%3DModulation%2520of%2520group%2520II%2520metabotropic%2520glutamate%2520receptor%2520signaling%2520by%2520chronic%2520cocaine%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2002%26volume%3D303%26spage%3D608%26epage%3D615" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Kalivas, P. W.</span><span> </span><span class="NLM_article-title">The glutamate homeostasis hypothesis of addiction</span> <span class="citation_source-journal">Nat. Rev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">561</span><span class="NLM_x">–</span> <span class="NLM_lpage">572</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm3005306&amp;key=10.1038%2Fnrn2515" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm3005306&amp;key=19571793" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm3005306&amp;key=1%3ACAS%3A528%3ADC%252BD1MXnvFans74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2009&pages=561-572&author=P.+W.+Kalivas&title=The+glutamate+homeostasis+hypothesis+of+addiction"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">The glutamate homeostasis hypothesis of addiction</span></div><div class="casAuthors">Kalivas, Peter W.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neuroscience</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">561-572</span>CODEN:
                <span class="NLM_cas:coden">NRNAAN</span>;
        ISSN:<span class="NLM_cas:issn">1471-003X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Addiction is assocd. with neuroplasticity in the corticostriatal brain circuitry that is important for guiding adaptive behavior.  The hierarchy of corticostriatal information processing that normally permits the prefrontal cortex to regulate reinforcement-seeking behaviors is impaired by chronic drug use.  A failure of the prefrontal cortex to control drug-seeking behaviors can be linked to an enduring imbalance between synaptic and non-synaptic glutamate, termed glutamate homeostasis.  The imbalance in glutamate homeostasis engenders changes in neuroplasticity that impair communication between the prefrontal cortex and the nucleus accumbens.  Some of these pathol. changes are amenable to new glutamate- and neuroplasticity-based pharmacotherapies for treating addiction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmzMH0MPPhgLVg90H21EOLACvtfcHk0lg_ML5rq1R8fA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXnvFans74%253D&md5=1735bd00dc118bbd3438103f734a0394</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Fnrn2515&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrn2515%26sid%3Dliteratum%253Aachs%26aulast%3DKalivas%26aufirst%3DP.%2BW.%26atitle%3DThe%2520glutamate%2520homeostasis%2520hypothesis%2520of%2520addiction%26jtitle%3DNat.%2520Rev.%2520Neurosci.%26date%3D2009%26volume%3D10%26spage%3D561%26epage%3D572" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Semenova, S.; Markou, A.</span><span> </span><span class="NLM_article-title">Metabotropic glutamate receptors as targets for the treatment of drug and alcohol dependence</span>. In <i>Glutamate-based Therapies for Psychiatric Disorders</i>; <span class="NLM_contrib-group">Skolnick, P.</span>, Vol. Ed.; <span class="NLM_contrib-group">Parnham, M.J.; ; Bruinvels, J.</span>, Series Eds.;  <span class="citation_source-book">Milestones in Drug Therapy</span>; <span class="NLM_publisher-name">Springer Birkhauser</span>: <span class="NLM_publisher-loc">Basel</span>,<span class="NLM_x"> </span><span class="NLM_year">2010</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">133</span><span class="NLM_x">–</span> <span class="NLM_lpage">156</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm3005306&amp;key=10.1007%2F978-3-0346-0241-9_8" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&pages=133-156&author=S.+Semenova&author=A.+Markouauthor=P.+Skolnickauthor=M.J.+Parnham&author=J.+Bruinvels&title=Milestones+in+Drug+Therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1007%2F978-3-0346-0241-9_8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-3-0346-0241-9_8%26sid%3Dliteratum%253Aachs%26aulast%3DSemenova%26aufirst%3DS.%26atitle%3DMetabotropic%2520glutamate%2520receptors%2520as%2520targets%2520for%2520the%2520treatment%2520of%2520drug%2520and%2520alcohol%2520dependence%26aulast%3DSkolnick%26aufirst%3DP.%26aulast%3DParnham%26aufirst%3DM.J.%26btitle%3DMilestones%2520in%2520Drug%2520Therapy%26pub%3DSpringer%2520Birkhauser%26date%3D2010%26spage%3D133%26epage%3D156" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Liechti, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lhuillier, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaupmann, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markou, A.</span><span> </span><span class="NLM_article-title">Metabotropic glutamate 2/3 receptors in the ventral tegmental area and the nucleus accumbens shell are involved in behaviors relating to nicotine dependence</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">9077</span><span class="NLM_x">–</span> <span class="NLM_lpage">9085</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm3005306&amp;key=10.1523%2FJNEUROSCI.1766-07.2007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm3005306&amp;key=17715344" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm3005306&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVSnsLnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2007&pages=9077-9085&author=M.+E.+Liechtiauthor=L.+Lhuillierauthor=K.+Kaupmannauthor=A.+Markou&title=Metabotropic+glutamate+2%2F3+receptors+in+the+ventral+tegmental+area+and+the+nucleus+accumbens+shell+are+involved+in+behaviors+relating+to+nicotine+dependence"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Metabotropic glutamate 2/3 receptors in the ventral tegmental area and the nucleus accumbens shell are involved in behaviors relating to nicotine dependence</span></div><div class="casAuthors">Liechti, Matthias E.; Lhuillier, Loic; Kaupmann, Klemens; Markou, Athina</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">34</span>),
    <span class="NLM_cas:pages">9077-9085</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">The motivation to maintain nicotine self-administration and dependence may involve alterations in glutamatergic neurotransmission.  Metabotropic glutamate (mGlu) 2/3 receptors regulate glutamate and dopamine release in the ventral tegmental area (VTA) and the nucleus accumbens (NAc) shell, two brain areas critically involved in reward and motivational processes.  We found that acute systemic, as well as intra-VTA or intra-NAc, administration of the mGlu2/3 receptor agonist LY379268 [(-)-2-oxa-4-aminobicyclo[3.1.0]hexane-4,6-dicarboxylate] decreased nicotine, but not food, self-administration in rats.  In addn., nicotine self-administration downregulated mGlu2/3 receptor function in corticolimbic rat brain sites including the VTA and the NAc, demonstrated by decreased coupling of mGlu2/3 receptor to G-proteins in the [35S]GTPγS binding assay.  Furthermore, repeated treatment with LY379268 reduced nicotine self-administration at the beginning of a 14 d treatment period; however, the no. of nicotine infusions earned gradually returned to baseline levels, indicating tolerance to the effects of repeated LY379268 treatment.  Finally, LY379268 administration decreased both cue-induced reinstatement of nicotine- and food-seeking behavior.  Together, these findings indicate an important role for mGlu2/3 receptors in the posterior VTA and the NAc shell in the mediation of the rewarding effects of nicotine and potentially in cue-induced nicotine-seeking behavior.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQ7-uDyGc0jrVg90H21EOLACvtfcHk0lg_ML5rq1R8fA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVSnsLnL&md5=73e420d3b66d2a6941302717dce4d988</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.1766-07.2007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.1766-07.2007%26sid%3Dliteratum%253Aachs%26aulast%3DLiechti%26aufirst%3DM.%2BE.%26aulast%3DLhuillier%26aufirst%3DL.%26aulast%3DKaupmann%26aufirst%3DK.%26aulast%3DMarkou%26aufirst%3DA.%26atitle%3DMetabotropic%2520glutamate%25202%252F3%2520receptors%2520in%2520the%2520ventral%2520tegmental%2520area%2520and%2520the%2520nucleus%2520accumbens%2520shell%2520are%2520involved%2520in%2520behaviors%2520relating%2520to%2520nicotine%2520dependence%26jtitle%3DJ.%2520Neurosci.%26date%3D2007%26volume%3D27%26spage%3D9077%26epage%3D9085" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Conn, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pin, J. P.</span><span> </span><span class="NLM_article-title">Pharmacology and functions of metabotropic glutamate receptors</span> <span class="citation_source-journal">Annu. Rev. Pharmacol. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">205</span><span class="NLM_x">–</span> <span class="NLM_lpage">237</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm3005306&amp;key=10.1146%2Fannurev.pharmtox.37.1.205" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm3005306&amp;key=9131252" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm3005306&amp;key=1%3ACAS%3A528%3ADyaK2sXisl2ktr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1997&pages=205-237&author=P.+J.+Connauthor=J.+P.+Pin&title=Pharmacology+and+functions+of+metabotropic+glutamate+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacology and functions of metabotropic glutamate receptors</span></div><div class="casAuthors">Conn, P. Jeffrey; Pin, Jean-Philippe</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Pharmacology and Toxicology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">205-237</span>CODEN:
                <span class="NLM_cas:coden">ARPTDI</span>;
        ISSN:<span class="NLM_cas:issn">0362-1642</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews</span>)
        </div><div class="casAbstract">A review, with 198 refs.  In the mid to late 1980s, studies were published that provided the first evidence for the existence of glutamate receptors that are not ligand-gated cation channels but are coupled to effector systems through GTP-binding proteins.  Since those initial reports, tremendous progress has been made in characterizing these metabotropic glutamate receptors (mGluRs), including cloning and characterization of cDNA that encodes a family of eight mGluR subtypes, several of which have multiple splice variants.  Also, tremendous progress has been made in developing new highly selective mGluR agonists and antagonists and toward detg. the physiol. roles of the mGluRs in mammalian brain.  These findings have exciting implications for drug development and suggest that the mGluRs provide a novel target for development of therapeutic agents that could have a significant impact on neuropharmacol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGph1fuaHYNvC7Vg90H21EOLACvtfcHk0lj19j9c0C-33w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXisl2ktr0%253D&md5=d9df228141c4747f80bbd9d2f0843a24</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1146%2Fannurev.pharmtox.37.1.205&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.pharmtox.37.1.205%26sid%3Dliteratum%253Aachs%26aulast%3DConn%26aufirst%3DP.%2BJ.%26aulast%3DPin%26aufirst%3DJ.%2BP.%26atitle%3DPharmacology%2520and%2520functions%2520of%2520metabotropic%2520glutamate%2520receptors%26jtitle%3DAnnu.%2520Rev.%2520Pharmacol.%2520Toxicol.%26date%3D1997%26volume%3D37%26spage%3D205%26epage%3D237" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Sheffler, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinkerton, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dahl, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markou, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cosford, N. D. P.</span><span> </span><span class="NLM_article-title">Recent progress in the synthesis and characterization of group II metabotropic glutamate receptor allosteric modulators</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">382</span><span class="NLM_x">–</span> <span class="NLM_lpage">393</span></span><div class="citationLinks">[<a href="/doi/10.1021/cn200008d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm3005306&amp;key=1%3ACAS%3A528%3ADC%252BC3MXksFaqtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=382-393&author=D.+J.+Shefflerauthor=A.+B.+Pinkertonauthor=R.+Dahlauthor=A.+Markouauthor=N.+D.+P.+Cosford&title=Recent+progress+in+the+synthesis+and+characterization+of+group+II+metabotropic+glutamate+receptor+allosteric+modulators"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Recent Progress in the Synthesis and Characterization of Group II Metabotropic Glutamate Receptor Allosteric Modulators</span></div><div class="casAuthors">Sheffler, Douglas J.; Pinkerton, Anthony B.; Dahl, Russell; Markou, Athina; Cosford, Nicholas D. P.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">382-393</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Group II metabotropic glutamate (mGlu) receptors consist of the metabotropic glutamate 2 (mGlu2) and metabotropic glutamate 3 (mGlu3) receptor subtypes which modulate glutamate transmission by second messenger activation to neg. regulate the activity of adenylyl cyclase.  Excessive accumulation of glutamate in the perisynaptic extracellular region triggers mGlu2 and mGlu3 receptors to inhibit further release of glutamate.  There is growing evidence that the modulation of glutamatergic neurotransmission by small mol. modulators of Group II mGlu receptors has significant potential for the treatment of several neuropsychiatric and neurodegenerative diseases.  This review provides an overview of recent progress on the synthesis and pharmacol. characterization of pos. and neg. allosteric modulators of the Group II mGlu receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpN3kTaVydOYbVg90H21EOLACvtfcHk0lj19j9c0C-33w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXksFaqtbg%253D&md5=98860a15e30c38b831332dcc82425f14</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fcn200008d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn200008d%26sid%3Dliteratum%253Aachs%26aulast%3DSheffler%26aufirst%3DD.%2BJ.%26aulast%3DPinkerton%26aufirst%3DA.%2BB.%26aulast%3DDahl%26aufirst%3DR.%26aulast%3DMarkou%26aufirst%3DA.%26aulast%3DCosford%26aufirst%3DN.%2BD.%2BP.%26atitle%3DRecent%2520progress%2520in%2520the%2520synthesis%2520and%2520characterization%2520of%2520group%2520II%2520metabotropic%2520glutamate%2520receptor%2520allosteric%2520modulators%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2011%26volume%3D2%26spage%3D382%26epage%3D393" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Fell, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witkin, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falcone, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katner, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perry, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hart, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rorick-Kehn, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Overshiner, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rasmussen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaney, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benvenga, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marlow, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luecke, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wafford, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seidel, W. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edgar, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quets, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felder, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heinz, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nikolayev, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, M.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayhugh, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khilevich, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ebert, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eckstein, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ackermann, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swanson, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catlow, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dean, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tauscher-Wisniewski, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marek, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schkeryantz, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svensson, K. A.</span><span> </span><span class="NLM_article-title">N-(4-((2-(Trifluoromethyl)-3-hydroxy-4-(isobutyryl)phenoxy) methyl)benzyl)-1-methyl-1H-imidazole-4-carboxamide (THIIC), a novel metabotropic glutamate 2 potentiator with potential anxiolytic/antidepressant properties: in vivo profiling suggests a link between behavioral and central nervous system neurochemical changes</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">336</span><span class="NLM_x">, </span> <span class="NLM_fpage">165</span><span class="NLM_x">–</span> <span class="NLM_lpage">177</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm3005306&amp;key=10.1124%2Fjpet.110.172957" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm3005306&amp;key=20947638" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm3005306&amp;key=1%3ACAS%3A528%3ADC%252BC3MXls1erug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=336&publication_year=2011&pages=165-177&author=M.+J.+Fellauthor=J.+M.+Witkinauthor=J.+F.+Falconeauthor=J.+S.+Katnerauthor=K.+W.+Perryauthor=J.+Hartauthor=L.+Rorick-Kehnauthor=C.+D.+Overshinerauthor=K.+Rasmussenauthor=S.+F.+Chaneyauthor=M.+J.+Benvengaauthor=X.+Liauthor=D.+L.+Marlowauthor=L.+K.+Thompsonauthor=S.+K.+Lueckeauthor=K.+A.+Waffordauthor=W.+F.+Seidelauthor=D.+M.+Edgarauthor=A.+T.+Quetsauthor=C.+C.+Felderauthor=X.+Wangauthor=B.+A.+Heinzauthor=A.+Nikolayevauthor=M.-S.+Kuoauthor=D.+Mayhughauthor=A.+Khilevichauthor=D.+Zhangauthor=P.+J.+Ebertauthor=J.+A.+Ecksteinauthor=B.+L.+Ackermannauthor=S.+P.+Swansonauthor=J.+T.+Catlowauthor=R.+A.+Deanauthor=K.+Jacksonauthor=S.+Tauscher-Wisniewskiauthor=G.+J.+Marekauthor=J.+M.+Schkeryantzauthor=K.+A.+Svensson&title=N-%284-%28%282-%28Trifluoromethyl%29-3-hydroxy-4-%28isobutyryl%29phenoxy%29+methyl%29benzyl%29-1-methyl-1H-imidazole-4-carboxamide+%28THIIC%29%2C+a+novel+metabotropic+glutamate+2+potentiator+with+potential+anxiolytic%2Fantidepressant+properties%3A+in+vivo+profiling+suggests+a+link+between+behavioral+and+central+nervous+system+neurochemical+changes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">N-(4-((2-(trifluoromethyl)-3-hydroxy-4-(isobutyryl)phenoxy)methyl)benzyl)-1-methyl-1H-imidazole-4-carboxamide (THIIC), a novel metabotropic glutamate 2 potentiator with potential anxiolytic/antidepressant properties: in vivo profiling suggests a link between behavioral and central nervous system neurochemical changes</span></div><div class="casAuthors">Fell, Matthew J.; Witkin, Jeffrey M.; Falcone, Julie F.; Katner, Jason S.; Perry, Kenneth W.; Hart, John; Rorick-Kehn, Linda; Overshiner, Carl D.; Rasmussen, Kurt; Chaney, Stephen F.; Benvenga, Mark J.; Li, Xia; Marlow, Deanna L.; Thompson, Linda K.; Luecke, Susan K.; Wafford, Keith A.; Seidel, Wesley F.; Edgar, Dale M.; Quets, Anne T.; Felder, Christian C.; Wang, XuShan; Heinz, Beverly A.; Nikolayev, Alexander; Kuo, Ming-Shang; Mayhugh, Daniel; Khilevich, Albert; Zhang, Deyi; Ebert, Philip J.; Eckstein, James A.; Ackermann, Bradley L.; Swanson, Steven P.; Catlow, John T.; Dean, Robert A.; Jackson, Kimberley; Tauscher-Wisniewski, Sitra; Marek, Gerard J.; Schkeryantz, Jeffrey M.; Svensson, Kjell A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">336</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">165-177</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The normalization of excessive glutamatergic neurotransmission through the activation of metabotropic glutamate 2 (mGlu2) receptors may have therapeutic potential in a variety of psychiatric disorders, including anxiety/depression and schizophrenia.  Here, we characterize the pharmacol. properties of N-(4-((2-(trifluoromethyl)-3-hydroxy-4-(isobutyryl)phenoxy)methyl)benzyl)-1-methyl-1H-imidazole-4-carboxamide (THIIC), a structurally novel, potent, and selective allosteric potentiator of human and rat mGlu2 receptors (EC50 = 23 and 13 nM, resp.).  THIIC produced anxiolytic-like efficacy in the rat stress-induced hyperthermia assay and the mouse stress-induced elevation of cerebellar cGMP and marble-burying assays.  THIIC also produced robust activity in three assays that detect antidepressant-like activity, including the mouse forced-swim test, the rat differential reinforcement of low rate 72-s assay, and the rat dominant-submissive test, with a maximal response similar to that of impiramine.  Effects of THIIC in the forced-swim test and marble burying were deleted in mGlu2 receptor null mice.  Anal. of sleep EEG showed that THIIC had a sleep-promoting profile with increased non-rapid eye movement (REM) and decreased REM sleep.  THIIC also decreased the dark phase increase in extracellular histamine in the medial prefrontal cortex and decreased levels of the histamine metabolite tele-methylhistamine (t-MeHA) in rat cerebrospinal fluid.  Collectively, these results indicate that the novel mGlu2-pos. allosteric modulator THIIC has robust activity in models used to predict anxiolytic/antidepressant efficacy, substantiating, at least with this mol., differentiation in the biol. impact of mGlu2 potentiation vs. mGlu2/3 orthosteric agonism.  In addn., we provide evidence that sleep EEG and CSF t-MeHA might function as viable biomarker approaches to facilitate the translational development of THIIC and other mGlu2 potentiators.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocfm6DC8ijJrVg90H21EOLACvtfcHk0lj19j9c0C-33w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXls1erug%253D%253D&md5=ab138f946460f041067c5330a1b5217a</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1124%2Fjpet.110.172957&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.110.172957%26sid%3Dliteratum%253Aachs%26aulast%3DFell%26aufirst%3DM.%2BJ.%26aulast%3DWitkin%26aufirst%3DJ.%2BM.%26aulast%3DFalcone%26aufirst%3DJ.%2BF.%26aulast%3DKatner%26aufirst%3DJ.%2BS.%26aulast%3DPerry%26aufirst%3DK.%2BW.%26aulast%3DHart%26aufirst%3DJ.%26aulast%3DRorick-Kehn%26aufirst%3DL.%26aulast%3DOvershiner%26aufirst%3DC.%2BD.%26aulast%3DRasmussen%26aufirst%3DK.%26aulast%3DChaney%26aufirst%3DS.%2BF.%26aulast%3DBenvenga%26aufirst%3DM.%2BJ.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DMarlow%26aufirst%3DD.%2BL.%26aulast%3DThompson%26aufirst%3DL.%2BK.%26aulast%3DLuecke%26aufirst%3DS.%2BK.%26aulast%3DWafford%26aufirst%3DK.%2BA.%26aulast%3DSeidel%26aufirst%3DW.%2BF.%26aulast%3DEdgar%26aufirst%3DD.%2BM.%26aulast%3DQuets%26aufirst%3DA.%2BT.%26aulast%3DFelder%26aufirst%3DC.%2BC.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DHeinz%26aufirst%3DB.%2BA.%26aulast%3DNikolayev%26aufirst%3DA.%26aulast%3DKuo%26aufirst%3DM.-S.%26aulast%3DMayhugh%26aufirst%3DD.%26aulast%3DKhilevich%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DD.%26aulast%3DEbert%26aufirst%3DP.%2BJ.%26aulast%3DEckstein%26aufirst%3DJ.%2BA.%26aulast%3DAckermann%26aufirst%3DB.%2BL.%26aulast%3DSwanson%26aufirst%3DS.%2BP.%26aulast%3DCatlow%26aufirst%3DJ.%2BT.%26aulast%3DDean%26aufirst%3DR.%2BA.%26aulast%3DJackson%26aufirst%3DK.%26aulast%3DTauscher-Wisniewski%26aufirst%3DS.%26aulast%3DMarek%26aufirst%3DG.%2BJ.%26aulast%3DSchkeryantz%26aufirst%3DJ.%2BM.%26aulast%3DSvensson%26aufirst%3DK.%2BA.%26atitle%3DN-%25284-%2528%25282-%2528Trifluoromethyl%2529-3-hydroxy-4-%2528isobutyryl%2529phenoxy%2529%2520methyl%2529benzyl%2529-1-methyl-1H-imidazole-4-carboxamide%2520%2528THIIC%2529%252C%2520a%2520novel%2520metabotropic%2520glutamate%25202%2520potentiator%2520with%2520potential%2520anxiolytic%252Fantidepressant%2520properties%253A%2520in%2520vivo%2520profiling%2520suggests%2520a%2520link%2520between%2520behavioral%2520and%2520central%2520nervous%2520system%2520neurochemical%2520changes%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2011%26volume%3D336%26spage%3D165%26epage%3D177" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Garbaccio, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brnardic, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fraley, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartman, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutson, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magliaro, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uslaner, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huszar, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fillgrove, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Small, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, M. A.</span><span> </span><span class="NLM_article-title">Discovery of oxazolobenzimidazoles as positive allosteric modulators for the mGluR2 receptor</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">406</span><span class="NLM_x">–</span> <span class="NLM_lpage">410</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml100115a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=406-410&author=R.+M.+Garbaccioauthor=E.+J.+Brnardicauthor=M.+E.+Fraleyauthor=G.+D.+Hartmanauthor=P.+H.+Hutsonauthor=J.+A.+O%E2%80%99Brienauthor=B.+C.+Magliaroauthor=J.+M.+Uslanerauthor=S.+L.+Huszarauthor=K.+L.+Fillgroveauthor=J.+H.+Smallauthor=C.+Tangauthor=Y.+Kuoauthor=M.+A.+Jacobson&title=Discovery+of+oxazolobenzimidazoles+as+positive+allosteric+modulators+for+the+mGluR2+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fml100115a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml100115a%26sid%3Dliteratum%253Aachs%26aulast%3DGarbaccio%26aufirst%3DR.%2BM.%26aulast%3DBrnardic%26aufirst%3DE.%2BJ.%26aulast%3DFraley%26aufirst%3DM.%2BE.%26aulast%3DHartman%26aufirst%3DG.%2BD.%26aulast%3DHutson%26aufirst%3DP.%2BH.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DJ.%2BA.%26aulast%3DMagliaro%26aufirst%3DB.%2BC.%26aulast%3DUslaner%26aufirst%3DJ.%2BM.%26aulast%3DHuszar%26aufirst%3DS.%2BL.%26aulast%3DFillgrove%26aufirst%3DK.%2BL.%26aulast%3DSmall%26aufirst%3DJ.%2BH.%26aulast%3DTang%26aufirst%3DC.%26aulast%3DKuo%26aufirst%3DY.%26aulast%3DJacobson%26aufirst%3DM.%2BA.%26atitle%3DDiscovery%2520of%2520oxazolobenzimidazoles%2520as%2520positive%2520allosteric%2520modulators%2520for%2520the%2520mGluR2%2520receptor%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D1%26spage%3D406%26epage%3D410" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brodney, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Candler, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doran, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duplantier, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Efremov, I. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evrard, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kraus, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganong, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haas, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanks, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenza, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lazzaro, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maklad, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarthy, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, B. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rottas, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siuciak, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tingley, F. D.,  III</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, A. Q.</span><span> </span><span class="NLM_article-title">1-[(1-Methyl-1<i>H</i>-imidazol-2-yl)methyl]-4-phenylpiperidines as mGluR2 positive allosteric modulators for the treatment of psychosis</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">1724</span><span class="NLM_x">–</span> <span class="NLM_lpage">1739</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm101414h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=1724-1739&author=L.+Zhangauthor=M.+A.+Brodneyauthor=J.+Candlerauthor=A.+C.+Doranauthor=A.+J.+Duplantierauthor=I.+V.+Efremovauthor=E.+Evrardauthor=K.+Krausauthor=A.+H.+Ganongauthor=J.+A.+Haasauthor=A.+N.+Hanksauthor=K.+Jenzaauthor=J.+T.+Lazzaroauthor=N.+Makladauthor=S.+A.+McCarthyauthor=W.+Qianauthor=B.+N.+Rogersauthor=M.+D.+Rottasauthor=C.+J.+Schmidtauthor=J.+A.+Siuciakauthor=F.+D.+Tingleyauthor=A.+Q.+Zhang&title=1-%5B%281-Methyl-1H-imidazol-2-yl%29methyl%5D-4-phenylpiperidines+as+mGluR2+positive+allosteric+modulators+for+the+treatment+of+psychosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm101414h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101414h%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DBrodney%26aufirst%3DM.%2BA.%26aulast%3DCandler%26aufirst%3DJ.%26aulast%3DDoran%26aufirst%3DA.%2BC.%26aulast%3DDuplantier%26aufirst%3DA.%2BJ.%26aulast%3DEfremov%26aufirst%3DI.%2BV.%26aulast%3DEvrard%26aufirst%3DE.%26aulast%3DKraus%26aufirst%3DK.%26aulast%3DGanong%26aufirst%3DA.%2BH.%26aulast%3DHaas%26aufirst%3DJ.%2BA.%26aulast%3DHanks%26aufirst%3DA.%2BN.%26aulast%3DJenza%26aufirst%3DK.%26aulast%3DLazzaro%26aufirst%3DJ.%2BT.%26aulast%3DMaklad%26aufirst%3DN.%26aulast%3DMcCarthy%26aufirst%3DS.%2BA.%26aulast%3DQian%26aufirst%3DW.%26aulast%3DRogers%26aufirst%3DB.%2BN.%26aulast%3DRottas%26aufirst%3DM.%2BD.%26aulast%3DSchmidt%26aufirst%3DC.%2BJ.%26aulast%3DSiuciak%26aufirst%3DJ.%2BA.%26aulast%3DTingley%26aufirst%3DF.%2BD.%26aulast%3DZhang%26aufirst%3DA.%2BQ.%26atitle%3D1-%255B%25281-Methyl-1H-imidazol-2-yl%2529methyl%255D-4-phenylpiperidines%2520as%2520mGluR2%2520positive%2520allosteric%2520modulators%2520for%2520the%2520treatment%2520of%2520psychosis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D1724%26epage%3D1739" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Cid, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duvey, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tresadern, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nhem, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furnari, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cluzeau, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Lucas, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matesanz, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alonso, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linares, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrés, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poli, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vega, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lutjens, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Himogai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rocher, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macdonald, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oehlrich, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavreysen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahnaou, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drinkenburg, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackie, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trabanco, A. A.</span><span> </span><span class="NLM_article-title">Discovery of 1,4-disubstituted 3-cyano-2-pyridones: A new class of positive allosteric modulators of the metabotropic glutamate 2 receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">2388</span><span class="NLM_x">–</span> <span class="NLM_lpage">2405</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm2016864" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=2388-2405&author=J.+M.+Cidauthor=G.+Duveyauthor=G.+Tresadernauthor=V.+Nhemauthor=R.+Furnariauthor=P.+Cluzeauauthor=A.+I.+de+Lucasauthor=E.+Matesanzauthor=J.+M.+Alonsoauthor=M.+L.+Linaresauthor=J.+I.+Andr%C3%A9sauthor=S.+M.+Poliauthor=J.+A.+Vegaauthor=R.+Lutjensauthor=H.+Himogaiauthor=J.-P.+Rocherauthor=G.+J.+Macdonaldauthor=D.+Oehlrichauthor=H.+Lavreysenauthor=A.+Ahnaouauthor=W.+Drinkenburgauthor=C.+Mackieauthor=A.+A.+Trabanco&title=Discovery+of+1%2C4-disubstituted+3-cyano-2-pyridones%3A+A+new+class+of+positive+allosteric+modulators+of+the+metabotropic+glutamate+2+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm2016864&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2016864%26sid%3Dliteratum%253Aachs%26aulast%3DCid%26aufirst%3DJ.%2BM.%26aulast%3DDuvey%26aufirst%3DG.%26aulast%3DTresadern%26aufirst%3DG.%26aulast%3DNhem%26aufirst%3DV.%26aulast%3DFurnari%26aufirst%3DR.%26aulast%3DCluzeau%26aufirst%3DP.%26aulast%3Dde%2BLucas%26aufirst%3DA.%2BI.%26aulast%3DMatesanz%26aufirst%3DE.%26aulast%3DAlonso%26aufirst%3DJ.%2BM.%26aulast%3DLinares%26aufirst%3DM.%2BL.%26aulast%3DAndr%25C3%25A9s%26aufirst%3DJ.%2BI.%26aulast%3DPoli%26aufirst%3DS.%2BM.%26aulast%3DVega%26aufirst%3DJ.%2BA.%26aulast%3DLutjens%26aufirst%3DR.%26aulast%3DHimogai%26aufirst%3DH.%26aulast%3DRocher%26aufirst%3DJ.-P.%26aulast%3DMacdonald%26aufirst%3DG.%2BJ.%26aulast%3DOehlrich%26aufirst%3DD.%26aulast%3DLavreysen%26aufirst%3DH.%26aulast%3DAhnaou%26aufirst%3DA.%26aulast%3DDrinkenburg%26aufirst%3DW.%26aulast%3DMackie%26aufirst%3DC.%26aulast%3DTrabanco%26aufirst%3DA.%2BA.%26atitle%3DDiscovery%2520of%25201%252C4-disubstituted%25203-cyano-2-pyridones%253A%2520A%2520new%2520class%2520of%2520positive%2520allosteric%2520modulators%2520of%2520the%2520metabotropic%2520glutamate%25202%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D2388%26epage%3D2405" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Trabanco, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tresadern, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macdonald, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vega, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Lucas, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matesanz, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">García, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linares, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Diego, S. A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alonso, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oehlrich, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahnaou, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drinkenburg, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackie, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrés, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavreysen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cid, J. M.</span><span> </span><span class="NLM_article-title">Imidazo[1,2-<i>a</i>]pyridines: Orally active positive allosteric modulators of the metabotropic glutamate 2 receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">2688</span><span class="NLM_x">–</span> <span class="NLM_lpage">2701</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm201561r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=2688-2701&author=A.+A.+Trabancoauthor=G.+Tresadernauthor=G.+J.+Macdonaldauthor=J.+A.+Vegaauthor=A.+I.+de+Lucasauthor=E.+Matesanzauthor=A.+Garc%C3%ADaauthor=M.+L.+Linaresauthor=S.+A.+A.+de+Diegoauthor=J.+M.+Alonsoauthor=D.+Oehlrichauthor=A.+Ahnaouauthor=W.+Drinkenburgauthor=C.+Mackieauthor=J.+I.+Andr%C3%A9sauthor=H.+Lavreysenauthor=J.+M.+Cid&title=Imidazo%5B1%2C2-a%5Dpyridines%3A+Orally+active+positive+allosteric+modulators+of+the+metabotropic+glutamate+2+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm201561r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201561r%26sid%3Dliteratum%253Aachs%26aulast%3DTrabanco%26aufirst%3DA.%2BA.%26aulast%3DTresadern%26aufirst%3DG.%26aulast%3DMacdonald%26aufirst%3DG.%2BJ.%26aulast%3DVega%26aufirst%3DJ.%2BA.%26aulast%3Dde%2BLucas%26aufirst%3DA.%2BI.%26aulast%3DMatesanz%26aufirst%3DE.%26aulast%3DGarc%25C3%25ADa%26aufirst%3DA.%26aulast%3DLinares%26aufirst%3DM.%2BL.%26aulast%3Dde%2BDiego%26aufirst%3DS.%2BA.%2BA.%26aulast%3DAlonso%26aufirst%3DJ.%2BM.%26aulast%3DOehlrich%26aufirst%3DD.%26aulast%3DAhnaou%26aufirst%3DA.%26aulast%3DDrinkenburg%26aufirst%3DW.%26aulast%3DMackie%26aufirst%3DC.%26aulast%3DAndr%25C3%25A9s%26aufirst%3DJ.%2BI.%26aulast%3DLavreysen%26aufirst%3DH.%26aulast%3DCid%26aufirst%3DJ.%2BM.%26atitle%3DImidazo%255B1%252C2-a%255Dpyridines%253A%2520Orally%2520active%2520positive%2520allosteric%2520modulators%2520of%2520the%2520metabotropic%2520glutamate%25202%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D2688%26epage%3D2701" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Dhanya, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sidique, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheffler, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nickols, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herath, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dahl, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ardecky, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Semenova, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markou, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cosford, N. D. P.</span><span> </span><span class="NLM_article-title">Design and synthesis of an orally active metabotropic glutamate receptor subtype-2 (mGluR2) positive allosteric modulator (PAM) that decreases cocaine self-administration in rats</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">342</span><span class="NLM_x">–</span> <span class="NLM_lpage">353</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm1012165" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm3005306&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFGlt7bO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=342-353&author=R.+Dhanyaauthor=S.+Sidiqueauthor=D.+J.+Shefflerauthor=H.+H.+Nickolsauthor=A.+Herathauthor=L.+Yangauthor=R.+Dahlauthor=R.+Ardeckyauthor=S.+Semenovaauthor=A.+Markouauthor=P.+J.+Connauthor=N.+D.+P.+Cosford&title=Design+and+synthesis+of+an+orally+active+metabotropic+glutamate+receptor+subtype-2+%28mGluR2%29+positive+allosteric+modulator+%28PAM%29+that+decreases+cocaine+self-administration+in+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Design and synthesis of an orally active metabotropic glutamate receptor subtype-2 (mGluR2) positive allosteric modulator (PAM) that decreases cocaine self-administration in rats</span></div><div class="casAuthors">Dhanya, Raveendra-Panickar; Sidique, Shyama; Sheffler, Douglas J.; Nickols, Hilary Highfield; Herath, Ananda; Yang, Li; Dahl, Russell; Ardecky, Robert; Semenova, Svetlana; Markou, Athina; Conn, P. Jeffrey; Cosford, Nicholas D. P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">342-353</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The modification of 3'-((2-cyclopentyl-6,7-dimethyl-1-oxo-2,3-dihydro-1H-inden-5-yloxy)methyl)biphenyl-4-carboxylic acid (BINA, I) by incorporating heteroatoms into the structure and replacing the cyclopentyl moiety led to the development of new mGluR2 pos. allosteric modulators (PAMs) with optimized potency and superior druglike properties.  These analogs are more potent than I in vitro and are highly selective for mGluR2 vs other mGluR subtypes.  They have significantly improved pharmacokinetic (PK) properties, with excellent oral bioavailability and brain penetration.  The benzisothiazol-3-one deriv. II decreased cocaine self-administration in rats, providing proof-of-concept for the use of mGluR2 PAMs for the treatment of cocaine dependence.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRmO8DAzKVg7Vg90H21EOLACvtfcHk0lgHZmNt2eGi3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFGlt7bO&md5=402c4f95aa11618fe07c8d146ffc2a8e</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjm1012165&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1012165%26sid%3Dliteratum%253Aachs%26aulast%3DDhanya%26aufirst%3DR.%26aulast%3DSidique%26aufirst%3DS.%26aulast%3DSheffler%26aufirst%3DD.%2BJ.%26aulast%3DNickols%26aufirst%3DH.%2BH.%26aulast%3DHerath%26aufirst%3DA.%26aulast%3DYang%26aufirst%3DL.%26aulast%3DDahl%26aufirst%3DR.%26aulast%3DArdecky%26aufirst%3DR.%26aulast%3DSemenova%26aufirst%3DS.%26aulast%3DMarkou%26aufirst%3DA.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26aulast%3DCosford%26aufirst%3DN.%2BD.%2BP.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520an%2520orally%2520active%2520metabotropic%2520glutamate%2520receptor%2520subtype-2%2520%2528mGluR2%2529%2520positive%2520allosteric%2520modulator%2520%2528PAM%2529%2520that%2520decreases%2520cocaine%2520self-administration%2520in%2520rats%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D342%26epage%3D353" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Jin, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Semenova, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ardecky, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheffler, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dahl, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cosford, N. D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markou, M.</span><span> </span><span class="NLM_article-title">The mGluR2 positive allosteric modulator BINA decreases cocaine self-administration, cue-induced cocaine-seeking and counteracts cocaine-induced enhancement of brain reward function in rats</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">2021</span><span class="NLM_x">–</span> <span class="NLM_lpage">2036</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2010&pages=2021-2036&author=X.+Jinauthor=S.+Semenovaauthor=L.+Yangauthor=A.+Ardeckyauthor=D.+J.+Shefflerauthor=R.+Dahlauthor=J.+P.+Connauthor=N.+D.+P.+Cosfordauthor=M.+Markou&title=The+mGluR2+positive+allosteric+modulator+BINA+decreases+cocaine+self-administration%2C+cue-induced+cocaine-seeking+and+counteracts+cocaine-induced+enhancement+of+brain+reward+function+in+rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJin%26aufirst%3DX.%26aulast%3DSemenova%26aufirst%3DS.%26aulast%3DYang%26aufirst%3DL.%26aulast%3DArdecky%26aufirst%3DA.%26aulast%3DSheffler%26aufirst%3DD.%2BJ.%26aulast%3DDahl%26aufirst%3DR.%26aulast%3DConn%26aufirst%3DJ.%2BP.%26aulast%3DCosford%26aufirst%3DN.%2BD.%2BP.%26aulast%3DMarkou%26aufirst%3DM.%26atitle%3DThe%2520mGluR2%2520positive%2520allosteric%2520modulator%2520BINA%2520decreases%2520cocaine%2520self-administration%252C%2520cue-induced%2520cocaine-seeking%2520and%2520counteracts%2520cocaine-induced%2520enhancement%2520of%2520brain%2520reward%2520function%2520in%2520rats%26jtitle%3DNeuropsychopharmacology%26date%3D2010%26volume%3D35%26spage%3D2021%26epage%3D2036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Van Wagenen, B.; Ukkiramapandian, R.; Clayton, J.; Egle, I.; Empfield, J.; Isaac, M.; Ma, F.; Slassi, A.; Steelman, G.; Urbanek, R.; Walsh, S.</span><span> </span><span class="NLM_article-title">Metabotropic glutamate receptor potentiating isoindolinones</span>. WO/2007/021308, Feb 22,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=B.+Van+Wagenen&author=R.+Ukkiramapandian&author=J.+Clayton&author=I.+Egle&author=J.+Empfield&author=M.+Isaac&author=F.+Ma&author=A.+Slassi&author=G.+Steelman&author=R.+Urbanek&author=S.+Walsh&title=Metabotropic+glutamate+receptor+potentiating+isoindolinones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BWagenen%26aufirst%3DB.%26atitle%3DMetabotropic%2520glutamate%2520receptor%2520potentiating%2520isoindolinones%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Niswender, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayala, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weaver, C. D.</span><span> </span><span class="NLM_article-title">A novel assay of Gi/o-linked G protein-coupled receptor coupling to potassium channels provides new insights into the pharmacology of the group III metabotropic glutamate receptors</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">1213</span><span class="NLM_x">–</span> <span class="NLM_lpage">1224</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2008&pages=1213-1224&author=C.+M.+Niswenderauthor=K.+A.+Johnsonauthor=Q.+Luoauthor=J.+E.+Ayalaauthor=C.+Kimauthor=P.+J.+Connauthor=C.+D.+Weaver&title=A+novel+assay+of+Gi%2Fo-linked+G+protein-coupled+receptor+coupling+to+potassium+channels+provides+new+insights+into+the+pharmacology+of+the+group+III+metabotropic+glutamate+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNiswender%26aufirst%3DC.%2BM.%26aulast%3DJohnson%26aufirst%3DK.%2BA.%26aulast%3DLuo%26aufirst%3DQ.%26aulast%3DAyala%26aufirst%3DJ.%2BE.%26aulast%3DKim%26aufirst%3DC.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26aulast%3DWeaver%26aufirst%3DC.%2BD.%26atitle%3DA%2520novel%2520assay%2520of%2520Gi%252Fo-linked%2520G%2520protein-coupled%2520receptor%2520coupling%2520to%2520potassium%2520channels%2520provides%2520new%2520insights%2520into%2520the%2520pharmacology%2520of%2520the%2520group%2520III%2520metabotropic%2520glutamate%2520receptors%26jtitle%3DMol.%2520Pharmacol.%26date%3D2008%26volume%3D73%26spage%3D1213%26epage%3D1224" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Di, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerns, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McConnell, O. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, G. T.</span><span> </span><span class="NLM_article-title">High throughput artificial membrane permeability assay for blood-brain barrier</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">223</span><span class="NLM_x">–</span> <span class="NLM_lpage">232</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm3005306&amp;key=10.1016%2FS0223-5234%2803%2900012-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm3005306&amp;key=12667689" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm3005306&amp;key=1%3ACAS%3A528%3ADC%252BD3sXitlKju7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2003&pages=223-232&author=L.+Diauthor=E.+H.+Kernsauthor=K.+Fanauthor=O.+J.+McConnellauthor=G.+T.+Carter&title=High+throughput+artificial+membrane+permeability+assay+for+blood-brain+barrier"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">High throughput artificial membrane permeability assay for blood-brain barrier</span></div><div class="casAuthors">Di, Li; Kerns, Edward H.; Fan, Kristi; McConnell, Oliver J.; Carter, Guy T.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">223-232</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Editions Scientifiques et Medicales Elsevier</span>)
        </div><div class="casAbstract">The recent advances in high throughput screening for biol. activities and combinatorial chem. have greatly expanded the no. of drug candidates.  Rapid screening for BBB penetration potential early in drug discovery programs provides important information for compd. selection and guidance of synthesis for desirable CNS properties.  In this paper, we discuss a modification of the parallel artificial membrane permeation assay (PAMPA) for the prediction of blood-brain barrier penetration (PAMPA-BBB).  The assay was developed with 30 structurally diverse com. drugs and validated with 14 Wyeth Research compds.  The PAMPA-BBB assay has the advantages of: predicting passive blood-brain barrier penetration with high success, high throughput, low cost, and reproducibility.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZCg9Ka4mziLVg90H21EOLACvtfcHk0lgHZmNt2eGi3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXitlKju7c%253D&md5=d228d5808ba8df23deed92c5e2bf3863</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2FS0223-5234%2803%2900012-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0223-5234%252803%252900012-6%26sid%3Dliteratum%253Aachs%26aulast%3DDi%26aufirst%3DL.%26aulast%3DKerns%26aufirst%3DE.%2BH.%26aulast%3DFan%26aufirst%3DK.%26aulast%3DMcConnell%26aufirst%3DO.%2BJ.%26aulast%3DCarter%26aufirst%3DG.%2BT.%26atitle%3DHigh%2520throughput%2520artificial%2520membrane%2520permeability%2520assay%2520for%2520blood-brain%2520barrier%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2003%26volume%3D38%26spage%3D223%26epage%3D232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Hemstapat, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Da Costa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nong, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brady, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niswender, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamagnan, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, P. J.</span><span> </span><span class="NLM_article-title">A novel family of potent negative allosteric modulators of group II metabotropic glutamate receptors</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">322</span><span class="NLM_x">, </span> <span class="NLM_fpage">254</span><span class="NLM_x">–</span> <span class="NLM_lpage">264</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm3005306&amp;key=10.1124%2Fjpet.106.117093" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm3005306&amp;key=17416742" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm3005306&amp;key=1%3ACAS%3A528%3ADC%252BD2sXntl2jtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=322&publication_year=2007&pages=254-264&author=K.+Hemstapatauthor=H.+Da+Costaauthor=Y.+Nongauthor=A.+E.+Bradyauthor=Q.+Luoauthor=C.+M.+Niswenderauthor=G.+D.+Tamagnanauthor=P.+J.+Conn&title=A+novel+family+of+potent+negative+allosteric+modulators+of+group+II+metabotropic+glutamate+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">A novel family of potent negative allosteric modulators of group II metabotropic glutamate receptors</span></div><div class="casAuthors">Hemstapat, Kamondanai; Da Costa, Herve; Nong, Yi; Brady, Ashley E.; Luo, Qingwei; Niswender, Colleen M.; Tamagnan, Gilles D.; Conn, P. Jeffrey</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">322</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">254-264</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Group II metabotropic glutamate receptors (mGluRs), mGluR2 and mGluR3, play a no. of important roles in mammalian brain and represent exciting new targets for certain central nervous system disorders.  We now report synthesis and characterization of a novel family of derivs. of dihydrobenzo[1,4]diazepin-2-one that are selective neg. allosteric modulators for group II mGluRs.  These compds. inhibit both mGluR2 and mGluR3 but have no activity at group I and III mGluRs.  The novel mGluR2/3 antagonists also potently block mGluR2/3-mediated inhibition of the field excitatory postsynaptic potentials at the perforant path synapse in hippocampal slices.  These compds. induce a rightward shift and decrease the maximal response in the glutamate concn.-response relation, consistent with a noncompetitive antagonist mechanism of action.  Furthermore, radioligand binding studies revealed no effect on binding of the orthosteric antagonist [3H]LY341495 [2S-2-amino-2-(1S,2S-2-carboxycyclopropan-1-yl)-3-(xanth-9-yl)propionic acid].  Site-directed mutagenesis revealed that a single point mutation in transmembrane V (N735D), previously shown to be an important residue for potentiation activity of the mGluR2 allosteric potentiator LY487379 [N-(4-(2-methoxyphenoxy)phenyl)-N-(2,2,2-trifluoroethylsulfonyl)pyrid-3-ylmethylamine], is not crit. for the inhibitory activity of neg. allosteric modulators of group II mGluRs.  However, this single mutation in human GluR2 almost completely blocked the enhancing activity of biphenyl-indanone A, a novel allosteric potentiator of mGluR2.  Our data suggest that these two pos. allosteric modulators of mGluR2 may share a common binding site and that this site may be distinct from the binding site for the new neg. allosteric modulators of group II mGluRs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqo14LJ7WYXzLVg90H21EOLACvtfcHk0lgHZmNt2eGi3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXntl2jtLw%253D&md5=f0bc1e67558e269bdd389a35b3acba75</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1124%2Fjpet.106.117093&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.106.117093%26sid%3Dliteratum%253Aachs%26aulast%3DHemstapat%26aufirst%3DK.%26aulast%3DDa%2BCosta%26aufirst%3DH.%26aulast%3DNong%26aufirst%3DY.%26aulast%3DBrady%26aufirst%3DA.%2BE.%26aulast%3DLuo%26aufirst%3DQ.%26aulast%3DNiswender%26aufirst%3DC.%2BM.%26aulast%3DTamagnan%26aufirst%3DG.%2BD.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26atitle%3DA%2520novel%2520family%2520of%2520potent%2520negative%2520allosteric%2520modulators%2520of%2520group%2520II%2520metabotropic%2520glutamate%2520receptors%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2007%26volume%3D322%26spage%3D254%26epage%3D264" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Engers, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niswender, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weaver, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jadhav, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menon, U. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zamorano, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hopkins, C. R.</span><span> </span><span class="NLM_article-title">Synthesis and evaluation of a series of heterobiaryl amides that are centrally penetrant metabotropic glutamate receptor 4 (mGluR4) positive allosteric modulators (PAMs)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">4115</span><span class="NLM_x">–</span> <span class="NLM_lpage">4118</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9005065" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=4115-4118&author=D.+W.+Engersauthor=C.+M.+Niswenderauthor=C.+D.+Weaverauthor=S.+Jadhavauthor=U.+N.+Menonauthor=R.+Zamoranoauthor=P.+J.+Connauthor=C.+W.+Lindsleyauthor=C.+R.+Hopkins&title=Synthesis+and+evaluation+of+a+series+of+heterobiaryl+amides+that+are+centrally+penetrant+metabotropic+glutamate+receptor+4+%28mGluR4%29+positive+allosteric+modulators+%28PAMs%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjm9005065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9005065%26sid%3Dliteratum%253Aachs%26aulast%3DEngers%26aufirst%3DD.%2BW.%26aulast%3DNiswender%26aufirst%3DC.%2BM.%26aulast%3DWeaver%26aufirst%3DC.%2BD.%26aulast%3DJadhav%26aufirst%3DS.%26aulast%3DMenon%26aufirst%3DU.%2BN.%26aulast%3DZamorano%26aufirst%3DR.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DHopkins%26aufirst%3DC.%2BR.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520a%2520series%2520of%2520heterobiaryl%2520amides%2520that%2520are%2520centrally%2520penetrant%2520metabotropic%2520glutamate%2520receptor%25204%2520%2528mGluR4%2529%2520positive%2520allosteric%2520modulators%2520%2528PAMs%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D4115%26epage%3D4118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm3005306&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2012.55.issue-22%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Barticle%3Aarticle%3A10.1021%2Fjm3005306%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm3005306" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                788KB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679943448dda2388","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
